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Many cellular functions depend on the tightly regulated expression of 
various proteins. Canonical control of the protein expression is associated 
with transcriptional regulation. However, the small non-coding RNAs 
called microRNAs (miRNAs) were identified as post-transcriptional 
regulators of gene expression. In a typical manner, miRNAs originate 
similarly to the coding RNAs and are processed in a multi-step maturation 
process. It has been shown that miRNAs are very important for the proper 
functioning of tissues. Interestingly, the human nervous system contains 
over 70% of all miRNAs; thus, the maturation process has to be tightly 
regulated. However, despite the important role of miRNAs, little is known 
about the mechanisms regulating their biogenesis. In my PhD project, I 
showed that during early stages of neuronal differentiation, Lin28a 
controls levels of neuro-specific miRNA-9. I demonstrated that Lin28a 
binds to the conserved terminal loop (CTL) of pre-miRNA-9 and decreases 
the cellular levels of miRNA-9 during retinoic acid-mediated neuronal 
differentiation of mouse teratocarcinoma P19 cells. I revealed that the 
Lin28a-mediated inhibition of miRNA-9 production was uridylation-
independent. Furthermore, constitutive expression of GFP-tagged Lin28a 
reduced the levels of let-7a but not miRNA-9, whereas untagged Lin28a 
inhibited both miR-9 and let-7a during the course of neuronal 
differentiation. Using small RNAseq analysis of P19 cells with constitutive 
expression of Lin28a I showed that it controls many more miRNAs than 
previously recognised. Intriguingly, many miRNAs were upregulated by 
Lin28a overexpression. I demonstrated with high-throughput, the limited 
function of GFP-tagged Lin28a results, and I also showed that untagged 
Lin28a inhibits the production of a number of brain-specific miRNAs 
including miRNA-9. Finally, I revealed that 3’-5’exoribonuclease Dis3l2 
was responsible for uridylation-independent degradation of pre-miRNA-
9. Altogether, my results provided evidence that Lin28a has both positive 
and negative roles in the regulation of miRNA production and has a dual 
role in triggering pre-miRNA degradation.  
 XIV 
Lay	  abstract	  
The human brain consists of millions of cells that have clearly stipulated 
roles in the proper functioning of the nervous system. A single cell can 
customise its own functions through proper regulation of the molecules 
that execute these functions. These molecules are called proteins and are 
encoded by genes during the process known as gene expression. In a 
canonical manner, this process can be controlled by factors that associate 
with the region of DNA containing the expressed gene. However, a new 
class of regulators called microRNAs (miRNAs) was recently identified to 
play an essential independent role in the regulation of gene expression. 
The importance of miRNAs has been shown in many studies displaying 
their defective function during disease development, including the 
progression of cancer. Interestingly, the nervous system, compared to all 
human tissues, harbours a major fraction of all miRNAs. These molecules 
are produced in cells during the biogenesis pathways that involve several 
steps in which a miRNA precursor is converted into mature miRNA. 
Despite the importance of miRNAs, little is known about the cellular 
mechanisms regulating their production. In my PhD project, I employed 
cutting-edge techniques to identify Lin28a (protein factor) as the regulator 
of miR-9 biogenesis (miRNA involved in the neuronal differentiation). 
Furthermore, I used genome-wide approaches to investigate the broad 
role of this regulator in miRNAs biogenesis during the neuronal 
development and identified large group of miRNA that levels are 
positively and negatively regulated by Lin28a.  I also investigated the 
molecular mechanism of this regulation and identified Dis3l2 as an 
enzyme involved in degradation of the miR-9 precursor during the early 
stages of neuronal development. In the future, the results obtained in this 
study can be used in biomedical applications where the induced 





3'-, 5'-UTR 3'-, 5'-Untranslated Region 
ADAR Adenosine Deaminase acting on RNA 
AGO Argonaute family proteins 
AMP Adenine Mono-Phosphate 
AMPAR 
ɑ-amino-3-hydroxy 5-methylisoxazole 4-propionic acid 
receptor 
APT1 Acyl protein thioesterase 1 
ASEL Amphid Neuron Single Left 
ASER Amphid Neuron Single Right 
ATP Adenine Tri-phosphate 
AVS Avian Sarcoma Virus 
BAF Brahma-associated factor 
BCDIN3D BCDIN3 Domain Containing 
BDNF Brain-derived neurotrophic factor 
BMP Bone Morphogenic Protein 
BrdU Bromodeoxyuridine  
C3PO Component 3 promoter of RISC 
CAF1-CCR-
NOT 
Carbon Catabolite Repressor 4 and Negative On TATA 
proteins 
CCHC Cys-Cys-His-Cys  
ChIP  Chromatin Immunoprecipitation 
CLIP-
RNAseq cross-linking immunoprecipitation RNA-sequencing 
CMV Cytomegalovirus 
CNS Central Nervous System 
COG-1 Connection Of Gonad defective 
CREB cAMP response element binding protein 
CSD Cold Shock Domain 
CTL Conserved terminal loop 
DCP2 Decapping Enzyme 2 
Dcr2  Dicer 2 
 XVI 
DGCR8 DiGeorge Syndrome Critical Region 8 
DGS DiGeorge Syndrome 
DHX9 DEAH (Asp-Glu-Ala-His) box helicase 9 
DIE-1 Dorsal Intercalation and Elongation defect 1 
Dis3l2 DIS3 Like 3'-5' Exoribonuclease 2 
DMEM Dulbecco's Modified Eagle Medium 
DN Dopamine Neurons 
Dox Doxocycline 
dsRBD double-stranded RNA binding domain 
EB Embryonic bodies 
EDTA Ethylenediaminetetraacetic acid 
EF Elongation Factor 
eIF4G eukaryotic translation-initiation factor 4G 
EMSA Electromobility Shift Assay 
ER Endoplasmic Reticulum 
ERK  Extracellular-signal Regulated Kinase 
EXOSC3 Exosome Component 3 
FMR1  Fragile X Mental Retardation 1 
FXS Fragile  X Syndrome 
GB Glioblastomas 
GFAP Glial fibrillary acidic protein 
GFP Green Fluorescent Protein 
Gld2 Germ line development 2 
GluRs Glutamate receptors 
gRNA guide RNA 
GSK3β Glycogen Synthase Kinase 3β 
GST Glutathione S-Transferase 
H2a, b, -3,  -
4 Histone 2a, 2b, -3, - 4 
HBD Haem binding domain 
HDAC Histone Deacetylase 
HEK293 Human Embryonic Kidney 293 cells 
HeLa Henrietta Lacks cells 
 XVII 
hnRNP-A1 Heterogeneous nuclear Ribonucleoprotein A1  
HRP-ab HRP-anti-mouse antibody 
IAA Iodoacetamide  
iDo-PAR-
CLIP individual domain PAR-CLIP 
IGF2 Insuling Growth Factor 2 
IgG ab anti-IgG antibody 
IL-6 Interleukin 6 
IMPs  IGF2 mRNA-binding Proteins 
IP Immunoprecipitaiton 
IRES Internal Ribosome Entry Site 
JNK c-JUN N-terminal Kinase 
KSRP Far upstream element-binding protein 2  
Limk1 LIM domain kinase 1 
Lin28 Cell Lineage Abnormal 28 
lncRNAs long non-coding RNAs 
LTD Long-term depression 
LTP Long-term potentiation  
MAPK Mitogen-Activated Protein Kinase 
MB Meduloblastomas 
MCPIP1 MCP-induced protein 1 
MCPIP1 Monocyte chemotactic protein-induced protein 1 
Me-CP2 Methyl-CpG binding protein 2 
MHB Midbrain-hindbrain boundary  
miRISC miRNA-mediated silencing complex 
miRNAs micro RNAs 
mRNA messenger RNA 
MS Mass spectrometry 
MWKO Molecular Weight Cut Off 
NaAc Sodium Acetate 
ncRNAs non-coding RNAs 
NLoS Nucleolar Localisation Signal 
NLS Nuclear Localisation Signal 
 XVIII 
NMDAR N-methy-D-aspartate receptor 
NMR Nuclear Magnetic Resonance 
NSRF Neuron-restrictive silencer factor 
Oct4 Octamer-binding Transcription factor 4 
PABP poly-A binding protein 
PAZ-
domain Piwi Argonaut and Zwille domain 
PDGF Platelet-derived Growth Factor 
PI3K-mTOR 
Phosphoinositide 3-kinase - mammalian Target of 
Rapamycin  
piRNAs piwi-interacting RNAs 
PNK T4 polynucleotide kinase 
PNPT1 PNPase-old-35 
PolII Polymerase II 
PTEN 
Phosphatase and tensin homologue deleted on 
chromosome 10 
PTM  Post-translational modification 
QC Quality Control 
qRT-PCR 
qunatitative Reverse Transcription - Polymerase Chain 
Reaction 
RA Retinoic Acid 
RBD RNA Binding Domain  
REST RE1-silencing transcription factor 
RIIIDs RNAse III domains 
RNAi RNA inhibition 
RT Room Tempreature 
SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis  
SILAC Stable isotope labelling by amino acids 
siRNAs small interfering RNAs 
SIRT1 Sirtuin1 
SMAD Sma and Mad Related Family 
snoRNAs small nucleolar RNAs 
 XIX 
SOD-1  Superoxide Dismutase 1 
SOP Sensory precursors 
TBS-T Tris-Buffered Saline and Tween 20 
Tet Tetracycline 
TFIIB Transcription Factor II B 
TGF-β Transforming Growth Factor β 
TH Tyrosine Hydroxylase 
TRBP TAR RNA-binding protein 
TRIM32 Tripartite motif-containing protein 32 
TSS Transcription Start Site 
Tuj1 β-tubulin class III 
TUT4 Terminal Uridylyltransferase 4 
UTP Uridine Tri-Phosphate 
VSNL1 Visinin like 1 
XRN1 5'-3' exoribonuclease 1 
Zcchc11 Zinc Finger CCHC Domain Containing Protein 11 




















1   Introduction	  
Animal development requires the existence of molecular and cellular 
mechanisms that organise cells within tissues and tissues within bodies. 
The essential objective of these mechanisms is to achieve the correct 
spatial-temporal expression of genes into proteins, which execute a variety 
of developmental programs. A key component of these mechanisms is 
RNA – a molecule involved in the transcription of genetic information. 
Importantly, RNA also plays an active role in the regulation of processes 
converting the genetic information into functional signals. Moreover, less 
than 2% of the transcribed genetic information is considered protein-
coding transcripts with the remainder classified as non-coding (Dunham 
et al., 2012). For many years, the majority of this non-coding information 
was considered as genetic “junk”. However, with time, there was more 
evidence suggesting its regulatory role in the flow of genetic information. 
Furthermore, protein-coding sequences in the genome have encountered 
very modest changes during evolution, whereas the non-coding part has 
been considerably scaled-up and diversified across various organism 
within prokaryotic and eukaryotic kingdoms (Liu et al., 2013). Therefore, 
it is tempting to hypothesise that the development of more complex 
cellular arrangements can be, at least partially, explained by evolution of 
the systems that increased the genetic complexity allowing better spatial 
and temporal control of existing cellular processes. Consequently, non-
coding RNAs (ncRNAs), which are transcribed from the non-coding part 
of the genome, could facilitate that role, as they include classes of 
genetically conserved regulatory elements. One possible classification of 
non-coding RNAs is based on their size. Small non-coding RNAs 
(sncRNAs) are evolutionary well-conserved short RNAs that include small 
nucleolar RNAs (snoRNAs), small interfering RNAs (siRNAs), micro 
RNAs (miRNAs), and piwi-interacting RNAs (piRNAs). They are usually 
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less than 200bp long and have evolved at different points during 
evolution, but their functions are well conserved. Both siRNAs and 
miRNAs play an inhibitory role in gene expression by directing repression 
of target mRNA (Bartel, 2009; Shabalina and Koonin, 2008). snoRNAs are 
the oldest form of ncRNA species and are present in Archaea, bacteria and 
eukaryotes. They are involved in chemical modifications, such as 
methylation and pseudouridylation, of other RNA molecules, including 
transfer and ribosomal RNAs (Matera et al., 2007).  
The other class of ncRNAs, containing transcripts larger then 200bp, is 
called long non-coding RNAs (lncRNAs). This group evolved much later 
and is present in invertebrates, vertebrates and plants (Pauli et al., 2012; 
Young et al., 2012; Zhang and Chen, 2013). Interestingly, approximately 
one-third of lncRNAs are primate-specific (Derrien et al., 2012). LncRNAs 
are currently extensively studied and, similarly to sncRNAs, have been 
shown to have important regulatory functions in the cell. The brain is one 
of the organs where their function is particularly visible. For example, 
Malat1 is an lncRNA that acts as a decoy for splicing factors in neuronal 
cells and has also been shown to be involved in synaptogenesis (Anko and 
Neugebauer, 2010; Bernard et al., 2010). 
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1.1   miRNA biogenesis and function in vertebrate systems 
Among the sncRNA families, miRNAs are considered to dominate in 
somatic tissues. The first miRNA was discovered in 1993 by Lee and 
colleagues. Using technique called chromosomal walking followed by 
transformation rescue they identified a genomic sequence called lin-4, 
which encoded trans-acting element responsible for regulation of protein 
Lin-14 – important for temporal control of postembryonic developmental 
events in C. elegans. Interestingly lin-4 genomic region were not considered 
protein coding but instead two small transcripts, originating from this 
locus, were found to complement with regions within the 3’-UTR of Lin-
14. Therefore, they suggested a mechanism of post-transcriptional control 
of Lin-14 driven by RNA-RNA interaction (Lee et al, 1993). Field of 
miRNA rapidly grow and their mechanisms were extensively studied. In 
2000 Pasquinelli and colleagues identified other miRNA called let-7 to be, 
together with lin-4, important for postembryonic developmental events in 
C. elegans – former governing transition from larvae to adult stage whereas 
later controlling transition events between larvae first and second stages. 
Importantly let-7 and its mechanism of action turned out to be highly 
conserved across animal kingdom including vertebrate, ascidian, 
hemichordate, mollusc, annelid and arthropod (Pasquinelli et al, 2000). 
In general miRNAs are ~22nt long RNA molecules that are produced in a 
multi-step fashion by the RNAse III class enzymes Drosha and Dicer, as 
shown in extensive biochemical studies using in vitro processing assays 
(Bartel, 2004; Carthew and Sontheimer, 2009; Hutvagner et al., 2001; Lee et 
al., 2003). Following Dicer cleavage, one strand of mature miRNA duplex, 
selected based on thermodynamic properties and called the guide strand, 
is loaded into the miRNA-mediated silencing complex (miRISC complex). 
This complex is responsible for recognition of a target mRNA that is 
achieved by seed sequence, a 6-8nt sequence within the first nucleotides 
counting from the 5’-end of mature miRNA (Bartel, 2009) (Figure 1-1).  
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Figure 1-1 Summary of miRNA biogenesis 
miRNAs are produced in the cell in a multi-step process. In the first step, pri-
miRNA is transcribed from the genome and subsequently processed by the 
Drosha/DGCR-8 complex – also known as the microprocessor complex. 
Following the microprocessor trimming, pre-miRNA is exported to the 
cytoplasm where it is cleaved by the Dicer complex into a mature miRNA 
duplex. Following unwinding, one strand is incorporated into the miRISC 
complex which executes miRNA function in mRNA destabilisation or the 
repression of protein translation. 
 
In principle, miRNAs are considered to serve as guides recognising target 
mRNAs and recruiting a complex of Argonaute family proteins (AGO) 
together with effectors that induce mRNA degradation or translational 
repression (Huntzinger and Izaurralde, 2011). Several studies have 
suggested that translational repression could occur at either the initiation 
or post-initiation steps of the translation (Humphreys et al., 2005; 
Mathonnet et al., 2007; Olsen and Ambros, 1999; Pillai et al., 2005; 
Seggerson et al., 2002; Thermann and Hentze, 2007). For instance, one of 
the first studies in C. elegans showed that lin-4 miRNA represses the 
translation of Lin-14 and Lin-28 mRNAs (Olsen and Ambros, 1999; 
Seggerson et al., 2002). Moreover, sucrose gradient revealed that both of 
the mRNAs associate with active polysomes (Maroney et al., 2006; 
Nottrott et al., 2006; Petersen et al., 2006). Treatment of these polysomes 
with various translational inhibitors results in their dissociation into 
monosomes (Maroney et al., 2006). Therefore, it has been concluded that 
molecular mechanisms of translational repression are caused by miRNA-
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driven dissociation of polysomes (Petersen et al., 2006). Furthermore, in 
another study, Petersen and colleagues showed that translational 
repression also occurs in cases where translation is initiated from an 
internal ribosome entry site (IRES), which is a 5’-cap-independent 
mechanism, providing additional proof for miRNA affecting the post-
initiation stages of translation (Petersen et al., 2006). 
Nevertheless, several studies have displayed conflicting results suggesting 
that translational repression occurs at the translational initiation stage 
(Humphreys et al., 2005; Mathonnet et al., 2007; Pillai et al., 2005; 
Thermann and Hentze, 2007). Pillali and colleagues showed that using 
sucrose gradient that the expression of certain miRNAs does not lead to 
accumulation of their targets in polysomes but instead results in the 
formation of lower molecular weight free messenger ribonucleoproteins 
(Pillai et al., 2005). Moreover, at least two studies reported in cells that 
IRES driven translation was resistant to the presence of miRNA 
(Humphreys et al., 2005; Pillai et al., 2005). This finding was confirmed in 
vitro using cell-free extracts where IRES-initiated translation was not 
inhibited in the presence of miRNAs (Mathonnet et al., 2007; Wakiyama et 
al., 2007). At the initiation stages, poly-A binding protein (PABP), which is 
associated with 3’-poly-A tail of mRNA, interacts with eukaryotic 
translation-initiation factor 4G (eIF4G) that is associated with 5’-cap 
structure of mRNA (Derry et al., 2006). Molecularly, it has been suggested 
that miRNAs act at the initiation stages by targeting the 5’-cap structure 
and subsequently interfering with eIF4G function (Ding and Grosshans, 
2009; Zdanowicz et al., 2009).  
Nevertheless, dozens of studies using specific miRNAs or transcriptome-
wide profiling showed that the expression of cognate miRNAs led to a 
reduction in their target mRNA levels (Bagga et al., 2005; Eulalio et al., 
2009; Guo et al., 2010; Hendrickson et al., 2009; Lim et al., 2005; Rehwinkel 
et al., 2006; Schmitter et al., 2006). In particular, ectopic expression of 
miRNAs in cells leads to decrease of the transcript levels containing their 
binding sites (Guo et al., 2010; Lim et al., 2005; Selbach et al., 2008). In 
contrast, depletion of miRNAs resulted in an increase of their mRNA 
targets (Baek et al., 2008; Krutzfeldt et al., 2005; Selbach et al., 2008). Also, 
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depletion of the components of miRNA biogenesis factors (Dicer, Ago, 
GW182) subsequently resulted in an overall increase of mRNA levels 
(Rehwinkel et al., 2005; Rehwinkel et al., 2006; Schmitter et al., 2006). 
Molecularly, it has been shown that miRNAs direct their targets to the 5’-
to-3’ mRNA decay pathway (Behm-Ansmant et al., 2006; Giraldez et al., 
2006; Piao et al., 2010; Rehwinkel et al., 2005; Wu and Belasco, 2005). In the 
first step of this pathway, targeted mRNA is deadenylated by the 
deadenylase complex composed of chromatin assembly factor 1, carbon 
catabolite repressor 4 and negative on TATA proteins (CAF1-CCR-NOT 
complex) (Behm-Ansmant et al., 2006; Piao et al., 2010). Subsequently, 
mRNA decapping enzyme 2 (DCP2) leads to the removal of a 5’-cap, 
which triggers major cytoplasmic 5’-3’ exoribonuclease 1 (XRN1) to 
degrade the miRNA target (Giraldez et al., 2006; Rehwinkel et al., 2005). 
Several studies have provided evidence that a depletion of either 
deadenylation or decapping pathway components led to an increase in the 
abundance of miRNA targets – providing evidence for miRNA-driven 
destabilisation of their mRNA targets (Behm-Ansmant et al., 2006; Eulalio 
et al., 2009; Eulalio et al., 2007).  
Moreover, studies measuring both mRNA and protein levels displayed 
that mRNA destabilisation is a major pathway of miRNA action and 
translation is only modestly inhibited, rarely exceeding four-fold 
reduction in protein synthesis (Baek et al., 2008; Selbach et al., 2008). In 
particular, measuring mRNA and protein levels in HEK-293 cells 
transfected with miR-124 showed that among 600 identified mRNA 
targets, a reduction in their protein levels is seen in 75% of cases for 
mRNA degradation (Hendrickson et al., 2009). Moreover, Bartel and 
colleagues also showed using high-resolution ribosome mapping that a 
decrease of steady-state mRNA levels could explain an 84% reduction in 
protein synthesis mediated my miRNAs (Guo et al., 2010). 
 
miRNAs are widely distributed across  species and account for one of the 
largest gene families in their genomes (Griffiths-Jones et al., 2008). 
Interestingly, through extensive research and abundant access to next-
generation genome wide sequencing data, new miRNAs are still being 
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discovered. For example, in humans alone, over 2000 new miRNAs have 
been described since 2010 (Ha and Kim, 2014; Krol et al., 2010b). 
Currently, 434 miRNAs in Caenorhabditis elegans, 466 miRNAs in Drosophila 
melanogaster and 2588 miRNAs in Homo sapiens have been deposited in 
miRBASe – a commonly used miRNA repository (Kozomara and Griffiths-
Jones, 2014). Comprehensive genomic research and sequencing proved 
that in many species, miRNAs of related sequences exist at multiple loci. 
This is most likely the result of gene duplication events (Berezikov, 2011; 
Hertel et al., 2006). If multiple genomic loci encode the same miRNAs, a 
numeric suffix is added at the end of the name; for instance, miR-124-1, 
miR-124-2, and miR-124-3 are the same miRNAs but located at different 
genomic locations. The most important domain responsible for its 
functional outcome is located at the 5’ end of the miRNA, between 
nucleotides 2-8, and is called the seed sequence. This sequence is essential 
for base pairing with the target mRNA. Moreover, miRNAs with the same 
seed sequence are classified as the same family (Bartel, 2009). For instance, 
using next-generation sequencing and bioinformatics, it has been shown 
that the let-7 family contains 14 paralogous miRNAs. Moreover, 34 
miRNA families are conserved from C. elegans to H. Sapiens and 196 
miRNA families are conserved among mammals only (Wheeler et al., 
2009).  
 
In addition, each miRNA locus can produce two mature miRNAs. For 
example, miR-29a-5p and miR-29a-3p are produced from the 5’ and 3’ 
ends, respectively, of precursor miR-29a. However, in many cases, only 
one miRNA (from the guide strand) is chosen for an executive AGO-
complex whereas the other (from the passenger strand) often undergoes 
degradation after the strands separate (Krol et al., 2010b).  
 
The abundance and spatiotemporal expression of miRNAs and their 
targets requires the existence of precise controlling events that can 
regulate the biogenesis of miRNAs. These events can be divided into 
transcriptional and post-transcriptional (Fig 1-2). 
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Figure 1-2 Summary of miRNA biogenesis regulation in the cell 
Production of miRNAs in the cell is regulated at the transcriptional and post-
transcriptional stages and involves a variety of auxiliary factors. 
The transcriptional stage of regulation involves mechanisms also regulating the 
transcription of protein coding genes. In particular, transcription and chromatin 
remodelling factors are the major contributors to this regulatory step. 
At the post-transcriptional stage, regulatory factors could directly associate with 
precursor miRNA molecules or interact with miRNA processing machinery. 
Major contributions in this step are associated with the editing of either the RNA 
molecule or the protein factor, which leads to stability alterations and 
consequently changes miRNA biogenesis.  
The functional miRISC complex with loaded miRNA strand could also be 
modified with various post-translational modifications affecting its regulatory 
efficiency.  
 
1.1.1   Transcriptional control of miRNA synthesis 
In the canonical, DGCR8/Drosha dependent, model miRNAs are 
transcribed from intronic regions of coding and non-coding transcripts as 
pri-miRNAs (Ha and Kim, 2014). It was shown that the majority of pri-
miRNAs are transcribed in the cell using Pol II (Ha and Kim, 2014). 
However, some pri-miRNAs that originate from t-RNAs or are related to 
viral RNAs utilise Pol III in their synthesis of primary transcripts (Babiarz 
et al., 2008; Pfeffer et al., 2005). The primary transcripts of miRNAs are 
very similar to those of coding mRNAs and have both a 5’-7-methyl-
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guanylate cap and 3’-poly A tail signalling sequences (Cai et al., 2004). 
Moreover, Chromatin Immunoprecipitation (ChIP), nucleosome-mapping 
and genetic analysis indicated the presence of DNA sequences associated 
with protein coding mRNAs, like frequencies of CpG islands, TATA-box 
TFIIB recognition and initiation sequences, as well as methylation sites. 
This would mean that the regulatory network associated with the 
expression of protein coding genes also influences the association of 
transcription factors and enhancers associated with the promoters of pri-
miRNA transcripts (Corcoran et al., 2009; Ozsolak et al., 2008).   
Bisulphite sequencing analysis showed that, in the case of bladder cancer, 
the expression of miR-127 is decreased due to hypermethylation of its 
promoter (Saito et al., 2006). Also, alterations of histones by Histone 
Deacetylase (HDAC) enzymes have been shown to affect the transcription 
of pri-miRNAs. For example, LAQ284 HDAC inhibitor treatment followed 
by microarray analysis showed that 27 miRNAs are affected by HDAC 
activity. This included miR-27a, which was strongly repressed by the 
inhibition of HDAC. Also, its target genes were shown to be affected by 
HDAC treatment (Scott et al., 2006). Furthermore, growth factors like 
platelet-derived growth factor (PDGF) and transforming growth factor-β 
(TGF-β) indirectly influence the levels of miRNAs (Chan et al., 2010; Davis 
et al., 2009).  
Feedback loops in gene regulation have previously been suggested to play 
an essential role in gene expression and the specification of terminal 
differentiated states (Jacob and Monod, 1961; Monod and Jacob, 1961). 
Due to the intrinsic nature of miRNA function, these molecules are 
particularly well-suited to playing a central role in regulatory feedback 
mechanisms. In fact, within the midbrain area, a simple negative circuit 
between miR-133b and the Pitx3 transcription factor controls the 
development of dopamine neurons (DNs). The Aphakia mouse strain (a 
Parkinson disease model which lacks the expression of Pitx3) was shown 
to have significantly lower levels of mir-133b (Kim et al., 2007). Using the 
luciferase reporter system, it was shown that the proximal promoter 
region of miR-133b is sufficient to convey Pitx3 binding. Concurrently, the 
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Pitx3 3’-untranslated region contains a motif that is recognised by miR-
133b. This reciprocal binding of the transcription factor and miRNA is 
sufficient to produce a physiological response as demonstrated in vivo 
using an oligonucleotide inhibiting miR-133b and by FACS sorting 
Tyrosine Hydroxylase (TH) positive DNs. In this setting, overexpression 
or reduction of miR-133b leads to a decrease or increase of Pitx3, 
respectively. Also, Pitx3 levels were upregulated in DNs from TH+FACS 
sorted Dicer mutant neurons, which is consistent with an overall role of 
miRNAs, specifically miR-133b, in the regulation of the expression of this 
transcription factor (Kim et al., 2007). 
In addition, even more complex regulatory circuits with miRNAs playing 
a central role have evolved. In C. elegans, neurons involved in the 
development of two distinctive taste receptors (ASEL and ASER) are 
initially interlocked in a quasi-stable hybrid state with the expression of 
genes specific for both types. In the course of cell fate specification, two 
miRNAs, lys-6 and miR-273, are required to determine the terminally 
stable states. Mutation analysis and gene reporter assays in ASER neurons 
helped to determine that the expression of ASEL-specific genes is blocked 
by expression of the transcription factors COG-1 and miR-273, which 
targets the transcription factor DIE-1. Conversely, the ASEL state is 
established when neurons retain expression of DIE-1 and the lys-6 
miRNA, which blocks the expression of COG-1 and fundamentally 
inhibits the expression of ASER-specific genes in this sensory organ 
(Johnston et al., 2005). 
Notably, the precise locations of the promoters of most miRNAs have not 
yet been experimentally determined, but can be inferred based on the 
positions of other transcriptional regulatory elements (Ozsolak et al., 
2008). Also, the transcription start sites (TSS) for some intronic miRNAs 
have been shown to be different from the TSS of their host genes (Monteys 
et al., 2010). 
1.1.2   Post-transcriptional mechanisms regulating miRNA production 
Since miRNAs have a substantial capacity to manage cellular and 
developmental programs, their expression has to be tightly regulated. 
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Transcriptional regulation is the first line in the control of miRNA 
expression. However, this regulation requires the means of controlling 
transcription factor levels, which by its own nature is an indirect effect and 
demands an additional amount of time. Therefore, more direct means 
could be more beneficial as they would require less time and would 
potentially benefit from being more precise, allowing the regulation of 
only specific subsets of miRNAs. Importantly, in vitro processing assays of 
radiolabelled precursor miRNAs revealed that their biogenesis pathway 
requires multi-step maturation events occurring post-transcriptionally 
(Lee et al., 2002). Hence, this provides several opportunities for the direct 
regulation of each processing step, allowing for greater fine-tuning of 
miRNA levels.  
1.1.2.1   Drosha mediated pri-miRNA processing in the cell nucleus  
Pri-miRNAs are on average 1kb long and consist of multiple intrinsic 
features including a stem (32-35bp) and a single-stranded terminal loop 
and are flanked by single-stranded regions at both sides of the base of the 
stem. (Davis-Dusenbery and Hata, 2010). In the first step of maturation, 
the Microprocessor complex, consisting of Drosha and its partner DGCR8, 
crop at the base of the pri-miRNA stem releasing a 60-70bp long hairpin-
like structure called the pre-miRNA. Drosha-DGCR8 cleavage determines 
the terminus of the miRNA, which will ultimately affect the miRNA 
functional output (Han et al., 2004). Therefore, the microprocessor 
trimming point has to be precisely guided. It has been shown that the 
microprocessor cleaves approximately 11nt from the basal junction 
between ssRNA and dsRNA and 22nt away from the apical junction 
converging with the terminal loop (Han et al., 2006; Zeng et al., 2005), 
leaving an overhang that is characteristic of RNAse-III-mediated cleavage 
reactions (Zamore, 2001). Deletion mutagenesis and in vitro processing 
assay showed that cis-acting regulatory elements reside in close proximity, 
covering a ~50bp region across the cleavage site (Lee et al., 2003). 
Furthermore, site-directed mutagenesis revealed that internal loops are 
not essential for Microprocessor processivity; however, disruption of 
dsRNA significantly reduced the efficiency of the reaction, proving again 
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the RNAse-III class characteristics of the Drosha/DGCR8 complex 
(Blaszczyk et al., 2001; Lee et al., 2003).  
 
Drosha is a 160kDa nuclear protein that belongs to a family of RNAse III-
type endonucleases (Denli et al., 2004). The N-terminal part of Drosha is 
responsible for its cellular localisation, whereas the C-terminal region 
contains tandem RNAse III domains (RIIIDs) and a dsRNA-binding 
domain (dsRBD) (Han et al., 2004; Tang et al., 2010). The RIIIDs dimerise 
intramolecularly forming a processing centre at their interface (Han et al., 
2004). The first RIIID (RIIIDa) cuts at the 3’ end whereas the second RIIID 
(RIIIDb) cuts at the 5’ end of the pri-miRNA, leaving a 2-nt long 3’ 
overhang (Blaszczyk et al., 2001; Han et al., 2004). In-vitro processing 
assays showed that Drosha dsRBD interaction with the pri-miRNA is not 
sufficient for efficient cleavage (Han et al., 2004). However, the reaction 
normally occurs upon the association of DGCR8 with the middle part of 
Drosha, which contain an Arginine, Serine-rich region (Han et al., 2004).  
DGCR8 is also a nucleolar protein with a molecular weight of around 
90kDa. The N-terminal part of DGCR8, similarly to Drosha, is involved in 
localisation events (Shiohama et al., 2007; Yeom et al., 2006). The central 
part of the protein contains a haem-binding domain (HBD) involved in 
ferric-ion binding (ferric-ions have a positive effect on processing 
efficiency) and two dsRBDs involved in the interaction with pri-miRNA 
molecules (Cochran and Michael, 2008; Han et al., 2006; Yeom et al., 2006). 
The remaining C-terminal part of DGCR8 is involved in the interaction 
with Drosha and formation of the microprocessor complex (Yeom et al., 
2006). 
 
In most cases, microprocessor activity shapes the levels of mature 
miRNAs; consequently, its expression and activity is controlled at three 
distinct levels. In the first instance, the auto-regulatory mechanism 
between Drosha and DGCR8 has a strong effect on the overall activity of 
the microprocessor complex (Gregory et al., 2004). DGCR8 has a positive 
effect on the stability of the complex via its interaction with the middle 
region of Drosha. On the other hand, Drosha destabilises the DGCR8 
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mRNA leading to its degradation. This cross-regulatory loop is very 
important for the processing efficiency of the microprocessor, as it has 
previously been shown using in vitro processing that even a three-fold 
increase in DGCR8 significantly reduces the activity of the microprocessor 
complex. 
In addition to the auto-regulatory mechanism, several posttranslational 
modifications (PTM) of microprocessor components have been shown to 
affect its stability, localisation and reactivity. Fluorescent microscopy 
studies and in vitro kinase assay suggested that Drosha is a target for 
glycogen synthase kinase 3β (GSK3β), with residues S300 and S302 being 
phosphorylated, allowing the protein to localise to the nucleus (Tang et al., 
2011). 
Mass spectrometry analysis of phosphorylation sited showed that DGCR8 
is phosphorylated at 23 sites (Herbert et al., 2013). In this study, co-
immunoprecipitation assays were used to identify JNK and ERK kinases 
as the enzymes phosphorylating DGCR8. Additionally, an in vitro kinase 
assay coupled with phosphatase inhibitors showed that the role of DGCR8 
phosphorylation is to increase the stability of DGCR8 (Herbert et al., 2013).  
Acetylation was also shown to play a role in activity of the 
microprocessor. It has been shown with in vitro acetylation assays that 
acetylation and de-acetylation of Drosha and DGCR8, respectively, 
positively regulates the reactivity of the microprocessor (Tang et al., 2013; 
Wada et al., 2012). Mass spectrometry analysis showed that K382 was one 
of the acetylated Drosha residues (Tang et al., 2013). In this study, it was 
shown that acetylation competes with ubiquitination of Drosha and 
ultimately leads to stabilisation of the protein. Consequently, gene 
reporter assays and qRT-PCR analysis demonstrated that acetylation leads 
to increased levels of certain miRNAs, including miR-143 (Tang et al., 
2013). Recently, another study illustrated that phosphorylation of MeCP-2, 
a protein involved in binding to methylated CpG islands, leads to its 
association with DGCR8 (Cheng et al., 2014). MeCP-2 competes for Drosha 
binding and decreases miRNA production. Deep sequencing analysis 
showed that MeCP-2 knockout mice have an overall increased production 
of miRNAs. Moreover, co-immunoprecipitation analysis showed that 
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interaction between phosphorylated MeCP-2 and DGCR8 is direct and 
depends on the phosphorylation of Ser80 in MeCP-2.  
The last vital regulatory category involves auxiliary proteins that interact 
either with the microprocessor complex or the pri-miRNA and influence 
activity of the complex. It has been reported that TGF-β and bone 
morphogenetic protein (BMP) leads to activation of SMAD signalling 
molecules. They were shown to interact with p68 and the stem of certain 
pri-miRNAs and consequently increase the activity of the microprocessor 
(Davis et al., 2008; Davis et al., 2010).  
Several proteins have been shown to interact with the terminal loop or 
stem of pri-miRNAs. For instance, in vitro footprinting analysis 
demonstrated that hnRNP-A1 interacts directly across various positions 
with pri-miR-18a. Structural analysis suggested that this interaction leads 
to some essential re-arrangements within pri-miR-18a that consequently 
trigger increased activity of the microprocessor (Guil and Caceres, 2007; 
Michlewski et al., 2008). Interestingly, hnRNP-A1 was also suggested to 
inhibit processing of pri-let-7a-1. Footprinting analysis and in vitro 
processing assays showed that hnRNP-A1 binds to the terminal loop of 
pri-let-7 and its depletion from extracts leads to an increase in the in vitro 
processing of pri- to pre-let-7 (Michlewski and Caceres, 2010). Even more 
importantly, hnRNP-A1 was shown to compete with KSRP for binding 
with the pri-let-7 terminal loop. KSRP is an alternative splicing factor that 
was shown, with UV-crosslinking, to associate directly with the pri-let-7 
terminal loop and positively regulate the in vitro processing of pri-let-7 
and, if supplemented with Dicer, also of pre-let-7 (Trabucchi et al., 2009). 
There have been several other studies describing the role of auxiliary 
proteins binding directly to pri-miRNAs and regulating their processing. 
For example, pluripotency-promoting factor Lin28a has been shown to 
interact with the pri-let-7 precursor and inhibit its maturation 
(Viswanathan and Daley, 2010). Similarly, other studies linked the role of 
the HuR and Msi2 proteins in the processing of the miR-7 precursor 
(Choudhury et al., 2013). 
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1.1.2.2   Dicer-mediated pre-miRNA processing in the cell cytoplasm 
Following microprocessor-mediated processing of the pri-miRNA to pre-
miRNA, the pre-miRNA is exported by Exportin-5 to the cytoplasm 
(Gwizdek et al., 2003; Okada et al., 2009; Yi et al., 2003). Upon being 
released from the exporting complex, the pre-miRNA undergoes the final 
step of maturation directed by Dicer, as shown by a series of in vitro 
processing assays and Dicer silencing assays (Hutvagner et al., 2001; 
Ketting et al., 2001). Dicer, similarly to Drosha, belongs to RNAse III type 
endonucleases and has a molecular weight of approximately 200kDa 
(Zhang et al., 2004). The C-terminal part of Dicer contains two tandem 
RIIIDs. Crystallographic studies and in vitro processing of various Dicer 
point mutants showed that these RIIIDs form an intramolecular dimer and 
the processing centre of the protein (Figure 1-3) (Zhang et al., 2004). The 
N-terminal part of the protein contains a helicase that is involved in the 
recognition of the single-stranded terminal loop of pre-miRNA, as shown 
by EMSA analysis (Tsutsumi et al., 2011). Moreover, in vitro dicing 
reactions indicated that the interaction between the N-terminus of Dicer 
and the terminal loop of the pre-miRNA is essential for efficient activity of 
the reaction (Gu et al., 2012). The heart of the substrate recognition and 
specificity is within the PAZ domain of Dicer, which occupies the centre of 
the protein and is involved in the interaction with the terminus of the pre-
miRNA (Macrae et al., 2006; Park et al., 2011; Tian et al., 2014). The PAZ 
domain binds the 3’ end with the characteristic 2nt overhang of substrate 
pre-miRNA. It has been proposed that cleavage sites for Dicer are also 
determined based on the interaction of the PAZ-domain with the 3’ 
terminus (Zhang and Chen, 2013). The usual distance of 21-25nt between 
the RNA terminus and the cleavage sites is a consequence of the presence 
of the helix linking PAZ-domain and RIIIDs (Park et al., 2011). 
Interestingly, in flies and mammals, Dicer developed a more stringent 
method of controlling the position of cleavage sites (Park et al., 2011). In 
this case, the PAZ-domain contains an additional pocket for binding the 
phosphorylated 5’-terminus of the pre-miRNA. Moreover, the relative 
positions of both pockets require a 2nt overhang at the 3’ end. In vitro and 
in vivo analysis showed that binding to both pockets accurately determines 
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the product size of 22nt. Site directed mutagenesis and in vitro processing 
assay determined that residues Y926 and R927 are essential for 3’ terminus 
binding and their mutation results in an almost complete loss of the 
counting mechanism. However, mutations of residues R778, R780, R811, 
R986 and R993, which are important for 5’ terminus binding, resulted in 
loss of the cleavage precision and effectively the heterogeneous 
population of products characteristic of lower evolutionary organisms 
(Park et al., 2011). Moreover, crystal studies also suggested that the 5’ and 
3’ binding pockets within PAZ determine two different stages of Dicer, 




Figure 1-3 A pre-siRNA spans human Dicer between the cap and branch 
while a pre-miRNA binds the platform of the enzyme. 
(a,b) Cryo-EM reconstructions of human Dicer–37ab (a) and human Dicer–pre-
let7 (b) at ~29-Å and ~31-Å resolution, respectively. Regions labeled by the 
antibodies and the DExH/D are segmented and colored on the EM density. 
Orange, mAb 83-labeled region; green, mAb 77-labeled region; light blue, 
DExH/D domain. Ab Crystal structures of homologous domains have been 
docked into the map on the basis of c antibody localization and segmentation and 
are color coded and labeled. Yellow, RNase IIIa; green, RNase IIIb; orange, PAZ 
domain from Giardia intestinalis Dicer (PDB 2QVW28), Red, ATP-binding 
domain; light blue, helicase domains from a homology model of Dicer’s helicase 
based on human RIG-I (PDB 2YKG30). The pre-siRNA, 37ab, is modeled as a 35-
bp A-form RNA duplex within its segmented density, colored purple in a. The 
pre-miRNA, pre-let7, is not modeled, and the segmented density is colored red in 
b.  
Reprinted from the article of Taylor and colleagues “Substrate-specific structural 
rearrangements of human Dicer”. Permission obtained from NSMB journal - 
licence number 3772151319850. 
 
RNAse III class proteins have a tendency to interact with dsRBD proteins. 
Dicer, similarly to Drosha, interacts with the TAR RNA-binding protein 
(TRBP), which is a homologue of Drosophila’s Loqs-PB (Chendrimada et 
al., 2005; Haase et al., 2005). TRBP contains three dsRBD and the 
interaction with Dicer supports stabilisation of the former (Chendrimada 
et al., 2005; Melo et al., 2009). Northern blot and gene reporter assays 
showed that knockdown of TRBP leads to an overall decrease in mature 
miRNA levels but does not completely block their pre-miRNA processing 
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(Chendrimada et al., 2005). Interestingly, certain cancers have been 
described to have lower levels of TRBP (Melo et al., 2009). Additionally, 
phosphorylation assays showed that TRBP is under regulation of 
MAPK/ERK. Consequently, this regulation contributes to increased levels 
of miRNAs associated with growth stimulation. In contrast, TRBP 
phosphorylation leads to a decrease in mature levels of let-7 – a known 
suppressor of cell proliferation (Paroo et al., 2009).  
It has been demonstrated that auxiliary RNA binding proteins can affect 
the activity of the Dicer complex. For example, KSRP protein binds to a 
series of pre-miRNAs and induces their processing by Dicer (Trabucchi et 
al., 2009). On the other hand, Lin28a recognises the terminal loop of pre-
let-7 and inhibits Dicer cleavage. Lin28a-mediated inhibition relies on pre-
let-7 poly-uridylation, which ultimately leads to a decrease in mature let-7 
levels (Heo et al., 2009; Viswanathan and Daley, 2010; Viswanathan et al., 
2008). 
1.1.3   miRISC complex – executioner of miRNA function 
Following the final cropping step, the mature double-stranded miRNA 
duplex is loaded into the microRNA-induced silencing complex (miRISC) 
complex (Kawamata and Tomari, 2010). Fractionation studies indicated 
that this is a multiprotein complex with nuclease activity of around 
500kDa. Additional sub-fractionations followed by mass spectrometry 
analysis identified the Argonaute (Ago) protein as the main component of 
the complex (Hammond et al., 2001).  
Crystal structure studies showed that Ago arranges itself in bilobal fold 
(Figure 1-4). The overall structure is very well conserved across , bacteria, 
yeasts and humans, with the human one adopting the most open 
conformation (Elkayam et al., 2012; Nakanishi et al., 2012). The C-terminal 
lobe of Ago is shaped by the PIWI and MID domains that are in close 
proximity of the N-terminal lobe containing the N-domain. These two 
lobes form a cradle that is closed from the top by the PAZ-domain 
(Elkayam et al., 2012). The PIWI-MID interface contains a 5’-phosphate 
binding pocket that recognises the 5’-end of the guide RNA (gRNA). 
Additionally, human Ago2 contains a loop that favours either A or U at 
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the gRNA 5’-end (Frank et al., 2010). The remaining body of gRNA 
threads across a basic channel built by the PIWI-MID domain and its 3’-
end reaches to the PAZ domain (Wang et al., 2008a; Wang et al., 2008b). 
This arrangement allows the gRNA to take on an A-form conformation 
helix that allows efficient scanning of the target mRNA (Elkayam et al., 
2012; Song et al., 2004; Wang et al., 2008a; Wang et al., 2008b). Moreover, 
the crystal structure of the PIWI domain indicated that it arranges itself 
into a catalytic domain resembling the RNase H active site and avian 
sarcoma virus (AVS) integrase (Figure 1-4) (Liu et al., 2004). Upon mRNA 
recognition, the Ago active site was shown to slice the target between 
position 10 and 11 relative to the 5’ end of the gRNA (Song et al., 2004). 
Interestingly, all human AGO1-4 isoforms are capable of interacting with 
specific machinery that can induce translational repression or mRNA 
decay. However, only AGO-2 has the potential to slice perfectly matched 
target mRNA (Huntzinger and Izaurralde, 2011). 
 
Figure 1-4 Structure of human Ago2 
(A) Schematic of the Ago2 primary sequence. (B) Front and top views of Ago2 
with the N (purple), PAZ (navy), MID (green), and PIWI (gray) domains and 
linkers L1 (teal) and L2 (blue). A generic guide RNA (red) can be traced for 
nucleotides 1 to 8 and 21. Tryptophan molecules (orange) bind to tandem 
hydrophobic pockets in the PIWI domain.  
Reprinted from the article of Shirle and colleagues “The Crystal Structure of 
Human Argonaute2”. Permission obtained from Science – licence number 
3772150814815. 
 
Furthermore, flies have an additional mechanism allowing for segregating 
perfectly matching (siRNA) from not perfectly matching (miRNA) small 
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RNA guides into specific Ago isoforms. Immunoprecipitation assays and 
Northern blots showed that central mismatches at gRNA positions 9 and 
10 are essential structure characteristics responsible for ultimately guiding 
the duplex into Ago1 (Ghildiyal et al., 2010), whereas in vitro sorting 
assays, northern blots and site directed mutagenesis showed that Fly-Dcr2 
binds perfectly complementary duplex gRNAs, acting to a certain degree 
as a gate-keeper assuring loading of the gRNA into Ago2 (Okamura et al., 
2009). Also, Drosophila Ago have certain preferences towards the identity 
of the 5’ nucleotide of the gRNA. miRNA duplexes with a 5’ U is 
preferably bound to Ago1, whereas a 5’ C favours siRNAs to bind Ago2 
(Czech et al., 2009). 
In the final step of loading, the double stranded miRNA associated with 
the pre-miRISC complex undergoes unwinding, generating guide and 
passenger strands (Krol et al., 2010b). Two mechanisms directing this 
process were previously described and their selection depends on 
presence of a mismatch at the centre of the mature miRNA (Diederichs 
and Haber, 2007; Forstemann et al., 2007; Leuschner et al., 2006; Liu et al., 
2004; Matranga et al., 2005; Meister et al., 2004; Rand et al., 2005). The first 
and most common mechanism involves unwinding without cleavage 
(Diederichs and Haber, 2007; Kawamata et al., 2009; Yoda et al., 2010). A 
series of EMSA analyses using synthetic wild-type duplexes and their 
mutants suggested that unwinding was based on a mismatch present in 
the majority of miRNAs at positions 2-8 and 12-15 and did not require the 
slicing activity of Ago in most cases (Kawamata et al., 2009).  
However, in rare cases with perfect matching in the central position of the 
duplex miRNA, an alternative mechanism involving slicing of the 
passenger strand by Ago2 occurs (Miyoshi et al., 2005; Rand et al., 2005).  
In vitro reconstitution assays with Dcr2 and Ago2 indicated that additional 
protein co-factors could be involved to enhance unwinding of the dsRNA 
(Liu et al., 2009). Through immunoprecipitation followed by liquid 
chromatography, the component 3 promoter of RISC (C3PO) 
endonuclease complex was isolated, with a depletion of C3PO leading to 
decreased levels of mature miRNA in vivo. Step-wise in vitro reconstitution 
of the RISC complex showed that C3PO is an essential component 
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involved in the conversion of pre-RISC containing double-stranded 
miRNA into mature RISC with single-stranded guide miRNA (Liu et al., 
2009). Further crystallographic, mass spectrometry and processing assays 
showed that C3PO is an asymmetric octamer with six Translin and two 
Trax subunits, with the last component containing Mg-dependent 
endonuclease activity. These studies suggested that C3PO allows for 
efficient removal of the passenger strand from the pre-RISC, incorporating 
the guide miRNA in a complex with Ago2 (Liu et al., 2009; Ye et al., 2011).   
A key step of the unwinding process is the selection of the guide RNA that 
remains incorporated in the RISC. In vitro RNAi reactions using siRNAs 
targeting Superoxide dismutase 1 (SOD-1) sense and anti-sense and their 
modified synthetic versions showed that even a single hydrogen bond 
energy difference at the 5’-end is sufficient to determine the entry point for 
helicases (Schwarz et al., 2003). Furthermore, potential mismatches at 
positions 2-4 co-ordinated from the less stable 5’-end of the duplex 
(corresponding to the helicase binding sites) were shown to act in favour 
of strand selection (Hu et al., 2009; Khvorova et al., 2003; Schwarz et al., 
2003). Additional nucleotide specificity was observed, as strands with U at 
the 5’-end were frequently selected as guides (Hu et al., 2009; Kawamata et 
al., 2009). 
Various in vivo studies analysing post-translational modifications 
suggested that Ago could be efficiently hydroxylated, phosphorylated, 
ribosylated, as well as ubiquitinated. These modifications resulted 
dominantly in reduced overall activity of miRISC and in some instances 
were triggered by environmental factors like viral infection or hypoxic 
stress (Qi et al., 2008; Rudel and Meister, 2008; Rudel et al., 2011; Shen et 
al., 2013; Wu et al., 2011; Zeng et al., 2008). Interestingly, 
immunoprecipitation and kinase activity assays followed by in vitro 
cleavage assays indicated that Akt3-mediated phosphorylation of Ago2 at 
position S387 acts as a molecular switch (Horman et al., 2013). It was 
suggested that upon phosphorylation, the overall miRISC activity is 
redirected from target cleavage to translational repression. 
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1.1.4   Modifications of miRNAs and its role in biogenesis regulation 
In addition to the processes regulating miRNA biogenesis through 
interference with the processing machinery, the sequence of the precursor 
or mature miRNA can be chemically altered with considerable effects on 
its cellular fate (Ameres and Zamore, 2013).  
The pre-let-7 family of miRNAs have been found to interact with the 
pluripotency-promoting Lin28a protein, which inhibits let-7 biogenesis 
(Newman et al., 2008; Rybak et al., 2008; Wulczyn et al., 2007). The Lin28-
pre-let-7 complex was found to interact with Zcchc11, a member of the 
Tutase family (TUT) (Hagan et al., 2009) and in vitro processing assays 
found that reconstituted Lin28-TuT complex in the presence of UTP 
catalyse the reaction of adding a poly-U tail to pre-let-7. This ultimately 
results in pre-let-7 destabilisation and lack of mature let-7 (Hagan et al., 
2009; Heo et al., 2009). Global profiling of mature miRNAs revealed that 
the depletion of Zcchc11 leads to downregulation of mature let-7 levels 
across the whole family (Piskounova et al., 2011). This finding was in 
accordance with the gene reporter analysis that showed repression of 
known let-7 targets upon Zcchc11 RNAi (Piskounova et al., 2011). 
Interestingly, another study suggested that Lin28 functions as a molecular 
master switch that promotes the processing of pre-let-7 if a single uracil is 
added to its end or causes its degradation following the addition of a poly-
U tail (Heo et al., 2012). 
Another modification of the 3’ pre-miRNA that has been described is 
adenylation. Katoh and colleagues discovered a single A at the 3’-end of 
miR-122 (Katoh et al., 2009). Further immunoprecipitation analysis 
followed by an in vitro processing assay showed that this modification is 
added by poly-A RNA-polymerase, Gld2, that can add AMP monomers to 
the 3’-end of RNA. Finally, results obtained from Gld-2 knockout mice 
confirmed the functional relevance of miR-122 adenylation as a reduction 
in the miR-122 level was observed in the absence of the polymerase (Katoh 
et al., 2009). Interestingly, another study suggested that upon viral 
infection the viral poly-A, RNA-polymerase can adenylate the host 
miRNAs and subsequently trigger their degradation (Backes et al., 2012; 
Katoh et al., 2009). The exact molecular mechanism that could differentiate 
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between these two very different outcomes of miRNA adenylation 
remains unknown.  
Apart from tailing, three other mechanisms acting on the precursor 
miRNA were identified (Krol et al., 2010b).  One of the mechanisms 
involves the editing of adenosine to inosine within the stem of precursor 
miRNA, as previously shown with thin-layer chromatography in vitro and 
primer extension analysis in vivo for precursors of miR-142 (Yang et al., 
2006). In vitro processing assays indicated that Adenosine Deaminases 
acting on RNA 1 and 2 (ADAR1, ADAR2) are the enzymes responsible for 
the reaction, which was further supported by the fact that ADAR-1 null or 
ADAR2 null mice have increased levels of miR-142. 
The other mechanism involves recruiting the BCDIN3D enzyme, which is 
a methyltransferase that belongs to the Bin3 family (Xhemalce et al., 2012). 
It was shown in vitro that BCDIN3D is able to monomethylate the 5’-end 
of pre-miR-145, rendering it a poor substrate for Dicer processing. 
Moreover, qRT-PCR and northern blots confirmed that RNAi of BCDIN3D 
leads to increased levels of miR-145 but not pre-miR-145, suggesting that 
this modification is acting post-transcriptionally. Interestingly, a genome-
wide study of MCF-7 cells showed that knockdown of BCDIN3D affected 
a wide pool of pre-miRNAs and caused both an increase and decrease of 
certain miRNAs.  
Finally, endoribonucleases like MCP-induced protein 1 (MCPIP1) and 
Ser/Thr protein kinase/endoribonuclease Ire1α were shown to cleave 
within the terminal loops of several pre-miRNAs, for example pre-miR-
146a and pre-miR-17, resulting in lowered mature miRNA levels in vivo 
(Suzuki et al., 2011; Upton et al., 2012). Other studies showed that the 
stability of mature miRNAs could be regulated through various 
exonucleases. This in turn can modulate the functionality of the miRISC 
complex. However, the mechanisms regulating the specificity of 
degradation mediated by XRN-1, XRN-2 PNPT1 or ERI1 for instance, as 
well as the mechanisms of unloading mature miRNA from the miRISC 
complex remain unknown (Chatterjee and Grosshans, 2009; Das et al., 
2010; Krol et al., 2010a; Ramachandran and Chen, 2008; Thomas et al., 
2012).  
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1.2   The role of Lin28 in miRNA biogenesis 
 
Cell Lineage Abnormal 28 (Lin28) is one of the best-studied proteins in 
respect to its role in regulating miRNA biogenesis. It is very well 
conserved across many species and was first described in C. elegans where 
mutations of the protein caused defects in developmental timing and 
accelerated the differentiation of several types of cells (Moss et al., 1997). 
Expression profiling in C. elegans, D. melanogaster, X. laevis and H. sapiens 
showed that Lin28 is abundantly expressed during the embryonic stage 
and its expression is gradually restricted with lineage progression (Darr 
and Benvenisty, 2009; Moss and Tang, 2003; Seggerson et al., 2002). 
Lin28 has two paralogues, Lin28a and Lin28b, which in humans share 
around 50% sequence identity (EMBOSS, (Rice et al., 2000)). Many studies 
have associated both Lin28a and Lin28b proteins with the regulation of 
miRNAs, post-transcriptional RNA processing and the translational 
repression of mRNA (Mayr and Heinemann, 2013). Both of the paralogues 
share very similar protein domain arrangements. Two RNA binding 
domains essential for the protein activity are N-terminal Cold Shock 
Domain (CSD) and C-terminal Zinc-finger domain (ZnF), which contain 
two consecutive retroviral CCHC zinc knuckles (Nam et al., 2011) (Figure 
1-5). Additionally, Lin28b contains an N-terminal putative bipartite 
Nucleolar Localisation Signal (NLoS) and C-terminal Nuclear Localisation 
Signal (NLS) (Piskounova et al., 2011). Therefore, Lin28 proteins can access 
their targets in both the cytoplasm and nucleus to execute their functions. 
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Figure 1-5 Structure of the Lin28:PreEm-let7d complex 
Cartoon representations were colored by domain: blue, CSD; green, CCHCx2; 
gray, zinc; orange, RNA. 	 
(A)   Stereo representation of the monomeric complex. Interdomain linker is 
represented by a purple dotted line.  
(B)   Same complex in (A) represented with surface colored by electrostatic 
potential and rotated.  
(C)   Domain-swapped dimer. Arrow points from the domain-swapped to the 
biologically relevant CCHCx2 domain. Linker connecting swapped 
domains is marked in green, dotted line. Linker connecting unswapped 
domains is marked in purple, dotted line.  
Reprinted from the article of Nam and colleagues “Molecular basis for interaction 
of let-7 microRNAs with Lin28.” Permission obtained from Cell – licence number 
3774090155352. 
 
1.2.1   Implications to let-7 levels  
The implications of Lin28 on the regulation of let-7 have been very well 
studied. Expression levels of both molecules display mutually exclusive 
patterns during cellular differentiation and development (Moss and Tang, 
2003). In C. elegans, it was shown that Lin28 is expressed in the embryo 
and through the larval stages until day 20. In contrast, probing for let-7 
and its precursors with northern blot showed that pri-let-7 is expressed 
from early developmental stages, peaking at day 8-10. Interestingly, levels 
of mature let-7 and pre-let-7 are not observed prior to day 20 (Van 
Wynsberghe et al., 2011). Immunoprecipitation assays showed that Lin28 
associated co-transcriptionally with pri-let-7. Moreover, C. elegans Lin28-
null mutants expressed mature let-7 ten days earlier, proving the role of 
Lin28 in repressing let-7 (Van Wynsberghe et al., 2011). In a similar 
 26 
fashion, using a neuronal differentiation model of human embryonic stem 
cells, it was shown that miR-125 and let-7 are highly expressed in 
differentiated neuronal stem cells, but the expression of let-7 during the 
embryonic state is inhibited. This was mechanistically explained by the 
autoregulatory circuit activated during the differentiation steps and 
involving miR-125 and let-7 driven inhibition of Lin28 expression. Thus, 
Lin28 knockdown in undifferentiated cells release the blockage of pre-let-7 
processing (Rybak et al., 2008). Furthermore, mass spectrometry analysis 
of the proteins associated with the let-7 precursor identified Lin28 as a 
putative member of the complex, providing additional evidence for its 
direct involvement (Newman et al., 2008; Viswanathan et al., 2008).  
Two possible scenarios were proposed to regulate let-7 levels. The first 
relies on competition between Lin28 and the miRNA processing 
machinery. In his work, Newman and colleagues used cell extracts from 
teratocarcinoma P19 cells, a model cell for neuronal differentiation, to 
show that processing of pri-let-7 to pre-let-7 is significantly inhibited. 
Further, mutagenesis of several regions within the pri-let-7 terminal loop 
increased let-7 processing. UV-crosslinking of undifferentiated P19 cells, 
followed by immunoprecipitation, showed that Lin28 was bound to pri-
let-7. Furthermore, using specific terminal loop competitors, they showed 
that this interaction occurred in the evolutionarily conserved regions of 
the loop (Newman et al., 2008). RNAi knockdown and overexpression of 
Lin28 were shown to release the processing blockage and decrease levels 
of pre-let-7, respectively. This study speculated that the potential 
mechanism of this inhibitory action could be direct competition with the 
microprocessor machinery or a sequestration mechanism.  
Subsequently, other groups independently reported Zinc Finger CCHC 
Domain-Containing Protein 11 (Zcchc11), also known as Terminal 
Uridylyltransferase 4 TUT4, to be a factor that mediates cytoplasmic poly-
uridylation of pre-let-7 leading to its degradation (Hagan et al., 2009; Heo 
et al., 2009). Moreover, they used global miRNA profiling to show that the 
depletion of TUT4 almost exclusively affected the let-7 family of miRNAs. 
Heo and colleagues showed that a mutation in the Lin28a ZnF abolished 
uridylation of pre-let-7 but did not affect binding of the mutant to the 
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RNA (Heo et al., 2008). Previously, it was shown that the “GGAG” motif is 
a target for CCHC-Zinc finger domains and it was confirmed to be the key 
sequence within the pre-let-7 terminal loop. In his work, Heo and 
colleagues generated several mutants of pre-miR-16 with an artificial 
“GGAG” sequence. Interestingly, only one mutant was uridylated, which 
raised the possibility that additional molecular mechanisms restrict 
uridylation to a selected subset of pre-miRNAs, including pre-let-7. 
Indeed, in work from our group, Roy Choudhury and colleagues used 
pull-downs and mass spectrometry to identify the E3 ligase Trim25 to 
associate with pre-let-7 and act as a Lin28/TUT4 co-factor during the 
uridylation reaction (Choudhury et al., 2014).  
Poly-uridylation of pre-let-7 was shown to be an essential mechanism that 
mediates degradation of the precursor in undifferentiated ES cells (Chang 
et al., 2013). Pull-downs of protein complexes and subsequent mass 
spectrometry of peptides allowed two groups to determine that 
mammalian 3’-5’ Dis3l2 Pearlman syndrome exonuclease is involved in 
the degradation of poly(U)-pre-let-7 (Chang et al., 2013; Ustianenko et al., 
2013). Additionally, in vitro reconstitution cleavage assays as well as 
siRNA knockdown of Dis3l2 further verified the role of the RNA 
exonuclease in the degradation of pre-let-7 and the poly(U)-tail as its 
decay signal in embryonic cells. 
Additionally, Lin28a was shown to inhibit pre-let-7 processing in the 
cytoplasm not only through its degradation via the Trim25/TUT4/Dis3l2 
pathway but also by direct competition with Dicer to the pre-let-7 terminal 
loop (Lightfoot et al., 2011). In their work Lightfoot and colleagues 
showed that Lin28a binding to pre-let-7g induced relaxations of the 
double-stranded RNA region adjacent to the terminal loop (Lightfoot et 
al., 2011). In particular, the base-paired nucleotides U21 and U22 in the 
stem together with the stacked U23 base from the adjacent terminal loop 
displayed around a 3-fold increase in RNAse I enzymatic cleavage 
sensitivity. Furthermore, Dicer cleavage assays confirmed that this melting 
interfered with the binding of Dicer and the subsequent processing of pre-
let-7g, which was verified using an open-conformation mutant of pre-let-
7g (Lightfoot et al., 2011).  
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In other work, Piskounova and colleagues suggested that Lin28a and 
Lin28b act through independent molecular mechanisms. In a series of 
immunoprecipitation assays, they found that Lin28a but not Lin28b 
associates with Zcchc11 (TUT4) (Piskounova et al., 2011). Moreover, RNAi 
knockdown of Zcchc11 in a panel of cells suggested differential outcome 
on let-7 levels depending on the type of Lin28 expressed in these cells. 
Cells expressing Lin28a but not Lin28b had elevated levels of let-7 upon 
knockdown of both Zcchc11 and Lin28a, resulting in increased levels of 
let-7. In contrast, cells expressing Lin28b but not Lin28a had increased 
levels of mature let-7 upon knockdown of Lin28b but not Zcchc11 
(Piskounova et al., 2011). The authors suggest that these different 
observations could be accounted for by the distinctive subcellular 
localisation of Lin28a and Lin28b. In fact, as mentioned above, Lin28b 
contains two domains that are absent in Lin28a that could be responsible 
for its localisation. Using microscopy and various mutants of Lin28b, they 
showed that this protein paralogue localises to the nucleolus of the cell. 
Furthermore, this Lin28b localisation allowed for its compartmentalisation 
away from the microprocessor machinery (Piskounova et al., 2011). This 
study, together with the findings of Newman and colleagues, suggests 
that Lin28b inhibits pri-let-7 processing in the nucleus by sequestering it 
from Drosha and the processing machinery.  
 
1.2.2   Effect of Lin28-mRNA interaction on protein translation 
As mentioned above, Lin28 contains two very potent RNA binding 
domains. Therefore it is very likely that it also will interact with other 
RNA molecules. Bearing that in mind, Cho and colleagues carried out 
cross-linking immunoprecipitation RNA-sequencing (CLIP RNA-seq) and 
ribosomal footprinting and found that the majority of Lin28a targets are 
mRNA molecules (Cho et al., 2012). They were also able to show that in 
most cases the interaction of Lin28a with the mRNA lead to translational 
suppression. Building a similarity network, they identified purine-rich 
hexamers “AAGNNG”, “AAGNG(N)”, and “(N)UGUG(N)” as the most 
common Lin28a binding sites. Gene Ontology analysis showed strong 
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clustering of several groups related to integral membrane proteins, 
secretory proteins and Endoplasmic Reticulum (ER) or Golgi apparatus 
proteins. These proteins are known to be translated by ER-bound 
ribosomes and undergo co-translational ER translocation. For instance, 
mRNAs of integral membrane proteins were found to interact 4- to 6-fold 
stronger with Lin28a than other mRNAs.  However, they have not found 
significant enrichment of Lin28a binding motifs in ER-associated mRNAs 
compared to non-ER-associated mRNAs. They resolved this confusing 
finding by performing microscopy studies of sub-cellular Lin28a 
localisation. From this experiment, it was concluded that Lin28a localises 
in close vicinity to the ER and therefore interacts more strongly with 
mRNAs that are destined to the ER for completion of their translation 
(Cho et al., 2012). 
Interestingly, another group found that Lin28a associates with the 
translational initiation complex (Polesskaya et al., 2007). They found that 
associated in the complex with Lin28a were the poly(A)-binding protein, 
5′ cap-binding protein, nucleolin, hnRNP-F, H1, and IGF-2 mRNA-binding 
proteins (IMPs) 1, 2, and 3, as well as structural ribosomal proteins, eIF3β 
translation initiation factor, and elongation factors (EF1-α and EF1-α2) 
(Polesskaya et al., 2007). Moreover, using the sucrose gradient, they were 
able to show that Lin28a sedimented together with other components of 
active polysomes. In addition, immunoprecipitation following RNAse 
treatment validated that the interaction between EF1-α and Lin28a is 
direct and microscopy studies confirmed that these two proteins co-
localise in differentiated myoblasts and P19 cells. It was also shown that 
one of Lin28a’s targets is the Igf22 mRNA. Its levels are post-
transcriptionally regulated via a Lin28a-mediated increase in the number 
of translational initiation events reflected by an increase in the number of 
ribosomes per Igf2 mRNA molecule (Polesskaya et al., 2007).  
In a similar fashion, using Flag-tagged Lin28a, Xu and colleagues showed 
that Cdk4 and cyclin B mRNAs exhibited the most dramatic enrichment in 
the immunoprecipitated complexes, followed by cyclin A mRNA, Oct4, 
cdk6, and cyclin D mRNAs (Xu et al., 2009). Moreover, transient 
transfection of Lin28a or its RNAi-mediated knockdown confirmed that 
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the levels of these proteins were either upregulated or downregulated, 
respectively. These changes at the protein levels did not correspond to the 
changes of individual mRNAs as they were shown by qRT-PCR to remain 
stable. Furthermore, using gene reporter assays with 3’-UTRs of the 
regulated mRNAs they were able to conclude that the observed 
mechanism was similar to the stimulation of translation initiation of Igf2 
(Xu et al., 2009). 
Further evidence for a positive role of Lin28a in initiation of translation 
came from the work by Xu and colleagues. They were interested 
specifically in the possibility of Lin28a binding to replication-dependent 
histone mRNAs. Using radiolabelled mRNA of core histones (H2a, H2b, 
H3 and H4) and UV-crosslinking combined with competition assays, they 
showed that Lin28a interacts specifically with H2a. Additional gene 
reporter assays with a synthetic construct containing H2a 3’UTR and 
several mutants allowed the conclusion that two or more Lin28a binding 
motifs are required for enhanced regulation (Xu and Huang, 2009).  
1.2.3   Functional importance of the regulatory role of Lin28 
Lin28 was previously shown to be associated with several processes 
important for tissue homeostasis, including cell growth, differentiation 
and proliferation, as well as glucose metabolism (Polesskaya et al., 2007; 
Qiu et al., 2010; Xu and Huang, 2009; Xu et al., 2009; Zhu et al., 2011). 
Given the high abundance of Lin28 binding motifs across mRNA and 
miRNAs, it is very likely that more functions still remain unknown. 
Expression of Lin28a was shown to be particularly high in embryonic stem 
cells where it is required for maintenance of the pluripotent state and cell 
proliferation (Darr and Benvenisty, 2009; Moss and Tang, 2003; Qiu et al., 
2010; Yu et al., 2007; Zhu et al., 2011). One of the possible mechanisms 
involves the regulation of Oct-4, a very well conserved POU-transcription 
factor and regulator of cell fate (Pei, 2009). A two-fold increase in Oct-4 
directs cells towards the mesoderm and endoderm whereas its reduction 
points differentiation towards the trophectoderm, suggesting the existence 
of very precise regulatory mechanisms (Niwa et al., 2000). Moreover, Oct-
4 was shown to be a key pluripotency factor and was demonstrated to be 
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necessary and sufficient to reprogram mouse adult neuronal stem cells to 
pluripotency (Kim et al., 2009). Qiu and colleagues used Lin28a 
immunoprecipitation (IP) of protein-RNA complexes followed by qRT-
PCR as well as UV-crosslinking experiments to show that Lin28a binds 
directly to the Oct-4 mRNA in vivo. Loss-of-function experiments showed 
that a reduction in Lin28a leads to lower Oct-4 levels. IP of polysomes 
verified that the regulation of Oct-4 is achieved through translational 
activation. In fact, Lin28a was shown to act via RHA (also called DHX9) a 
conserved DEAD-box protein that functions in multiple cellular processes, 
including transcription, splicing, nuclear export, translation, and RNAi, by 
catalysing RNA–RNA and RNA–protein rearrangements in RNP 
complexes (Bleichert and Baserga, 2007). Furthermore, Lin28 was also 
shown to regulate other factors required for cell growth and proliferation. 
It has been demonstrated that higher Lin28a levels result in a 30% increase 
in ES cell numbers, while siRNA-mediated reduction of its levels 
corresponds to around 25% decrease in ES cell numbers. Moreover, BrdU 
incorporation and FACS sorting showed that endogenous Lin28a 
facilitates the progression of cells from S to M/G2 phase, which could 
accelerate proliferation (Xu et al., 2009). Similar findings were obtained 
from muscle myoblasts where increased levels of Lin28 resulted in 
increased muscle differentiation, contrary to a reduction of the protein 
which resulted in the decreased efficiency of differentiation (Polesskaya et 
al., 2007). 
Lin28/let-7 axis was also suggested to play a role in glucose metabolism 
via mechanism that targets several components of the PI3K-mTOR 
pathway (Zhu et al., 2011). Two inducible Lin28a and Lin28b mouse 
models individually demonstrated that ectopic expression of Lin28a/b 
allowed for more efficient metabolism of glucose. Induction of either 
protein in transgenic mice resulted in glucose metabolism that was four 
times faster, measured as a concentration decrease in blood during the 
twelve days after the diet commenced. Moreover, Lin28a knockout in mice 
caused growth defects and glucose metabolism intolerance. This study 
showed that these observations could be accounted for by Lin28a/b 
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regulation of let-7 and subsequent de-repression of let-7 targets, including 
members of the PI3K-mTOR pathway. Interestingly, similar effects to loss 
of Lin28a or overexpression of let-7 were observed using rapamycin - an 
mTOR pathway inhibitor (Zhu et al., 2011). In another study, Zhu and 
colleagues showed that Lin28a transgenic mice manifested increased 
body-size and crown-rump length, as well as delayed onset of puberty, 
findings that also relied on the Lin28-let-7 regulatory pathway (Zhu et al., 
2010). 
Involvement of Lin28 in cell cycle regulation and proliferation made this 
protein an interesting candidate to study in cancer biology. Importantly, 
Lin28a/b reactivation was observed in various malignancies, which 
suggested its role as an oncogene (Viswanathan et al., 2009). As a result, 
depletion of let-7 in nude mice resulted in tumour formation (Chang et al., 
2009b; Viswanathan et al., 2009). This is most likely a result of de-
repression of let-7 targets like c-myc, N-RAS, NF-κB and Il-6 that are well-
known oncogenes (Iliopoulos et al., 2009). Finally, it was suggested that re-
activation of Lin28a/b is correlated with tumour aggressiveness and its 
advanced stages (Viswanathan et al., 2009; Yang et al., 2010).  
1.2.4   Structural determinants for Lin28 action 
Both Lin28 paralogues contains two RNA-binding domains essential for 
protein function (Piskounova et al., 2008). Using EMSA of pre-let-7 with 
the wild-type and point-mutants of Lin28a, it was shown that both 
domains support pre-let-7 binding. Specifically, substitutions of F47A and 
F73A within the Cold-Shock Domain (CSD) and C161A in Cys-Cys-His-
Cys (CCHC) within the Zn-Finger Domain (ZnFD) abolished this 
interaction (Piskounova et al., 2008). However, Graf and colleagues 
applied individual domain PAR-CLIP (iDo-PAR-CLIP) to characterise the 
sequence-specificity of the individual domains in their binding to mRNA 
(Graf et al., 2013). They determined that GGGAG is the lead sequence that 
is recognised by the CCHC ZnFD where the CSD is bound to less specific 
U-rich stretches within the pre-let-7 hairpin. 
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1.2.4.1   Role of the zinc-knuckle domain in substrate recognition and 
uridylation  
Upon interaction with pre-let-7, the second CCHC ZnFD undergoes a 
large conformational twist with 25Å transition of chelated Zn2+(Loughlin 
et al., 2012; Nam et al., 2011). Characteristic within the CCHC domain is a 
Pro-rich linker and its Pro158 undergoes a 130° rotation that greatly 
contributes to the overall transition of the ZnFD. Structural studies also 
showed that each CCHC domain interacts specifically with the first (G1) 
and fourth (G4) guanosine of the GGAG motif by sequence-specific 
hydrogen bonds to the nucleobases (Mayr et al., 2012). Moreover, apart 
from the formation of hydrogen bonds, G1 and G4 were also shown to be 
placed in a hydrophobic pocket formed by the conserved Tyr and His 
residues of the first CCHC and His and Met residues of the second CCHC 
(Nam et al., 2011). 
Interestingly, mLin28a and hLin28a displayed certain differences in the 
mode of binding to the terminal loop. In the mLin28a:GGAG complex, it 
was shown that the G2 residue also interacts with the A3 residue which 
contributes to the formation of a strong kink within the RNA-backbone 
and allowing an additional interaction between A3 and G1 (Nam et al., 
2011). This could explain the potential molecular mechanism by which 
Lin28 interferes with Dicer processing. However, such strong bending of 
the terminal loop was not observed in the case of the hLin28a:GGAG 
complex, which stayed in a more open conformation (Mayr et al., 2012; 
Nam et al., 2011).   
1.2.4.2   Implications of the Cold Shock Domain’s role in structural 
rearrangement of RNA  
The second RNA-binding domain (RBD) that is important for the 
interaction between Lin28 and the pre-let-7 terminal loop is the Cold 
Shock Domain (CSD). CSDs are very broadly distributed RBDs, across 
several kingdoms, and contribute to many processes related to RNA-
metabolism (Mihailovich et al., 2010). 
Mayer and colleagues performed systematic analysis of Xenopus Lin28b 
CSD-binding specificity and they showed that this CSD has highest 
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affinity towards pyrimidine-rich RNA octamers that has at least one 
guanosine at the 5’ flank (Mayr et al., 2012). Other groups who used PAR-
CLIP and genome-wide approach to analyse Lin28 binding motifs 
validated these findings. In general, CSD-specific motifs were located 
upstream of ZnFD “GGAG” motifs, suggesting a fixed arrangement of 
Lin28’s domains on its targets (Graf et al., 2013). 
Co-crystal studies of Lin28 with the pre-let-7 terminal loop showed 
substantial differences between ZnFD and CSD modes of binding. The 
CSD proved to be more rigid and only subtle changes were allowed 
during the formation of the complex (Mayr et al., 2012). The association of 
Lin28a with ssRNA was dominated by π-stacking interactions between the 
RNA molecule and the aromatic residues of the CSD-binding platform. In 
particular, the Lin28 CSD binding platform was determined to bind up to 
8-nucleotides organised in a curved single-stranded stretch with a defined 
orientation (Nam et al., 2011). Moreover, Mayer and colleagues showed 
that the specificity of interaction is mainly achieved via interaction with 
the sixth nucleotide of the octamer. A Lys-Asp salt bridge present in the 
vicinity was shown to limit the flexibility and size of a binding pocket at 
that position, contributing to the formation of a hydrogen bond with 
Uracil (Mayr et al., 2012; Nam et al., 2011). However, the nature of the π-
stack interactions was suggested to play an essential role in the 
recognition of a broader group of targets compared to ZnFD (Mayr et al., 
2012). 
Importantly, aside from its binding affinity, the Lin28 CSD domain was 
suggested to play an important role in remodelling of the secondary 
structure of target RNAs. Nam and colleagues showed that the CSD was 
able to partially melt dsRNA to achieve proper binding properties (Nam et 
al., 2011). Previous enzymatic footprinting studies also showed that upon 
Lin28a binding pre-let-7g was more susceptible to RNAse I cleavage, a 
pattern which is characteristic for ssRNA (Lightfoot et al., 2011). 
Furthermore, using point-mutants of Lin28a, it was shown that the CSD 
binds the terminal loop introducing secondary structure rearrangements 
that facilitates the subsequent binding of the ZnFD to the “GGAG” motif. 
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(Mayr et al., 2012). This co-operative binding hypothesis is strongly 
supported by genome-wide studies showing that the majority of Lin28 




1.3   The role of miRNAs in the development and 
pathogenesis of the nervous system 
 
miRNA-mediated repression of gene expression plays an essential role 
during early animal development and adulthood. The brain is one of the 
tissues that display an extraordinary level of complexity, achieved by a 
multitude of orchestrated cellular programmes. Approximately 70% of 
experimentally detectable miRNAs are expressed in the human nervous 
system and, by regulating the production of thousands of genes, they 
ensure the complex development and function of this elusive organ (Cao 
et al., 2006).  
Surprisingly, only a handful of miRNAs are expressed in a brain-enriched 
or brain-specific manner (Landgraf et al., 2007). Despite this, the time-
dependent accumulation of some ubiquitously expressed miRNAs is 
essential for proper neurogenesis. Several well-studied examples have 
been reported on how miRNAs can regulate the function of the nervous 
system at various stages of development, starting from embryonic 
neurogenesis to synaptogenesis and synaptic plasticity in adults.  
Moreover, it has also been shown how disruptions of global or discrete 
profiles in miRNA networks may lead to aberrant development and 
various neurological disorders.   
1.3.1   The role of miRNAs in neuronal differentiation 
1.3.1.1   let-7 
At the early stages of neuronal differentiation, Lin28a and Lin28b inhibit 
the maturation of miRNAs from the let-7 family (Wulczyn et al., 2007). 
Subsequently, low levels of Lin28 allow let-7 miRNAs to be expressed in 
embryonic and adult brains (Piskounova et al., 2011). The role of let-7 in 
inducing the maturation of neuronal progenitor cells into early neurons 
can be explained by several mechanisms (Nishino et al., 2008). One 
mechanism involves the interaction of Ago1/let-7 with the NHL domain 
of TRIM32 (tripartite motif-containing protein 32) (Schwamborn et al., 
2009). This complex facilitates the asymmetric division of neural 
progenitor cells by activation of let-7 and ubiquitin-mediated degradation 
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of the transcription factor c-Myc (Schwamborn et al., 2009). An alternative 
mechanism suggests that let-7 acts as a suppressor of Tlx and cyclin D1 
expression (Zhao et al., 2009). These proteins are important in regulation 
of neuronal stem cell proliferation and differentiation, by the recruitment 
of histone deacetylases to genes encoding cyclin-dependent kinase 
inhibitor (p21) and PTEN (phosphatase and tensin homologue deleted on 
chromosome 10) (Shi et al., 2004). Both of the above examples highlight the 
importance of co-ordinated expression and maturation of let-7.  
1.3.1.2   miR-9 and miR-124 
miR-9 and miR-124 display a brain-specific expression pattern and have a 
crucial role in neuronal development (Krichevsky et al., 2006). mir-9 is 
expressed from three different loci, pri-miR-9- 1, pri-miR-9-2 and pri-mR-
9-3, which are highly conserved at the nucleotide level. Interestingly, miR-
9 displays a diverse expression profile within the nervous system across 
different species (Leucht et al., 2008; Li et al., 2006; Shibata et al., 2008). In 
Drosophila, miR-9 has been suggested to repress the transcriptional 
activator senseless in selected maturating neurons and developing sensory 
organ precursors (Li et al., 2006). In the zebrafish nervous system, miR-9 is 
linked with the development and maintenance of the MHB (midbrain– 
hindbrain boundary), one of the central organisers of the vertebrate CNS 
(central nervous system) (Wurst and Bally-Cuif, 2001). The suggested 
mechanism of miR-9’s role in the formation of the MHB involves the 
repression of neuron production via inhibition of the mammalian 
transcription factor Hes orthologues Her-5 and Her-9 (Leucht et al., 2008). 
Furthermore, miR-9 was shown to interfere with the signalling cascade of 
the Fgf8 (fibroblast growth factor 8) molecule (Leucht et al., 2008). This 
signalling pathway was previously shown to be important during neural 
plate patterning and the development of the MHB (Wurst and Bally-Cuif, 
2001). Interestingly, it has been proposed that miR-9 regulates the 
neurogenesis of the mouse telencephalon by orchestrating the adjustments 
of a network of transcription factors rather than by the strong inhibition of 
individual elements (Shibata et al., 2011). In human neuronal progenitor 
cells, miR-9 regulates proliferation and migration by targeting Stathmin, a 
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gene implicated in the regulation of microtubule assembly (Delaloy and 
Gao, 2010). Similarly to let-7, miR-9 was also suggested to suppress the 
function of Tlx and leads to the inhibition of neuronal stem cell 
proliferation, resulting in enhanced neuronal differentiation (Zhao et al., 
2009).  
Like miR-9, miR-124 is expressed from three different loci (pri-miR-124-1, 
pri-miR-124-2 and pri-miR-124-3) and is limited to the nervous system and 
is implicated in neurogenesis. One suggested mechanism indicates a link 
between miR-124 and PTBP (polypyrimidine-tract binding protein) (Cao 
et al., 2006; Makeyev et al., 2007). PTBP is a RNA-binding protein that 
exerts a variety of functions that are important in RNA metabolism 
(Dreyfuss et al., 2002). Previous studies have shown that the PTBP 
function differs among various cell types depending on which isoform 
and splice variant is expressed (Romanelli et al., 2000). It has been shown 
that miR-124 regulates neurogenesis by reducing levels of non-neuronal 
PTBP-1, a global repressor of alternative splicing in non-neuronal cells. 
One of the targets of PTBP-1 is an exon of neural-specific PTBP-2. 
Therefore, miR-124 mediated downregulation of PTBP-1 leads to the direct 
activation of a neural-specific PTBP-2 variant (Makeyev et al., 2007). 
Similarly to miR-9, proper co-ordination of Lin28a’s neurogenesis driven 
by the miR-124 is complex and many targets for miR-124 have been 
identified (Fowler et al., 2011; Visvanathan et al., 2007).  
Co-ordination of neuronal development is mainly driven by chromatin-
mediated regulation of multiple genes. The REST [RE1 (repressor element 
1)-silencing transcription factor]/NSRF (neuron-restrictive silencer factor) 
complex is a suppressor of neurogenesis in non-neuronal cells and its 
major function is to bind RE1 at neuronal gene loci and further recruit the 
co-repressor complex containing histone deacetylases and MeCP2 (methyl 
CpG-binding protein 2) (Huang et al., 1999). It has been shown that miR-
124 contributes to the down-regulation of several components of the 
REST/NSRF complex by targeting the expression of SCP1 (small C- 
terminal domain phosphatase 1), MeCP2 and CoREST (co-RE1-silencing 
transcription factor) (Visvanathan et al., 2007). Interestingly, REST also 
regulates the expression of miR-124 via RE1 in all three genomic pri-miR-
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124 loci, suggesting that a feedback loop generated between miR-124 and 
the REST function is important for proper neuronal development (Conaco 
et al., 2006).  
miR-9 and miR-124 have been shown to co-operate during neurogenesis 
by regulating the stage-specific activity of the chromatin-remodelling 
enzyme BAF (Brahma-associated factor) complex (Ho and Crabtree, 2010). 
The BAF complex displays its function during neuronal specification 
depending on its subunit composition, which is remodelled during the 
course of maturation. The BAF53a subunit is associated with the complex 
during the neuronal progenitor phase and becomes replaced by BAF53b at 
the post-mitotic neuronal stage. It has been shown that BAF53a represses 
expression of BAF53b during neurogenesis (Ho and Crabtree, 2010). 
However, during progression through neuronal maturation, REST-
mediated repression of miR-9 and miR-124 is disrupted. It has been 
suggested that up-regulation of these miRNAs inhibits BAF53a 
translation, allowing the BAF53b subunit to enter the BAF complex (Ho 
and Crabtree, 2010). Finally, miR-9 and miR-124 alone displayed the 
capacity to transform adult fibroblasts into neurons (Yoo et al., 2011), 
proving their role as master regulators of neuronal development.  
1.3.2   Role of miRNAs in synaptic plasticity and adult neurogenesis 
The regulation of adult neurogenesis and synaptic plasticity has also been 
linked with various miRNAs (Shi et al., 2010). The architecture of fully 
matured neurons, with protrusions leading from cell bodies to synapses, 
suggests that local regulation of miRNA levels could play an important 
role during adaptation to environmental stimuli. In line with this 
hypothesis, miR-134, miR-132, miR-212 and miR-485 were reported to 
have a function in the regulation of local translation, which shapes long-
term synaptic plasticity (Shi et al., 2010).  
1.3.2.1   miR-132 and miR-212 
LTP (long-term potentiation) or LTD (long-term depression) have been 
linked with instant changes in miRNA levels in the adult mouse 
hippocampus (Park and Tang, 2009). These changes triggered temporal 
mRNA expression profiles that differed between these two forms of 
 40 
activities (Park and Tang, 2009). LTD activity mediated via GluRs 
(glutamate receptors) in the adult hippocampus was shown to cause 
spikes of miR-132 and miR-212 expression (Wibrand et al., 2010). 
Knockout of miR-132/miR-212 resulted in deleterious alterations of 
dendrites (Magill et al., 2010). Moreover, miR-132 has also been shown to 
regulate synaptic plasticity through NMDAR (N-methyl-D-aspartate 
receptor)-mediated LTP via a mechanism that involves the regulation of 
various downstream signalling events, remodelling of the actin 
cytoskeleton and voltage-dependent Ca2+ influx (Cull-Candy et al., 2001). 
Furthermore, it has been demonstrated that miR-132 interacts with FMRP 
(fragile X mental retardation protein), which can potentiate its role during 
development and neuronal function (Edbauer et al., 2010).  
1.3.2.2   miR-134 and miR-138 
Other miRNAs that play important roles in synaptic plasticity include 
miR-134 and miR-138. The former was shown to be involved in the 
processes of cytoskeletal rearrangements and transcriptional regulation of 
genes involved in neurogenesis (Sakamoto et al., 2011). miR-134 is 
suggested to target Limk1 (LIM domain kinase 1), a known regulator of 
actin filament growth, thus displaying potential to control the dynamics of 
spine development. Inhibition of this miRNA resulted in an increase in 
dendritic spine growth in rats (Schratt et al., 2006). The inhibitory effect of 
miR-134 on Limk1 expression is abolished by BDNF (brain-derived 
neurotrophic factor) which helps to maintain correct levels of Limk1 
during neuronal development. Furthermore, miR-134 was shown to 
inhibit BDNF both in vivo and in vitro concomitantly with CREB (cAMP-
response-element-binding protein), a transcription factor involved in both 
neurogenesis and synaptic plasticity (Sakamoto et al., 2011; Schratt et al., 
2006). Moreover, plasticity defects were observed upon knockdown of 
NAD-dependent histone deacetylase SIRT1 (sirtuin 1) in the mouse brain. 
SIRT1 binds to DNA-regulatory elements upstream of the miR-134 locus 
inhibiting its expression and therefore allowing the expression of CREB, 
BDNF and Limk1, as well as other targets of miR-134 involved in 
synaptogenesis and plasticity formation (Schratt et al., 2006).  
 41 
miR-138 has been found in the dendrites of rat hippocampal neurons 
where it regulates dendrite spine morphogenesis (He et al., 2007). The 
suggested mechanism involves miR-138-mediated local inhibition of APT1 
(acyl protein thioesterase 1) (Siegel et al., 2009). Post-translational 
modifications of APT1 regulate association of small G-protein subunits 
within the cell membrane, a process that could significantly alter the 
activity of various cellular receptors. It has been shown that expression of 
miR-138 results in shrinkage of GluR-containing AMPAR (α-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid receptor) clusters and 
subsequently alters the amplitude of postsynaptic currents at excitatory 
synapses (Siegel et al., 2009).  
 
All of the above examples demonstrate the importance of miRNAs at 
various stages of neuronal development. Their involvement in the 
processes related to the early stages of neurogenesis, as well as the 
regulation of the synapse morphogenesis, underline the detrimental 
consequences that could result from the disruption of miRNA levels 
during development and maintenance of the nervous system.  
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1.3.3   A link between miRNAs and selected neurological disorders 
Perturbations of neurogenesis and adult neural function are primary 
triggers of neurological disorders. Therefore, disruption of the neuronal 
miRNA network has the potential to lead to various pathologies of the 
nervous system. Although some genetic studies have shown the 
involvement of miRNAs in Alzheimer’s disease, Parkinson’s disease, 
schizophrenia and other diseases, the detailed molecular basis of their 
action remain largely unknown (Beveridge et al., 2008; Maes et al., 2009).  
 
1.3.3.1   Global disruption of miRNA function 
DGS (DiGeorge syndrome) and FXS (fragile X syndrome) exemplify 
neurological disorders that are associated with a general role for miRNAs. 
The clinical manifestations of DGS are linked to cognitive and behavioural 
deficits leading to various disorders such as obsessive-compulsive 
disorder or autism spectrum disorder (Chang et al., 2009a). The 
pathogenesis of DGS is the result of a common 3 Mb chromosomal 
deletion of a region on chromosome 22 (Chang et al., 2009a). Detailed 
analysis has revealed that the DGCR8 (DiGeorge syndrome critical region 
gene 8) gene lies within the deleted region (Chang et al., 2009a). The 
product of this gene is a component of the Microprocessor complex, 
which, together with the ribonuclease Drosha, mediates nuclear miRNA 
maturation. A mouse model of the 22q11 deletion showed the abnormal 
levels of the mature miRNA fraction in the brain of the animals with this 
chromosomal aberration (Stark et al., 2008).  
FXS was the first disorder to be linked with miRNA functions. Individuals 
suffering from FXS present with learning disabilities as well as cognitive 
and intellectual impairments (Chang et al., 2009a). Genetic analysis 
revealed the molecular basis of the FXS syndrome as expanded CGG 
trinucleotide repeats in the 5′-UTR (untranslated region) of the FMR1 
(fragile X mental retardation 1) gene, which cause instability of the gene 
locus as well as the inhibition of FMR1 expression. The product of the 
gene is FMRP, a small conserved RNA-binding protein implicated in 
translational repression (Chang et al., 2009a). FMRP has been suggested to 
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bridge miRNAs and their target mRNA to guide the miRNA–miRISC 
(miRNA-induced silencing complex) complex to facilitate its function (Jin 
et al., 2004). One model of FXS suggests that loss of FMRP results in the 
disruption of miRISC-mediated repression of translation and subsequent 
deleterious alteration of miRNA target levels.  
1.3.3.2   Individual miRNA-mediated disruption of neurogenesis 
Although there have been many studies linking the role of individual 
miRNAs to the molecular basis of neurological disorders, it is very 
difficult to dissect their molecular role in the pathogenesis of these 
disorders, mainly due to the daunting complexity of the miRNA/mRNA 
network in the brain. However, there is some evidence that individual 
miRNAs can contribute to the pathogenesis of certain neurological 
disorders. For instance, down-regulation of miR-9-5p/miR-9-3p has been 
linked to Huntington’s disease. In healthy neurons, the repressive function 
of the REST–CoREST repressor complex is abolished by its binding to 
huntingtin and its subsequent transfer to the cytoplasm. In Huntington’s 
disease patients, polyglutamine expansion of huntingtin abrogates its 
binding to the co-repressor complex, which remains active and represses 
many genes involved in the early stages of neurogenesis, including miR-9-
5p/miR-9-3p (Packer et al., 2008). In another example, miR-124 was linked 
with disrupted dendrite branching in the pathogenesis of FXS. 
Interestingly, it was suggested that dFMR1 (Drosophila FMR1) assists in the 
biogenesis of miR-124 (Chang et al., 2009a). Indeed, it has been shown that 
ectopic expression of miR-124 results in modulation of dendrite branching 
and this effect was disrupted by the loss of dFMR1 (Chang et al., 2009a). 
Further evidence, based on individual miRNA gene knockouts and 
transgenic animals, is still needed to prove a direct role for these miRNAs 
in neuronal disorders.  
1.3.3.3   miRNA-mediated disruption of neuron maturation and 
synaptogenesis 
Some studies suggest that the disruption of certain miRNAs involved in 
synaptic plasticity could play a role in disorders such as Rett syndrome or 
schizophrenia. Rett syndrome represents a severe autism spectrum 
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disorder in which inefficient silencing of certain regions of the genome 
facilitated by MeCP2 leads to progression of the disease (Amir et al., 1999; 
Wan et al., 1999). Interestingly, it has been suggested that miR-132 can 
modulate the expression of MeCP2 via the BDNF–CREB feedback loop 
(Klein et al., 2007). This could represent a potential mechanism for 
maintaining certain levels of MeCP2 during development of the nervous 
system (Klein et al., 2007).  
In patients with schizophrenia, levels of certain miRNAs involved in the 
development of synaptic plasticity, including miR-132, miR-181b or miR-
219, are elevated in the prefrontal cortex (Maes et al., 2009; Olde Loohuis 
et al., 2012). It has been suggested that miR-181b can regulate the levels of 
the AMPAR subunit GluR2, and RNA-binding protein VSNL1 (visinin-
like 1). GluR2 is involved in synaptic plasticity and regulation of 
excitatory potentials of neurons, whereas VSNL1 modulates neuronal 
maturation via targeting the BDNF signalling pathway (Olde Loohuis et 
al., 2012). These mechanistic insights could potentially explain how the 
up-regulation of miR-181b observed in schizophrenia patients can 




2   Materials	  and	  Methods	  
2.1   Cell culture and differentiation 
Mouse teratocarcinoma P19 and HeLa cells were maintained in standard 
DMEM medium (Life Technologies), supplemented with 10% foetal 
bovine serum (Life Technologies). Retinoic acid-induced neuronal 
differentiation of P19 cells was performed as described before (McBurney, 
1993). Briefly, ~12x106 cells were plated in a non-adhesive 100mm dish 
(Scientific laboratory supplies SLS2002) in DMEM supplemented with 5% 
serum and induced with 1µM of retinoic acid (RA). This induced the 
formation of embryonic bodies. After 4 days, the embryonic bodies were 
re-suspended in DMEM supplemented with 10% serum and re-plated in 
an adhesive dish. Differentiation was followed up to day 9 when cells in 
culture displayed neuronal-like morphology. 
For SILAC Mass Spectrometry, undifferentiated cells were cultured in 
DMEM supplemented with [13C]Arg/[13C]Lys isotopes and 
differentiation was performed using DMEM supplemented with 
[12C]Arg/[12Lys] isotopes (Pierce SILAC Proteins Quantitation Kit – 
ThermoScientific). 
2.1.1   Stable cell line generation 
The P19 cell lines with stable Lin28a-GFP or GFP only expression were 
gifts from Dr Eric Moss, The University of Medicine and Dentistry New 
Jersey, USA (Balzer et al., 2010). Both lines were maintained in standard 
culture conditions. A P19 cell line expressing untagged Lin28a was 
developed using the Flp-in system (Life Technologies), according to the 
manufacturer’s instructions. Briefly, the FRT site was randomly integrated 
in the genome and its integration was verified using Zeocin and lacZ 
selection markers. The Lin28a cDNA was integrated into the FRT site 
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using Flp-mediated recombination and the event was confirmed using 
hygromycin selection.  
P19 stable cell line with inducible expression of Lin28a was generated 
using the Tet-on-3G system from Clontech. In the first step, the Tet-on-3G 
transactivator was integrated in P19 genome. Briefly, 2µg of CMV-Tet3G 
plasmid was nucleofected in P19 cells. Following the first 48hr cells were 
split and after additional 48hr 500µg of G418 was added. Within the first 
two weeks, G418-resistant colonies appeared and 24 individual clones 
were harvested and transferred to the individual wells of 6-well plates. In 
the second step, 2µg of pCMV-3G-Lin28a vector was co-nucleofected with 
100ng of linearised puromycin selection marker. Following the first 48hr, 
cells were split and after an additional 48hr period, 500µg of puromycin 
was added. Within the first two weeks, G418- and puromycin-resistant 
P19 colonies appeared and 24 individual clones were harvested and 
transferred to the wells of 6-well plate. Doxocyclin (Dox) at a 
concentration of 1000ng/mL was then added to activate the expression of 
Lin28a. The induction of Lin28a was confirmed by western blot and clones 
expressing the protein were stored. 
2.2   Transient transfection of miRNA and protein coding 
plasmids 
The pCGT7 plasmids carrying sequences coding for the miRNAs or 
specified proteins were transfected into P19 or HeLa cells using 
Lipofectamine 2000 transfection reagent according to instructions 
provided by the supplier (Life Technologies). One day before transfection, 
cells were seeded in a 6-well plate in an amount of 2x106 cells per well. 
This allowed over 90% confluence to be obtained on the transfection day. 
For single over-expression experiments, 400ng of plasmid DNA was 
transfected into the cells, whereas for co-expression experiments, 200ng of 
plasmid-expressing recombinant protein was mixed with 400ng of 
plasmid expressing miRNA and transfected into the cells. The cells were 
incubated overnight at 37°C and RNA and protein samples were collected 
one day following the transfection. 
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2.3   RNAi in P19 cells 
Pools of siRNAs were obtained from Dharmacon in the format of three 
independent siRNAs targeting different regions of mRNA coding for the 
protein of interest. Then, 4µg of siRNAs was delivered into two 
transfection events separated by 48h using nucleofection technology from 
Lonza. Just prior, the reaction 2mL of media was added to each well of a 6-
well plate. Also, 500µL of media per reaction was transferred to a 15mL 
tube. The plate and tube were placed in the cell culture incubator for 
equilibration. P19 cells were trypsinised and counted. Approximately 
2x106 of cells were distributed accordingly to a number of reactions in 
15mL centrifuge tubes and spun. Cells were re-suspended in 100µL of 
nucleofector solution (82µL of nucleofector solution V plus 18µL of 
supplement – both provided by Lonza Amaxa).  Cells were transferred to 
a nucleofector cuvette containing 4µg of siRNA. Each cuvette was gently 
flicked to mix the solutions and placed into the nucleofector device. C-020 
program was run and briefly 500µL of previously equilibrated complete 
media was added to the cuvette. Content of the cuvette was transferred to 
the previously equilibrated 6-well plate. Cells were collected for analysis 
48h after the nucleofection procedure. If a second round of siRNA 
treatment was required, cell media was aspirated and 200µL of trypsine 
was added to each well. Briefly, after cells detached, 800µL of media was 
used to neutralise the reaction. Cells were subsequently collected by 
centrifugation. At that point, the process was repeated according to the 
description above. After an additional 48h (total of 96h), cells were 
collected for analysis.  
2.4   DNA sequence modification and standard cloning 
2.4.1   Mutagenesis of DNA sequences 
Mutations in DNA sequences were introduced using a PCR approach with 
primers bearing modified single nucleotide changes or designed to 
introduce deletion or insertion via non-complementary flanking sites. In 
the PCR reaction, high-fidelity KOD polymerase was used.  
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KOD polymerase reaction settings 
Component Volume Final Concentration 
10x KOD buffer 5µl 1x 
25mM Mg2SO4 3µl 1.5mM 
10mM Primer Forward 1.5µl 0.3µM 
10mM Primer Reverse 1.5µl 0.3µM 
2mM dNTPs 5µl 0.2mM 
Template DNA 1-5µl 1µg 
KOD polymerase 1µl 0.02U/µl 
water Up to 50µl  
KOD polymerase amplification settings 
Step Temperature Time/cycles 
Polymerase activation 95°C 2min/1 
Denaturation 95°C 20sec/40 
Annealing Lowest primer Tm°C 10sec/40 
Extension 75°C 25sec per kb/40 
 
2.4.2   Restriction Nuclease cleavage and gel extraction 
DNA inserts prepared via mutagenesis or PCR steps were digested 
accordingly to the requirements with specific complementary restriction 
enzymes. The reaction was performed in water in a total volume of 60µL 
containing up to 4µL of each restriction enzyme, and 6µL 10x Cutsmart 
buffer (or other NEB recommended buffer). Subsequently, the reaction 
was incubated at 37°C for a time in the range of 15-60min. Then, 10µL of 
6x loading buffer was added and products were resolved on 0.8–1.2% 
agarose gel with added ethidium bromide under 120V for 30min. The 
DNA bands were visualised under UV light, and then excised and 
weighed.  
Three volumes of buffer QG (Qiagen Gel Extraction Kit, 28704) were 
added to 1 volume of the gel (100mg ~ 100µL) in a 1.5mL microcentrifuge 
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tube. The gel slice was incubated at 50°C for 10min, periodically mixing 
vigorously. After the gel slice was completely dissolved, 10µL of 3M 
sodium acetate and 1 volume of isopropanol were added and mixed. The 
solution was transferred into the spin column provided with the collection 
tube and centrifuged 10000 rpm for 60sec. The column was washed with 
750µL of buffer PE (Qiagen Gel Extraction Kit) and centrifuged at 
13000rpm for 60sec.  Subsequently, this was dried by an additional 
centrifugation step as above. Then, 25µL of water was added and 
incubated at RT for 1min. DNA was collected in the new collection tube by 
centrifugation 13000rpm for 60sec. 
If DNA was used as a template for the T7 in vitro transcription reaction, an 
additional step of wash with 500µL QG buffer was added preceding the 
wash with PE buffer. 
2.4.3   Ligation with T4 DNA ligase 
The cleaved and gel-purified insert fragment was merged with a vector 
cleaved with reciprocal restriction enzymes using either T4 DNA ligase or 
Quick Ligation systems (NEB, M0202, M2200). For standard T4 ligation, 
50ng of vector was mixed with a suitable amount of insert to match the 3:1 
molarity ratio of insert to vector. The reaction was performed in water in a 
total volume of 20µL containing 2µL 10x T4 DNA ligase buffer and 1.5µL 
of T4 DNA ligase. The ligation was incubated at either 4°C overnight (for 
inserts <2kb) or 16°C overnight (for inserts >2kb).  
For the Quick Ligation system, 50ng of vector was mixed with a suitable 
amount of insert to match the 3:1 molarity ratio of insert to vector. The mix 
was made up to 10µL with water and 10µL of 2x Quick Ligation Buffer 
was added. Then, 1µL of Quick T4 DNA ligase was mixed thoroughly and 
the reaction was collected by a short spin. Subsequently, the mix was 
incubated at 25°C for 5min and chilled on ice. 
In the next step, ligated DNA was propagated in the bacteria. 
2.4.4   Bacterial transformation 
In the current work, the following E. coli strains were used in 
transformation procedures – DH5α, TOP10, Stbl3, and Mach1 (Life 
 50 
Technologies). DH5α strain was used as first choice method for standard 
cloning procedures. TOP10 strain has 1000x higher transformation 
efficiency then DH5α cells and was used for cloning of difficult targets. 
Stbl3 cells reduce the frequency of homologous recombination of long 
terminal repeats and result in 10x higher yield than TOP10 cells – these 
cells were used for transformation of large plasmids. Mach1 strain was 
engineered to reduce time required to produce plasmids and were used in 
instances were results had to be quickly obtained.  
Here, 50µL of cells was gently thawed on ice in a 1.5mL microcentrifuge. 
Up to 5µL of ligation reaction or DNA plasmid was added to the cells and 
gently mixed. Cells were incubated for 30min on ice. Subsequently, tubes 
were transferred to a thermo bloc and incubated for 45sec at 42°C. 
Following that, the cells were placed for 2min on ice and subsequently 
450µL of S.O.C. media was added. The reaction was incubated at 37°C for 
1hr with vigorous shaking. Subsequently, 200-500µL of the reaction was 
plated on the agar plate with a selective antibiotic. 
2.4.5   DNA extraction from bacterial cells 
A single colony from the transformant plate was used to inoculate 5mL LB 
liquid culture with an appropriate selection antibiotic. After 24h of 
vigorous shaking at 37°C, cells were spun down at 3000 x g for 15min at 
4°C. The supernatant was discarded and cells were re-suspended in 250µL 
of buffer P1 (QIAgen Spin miniprep kit) and transferred to a 
microcentrifuge tube. Here, 250µL Buffer P2 (QIAgen Spin miniprep kit) 
was added to initiate cell lysis, mixed by inversion and incubated for no 
longer then 5min at RT. Lysis was stopped by adding and inverting 350µL 
of Buffer N3 (QIAgen Spin miniprep kit). Lysed cells were centrifuged at 
12000 x g for 10min at RT.  Supernatants were transferred to the QIAgen 
Spin column by decanting and were centrifuged at 12000 x g for 60sec at 
RT. Subsequently, the flow-through was discarded and the column was 
washed with 750µL of Buffer PE. Following that step, flow-through was 
discarded and the columns were dried by an additional centrifugation 
step at 12000 x g for 60sec at RT. Subsequently, DNA was eluted using 20-
 51 
200µL of water, incubated for 1min at RT and centrifuged at 12000 x g for 
60sec at RT. The concentration of DNA was measured by the Nanodrop 
and transferred to other protocols or sent for sequencing. 
2.5   RNA pull down 
In vitro transcribed precursor miRNA or commercially synthesised RNA 
purchased from Sigma-Aldrich (table S1) was coupled to adipic acid 
dihydrazide-agarose beads (Sigma-Aldrich) in a two-step reaction. The 
activation step included mixing 1000pmol of RNA with 100mM sodium 
acetate and 5mM m-sodium periodate, away from light for 1h at room 
temperature. Following the 1h incubation step, the RNA was precipitated 
on dry ice for 30min by the addition of 800µL of 100% ethanol. The 
precipitated RNA was centrifuged at top-speed at 4°C for 20min. The 
pellet was washed with 1mL 70% ethanol and re-suspended in 500µL of 
100mM sodium acetate pH5.  
Then, 200 µL of beads washed and equilibrated with 100mM sodium 
acetate was mixed with 500µL periodate-treated RNA and left mixing 
overnight at 4°C away from the light. The non-bound fraction of RNA was 
washed away by incubation with 700µL 4M KCl for 30min at RT. The resin 
was collected by 2min centrifugation at 8000rpm. Beads were washed 
twice with 1mL of 2mM KCl and equilibrated with Roeder D buffer 
(100mM KCl, 20% (v/v) glycerol, 0.2mM EDTA, 100mM Tris pH8.0). Total 
protein extracts were prepared by sonication (two times for 5 minutes 
each in ice-chilled water bath) of p19 cells suspended in 600µL of RoederD 
buffer. Resin coupled with RNA was incubated with protein extract in the 
following reaction. Then, 1000µg of the total protein extract was mixed 
with 1.5mM MgCl2, 25mM Ceratin-phosphate, 0.5mM ATP, 5µL RNAse 
out (Roche) and water in a total volume of 650µL. The reaction was 
incubated shaking at 400RPM for 30min at 37°C. The RNA-protein 
complexes were collected by centrifugation for 3min at 1000RPM at 4°C. 
The reaction was washed four times with 1mL Roeder D buffer containing 
1.5mM MgCl2 and twice with Milli-Q-water. Beads were collected by 3min 
centrifugation at 1000rpm between each step.  
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Following the final wash step, the beads were mixed with 6µL of structure 
buffer (10mM Tris-HCl pH7.2, 1mM MgCl2, 40mM NaCl), 5µL A/T1 
RNAse, 5µL RNAse I, 44µL of water and incubated for 30min at 37°C 
shaking at 1400rpm for 10 seconds in one minute intervals. After 
incubation, the beads were collected by a short 1000rpm centrifugation 
and analysed by SDS-PAGE. 
2.6   SILAC assisted quantitative mass spectrometry 
2.6.1   In-gel digestion 
SDS-PAGE with protein samples was resolved briefly until two first size 
marker bands were clearly separated.  
Prior to the procedure, 50mM ABC solution was prepared by dissolving 
0.16g of ABC in 40mL of water in a well-rinsed bottle. The well-rinsed 
bottle was filled with 40mL of acetonitrile and the bench was washed with 
70% ethanol. Work was always performed in nitrile gloves to avoid 
contaminants common for mass spectrometry. The microcentrifuge tubes 
were prepared according to the number of reactions and 200µL of ABC 
solution was transferred into each tube.  
Subsequently, the gel was placed on glass slide and protein bands were 
cut out, sliced into small pieces and transferred into corresponding 
microcentrifuge tubes containing ABC solution. The gel slices were left for 
5min at RT in ABC solution, after which ABC solution was replaced with 
200µL of acetonitrile. These steps were repeated until the gel was de-
stained or the solution stopped turning blue. Subsequently, 50mM ABC 
was supplied with 10mM DTT (10µL 1M DTT added to 990µL 50mM 
ABC) and added to the gel slices until covered completely. The solution 
was left at 37°C for 30min.  
During that step, trypsin buffer was prepared. On ice, 20µL of 0.1% TFA 
was added to 20µg of trypsin in the vial provided. Trypsin buffer base 
containing 10% acetonitrile and 10mM ABC was prepared (100µL 100% 
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acetonitrile, 200µL 50mM ABC, 700µL water). Trypsin buffer was 
prepared by transferring 3µL of trypsin into 227µL of trypsin buffer base.  
After 30min of incubation, liquid was removed from the gel slice and 
200µL of acetonitrile was added for 5min. Subsequently, 50µL (or more 
until gel slice covered) 55mM Iodoacetamide (IAA, Sigma I1149 ) in ABC 
buffer was added and the gel slice was incubated for 20min at RT in the 
dark. IAA was removed and 50mM ABC solution was transferred to the 
gel slice followed by washing with acetonitrile for 5min. Subsequently, the 
wash solution was replaced with trypsin buffer in the amount sufficient to 
cover gel slices and incubated on ice for 15min. An additional amount of 
trypsin buffer was added to gel slices and incubated at 37°C overnight. 
On the following day, 1:1 volume of 0.1% TFA was added and left to 
incubate at RT for 20min (usually around 100µL). The pH was checked 
and brought to pH=1-3 if necessary by the step-wise addition of 0.5µL 10% 
TFA.  
C18 stage tip was made with two column pieces and labelled. The tip was 
activated with 20µL of methanol followed by 40µL of 0.1% TFA. The 
sample was loaded and washed with 60µL of 0.1% TFA until all of the 
liquid was removed. 
2.7   MS analysis and peptide identification 
 
MS-analysis were performed in a Velos LTQ-Orbitrap mass spectrometer 
(ThermoFisher Scientific, UK) coupled on-line to an Ultimate 3000 
RSLCnano System (Dionex, ThermoFisher Scientific, UK). Injections were 
performed in an analytical column with a self-assembled particle frit (34) 
and C18 material (ReproSil-Pur C18-AQ 3 μm; Dr. Maisch, GmbH) was 
packed into a spray emitter (75-μm ID, 8-μm opening, 300-mm length; 
New Objective) using an air-pressure pump (Proxeon Biosystems). Mobile 
phase A consisted of water and 0.1% formic acid; mobile phase B consisted 
of 80% acetonitrile and 0.1% formic acid. The gradient was used over 160 
min. The peptides were loaded onto the column at a flow rate of 0.5 μL 
min-1 and eluted at a flow rate of 0.2 μL min-1 according to the following 
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gradient: 2% to 40% buffer B for 120 min, then to 95% B for 16 min. FTMS 
spectra were recorded at 60,000 resolution and the twenty most intense 
peaks of the MS scan were selected in the ion trap for MS2 (normal scan, 
wideband activation, filling 5.0E5 ions for MS scan, 1.0E4 ions for MS2, 
maximum fill time 100 ms, dynamic exclusion for 60 s). The scan range 
was set between 300 and 1700 m/z. Data analysis was performed using 
the MaxQuant software (ver. 1.0) (Cox and Mann, 2008). Searches were 
conducted against Uniprot database containing Mus musculus sequences. 
Regarding the search parameters, the first search peptide tolerance was set 
to 20 ppm while the main search peptide tolerance was set to 4.5 pm. 
Isotope mass tolerance was 2 ppm and maximum charge 7.  Digestion 
mode was set to “specific” with trypsin allowing two missed cleavages. 
Fixed modifications were set to carbamidomethylation of cysteine and 
acetylation of the N-terminal while variable modifications were set to 
oxidation of methionine. Multiplicity was 2 with Lys6 and Arg10 to be the 
heavy labels. 
2.8   Western blot protein level analysis 
The total protein samples (100µg per lane), isolated by sonication, were 
resolved by standard SDS-PAGE electrophoresis and transferred onto 
nitrocellulose membrane. The membrane was blocked overnight at 4°C 
with blocking solution (1:10 Western Blocking Reagent (Roche) in TBS 
buffer with 0.1% of Tween-20 (TBS-T)). On the following day, the 
membrane was blotted for 1h at RT with antibody solution (1:20 Western 
Blocking Reagent in TBS-T, 1:1000 of primary antibody and 1:1000 of 
appropriate secondary antibody) (table S4). After incubation for 1h, the 
membrane was washed three times with TBS-T and the blot was 
developed with ECL Western Blotting Substrate (Pierce), according to the 
instructions provided by the supplier. 
2.9   Detection of miRNAs levels 
2.9.1   RNA extraction 
Total RNA was isolated from cells using TRIzol reagent (Life 
Technologies), which is a monophasic solution of phenol, guanidine 
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isothiocyanate, and other components that facilitate the extraction of 
various size RNA species. TRIzol reagent is an improvement to the single-
step RNA extraction method developed by Chomczynski and Sacchi 
(Chomczynski and Sacchi, 1987). 
TRIzol or TRIzol LS was used depending on whether the starting material 
was cells, tissues or liquid solution, for instance cell extract.  
Cells were washed with 1x PBS and re-suspended in 1mL of TRIzol (note: 
1mL per a 35mm, 3mL per a 60mm, 8mL per a 100mm dish). If the cell 
extract was used, 1mL of TRIzol LS was added to a total volume 1mL of 
cell extracts (note: cell extract can be diluted with lysis buffer to final 
volume 1mL). The solution was pipetted up and down and left at RT for 
5min to complete the TRIzol lysis. 0.2mL of chloroform was added per 
1mL of TRIzol reagent. The tube was shaken vigorously for 15sec at RT 
(not vortexed) and left to equilibrate for 3 min at RT. The solution was 
subsequently centrifuged at 12000 x g for 15min at 4°C, after which the 
mixture separated into three phases; the upper aqueous phase contains 
exclusively RNA. The tube containing the reaction was slightly tilted and 
the aqueous phase was transferred to the new tube. Here, 0.5mL of 100% 
isopropanol was added to the aqueous phase per 1mL of TRIzol reagent. 
The reaction was incubated for 10min at RT. Subsequently, the mix was 
centrifuged at 12000 x g for 10min at 4°C. The pellet was washed with 1mL 
of 70% ethanol. The reaction was centrifuged at 7500 x g for 5min at 4°C. 
The supernatant was discarded and the pellet was dried for 5-10min, after 
which the pellet was resuspended in 20-50µL of water and incubated at 
55°C. The quantity and quality of the RNA was assayed using the 
Nanodrop and agarose gel electrophoresis. Purified total RNA was 
subsequently used in the methods described below or stored at -80°C.  
2.9.2   Northern blots RNA absolute levels analysis 
Here, 20µg of total RNA was mixed with an equal volume of loading 
buffer (95% Formamide, 18mM EDTA, 0.025% SDS, Xylene Cyanol, 
Bromophenol blue) and resolved on a 10% PAGE-Urea gel. The ribosomal 
RNA was visualised with ethidium bromide to confirm equal loading. The 
RNA was transferred from the gel onto nitrocellulose membrane (Hybond 
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N). The membrane was cross-linked twice with UV and pre-hybridised 
overnight at 40°C with 10mL of hybridisation buffer (1xSSC, 1%SDS, 
200µg/mL ssDNA). 
A Northern probe was prepared using the mirVana™ miR Probe 
Construction Kit (Life Technologies). In the first step, a dsDNA template 
for T7 transcription was generated according to the manufacturer’s 
instructions. The probe was denatured at 95°C for 1min, placed on ice and 
hybridised against the membrane for 2h at 40°C in 10mL of hybridisation 
buffer. Subsequently, the membrane was washed 2-3 times for 30min each 
with 50mL of wash buffer (0.2%SSC, 0.2%SDS). The signal was registered 
with a radiographic film. 
2.9.3   qRT-PCR relative RNA fold change analysis 
In this step, 20µg of total RNA was mixed with an equal amount of 2x 
sample buffer and run on a 10% PAGE-Urea gel. The small RNA fraction 
was cut out of the gel and incubated with 300µL of elution buffer 
overnight at room temperature. The following day, the liquid phase was 
transferred to a new tube and the small RNAs precipitated with three 
volumes of 100% ethanol at -20°C. The samples were then centrifuged and 
washed with 70% ethanol. The RNA was re-suspended in 20µL of water. 
The levels of miRs were assayed using the miRscript kit (Qiagen) and 
Roche Lightcycler, as described by the manufacturer. 
2.10  In vitro transcription of precursor miRNA templates 
2.10.1   T7 templates synthesis  
Pri-miRNA templates for in vitro transcription were generated by 
linearisation of pGEM vector with cloned pri-miRNA sequence. 
Linearisation was performed using SpeI restriction enzyme. For this, 1µg 
of the vector containing pri-miRNA sequence was incubated with 1µL of 
SpeI (10,000 units/ml, NEB - R0133S), 2µL of 10x NEBcutter buffer and 
water in total volume of 20µL. The reaction was performed at 37°C for 1h.  
Pre-miRNA templates for in vitro transcription were generated from 
pGEM vector containing pri-miRNA sequence by standard PCR 
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conditions using Taq polymerase (Life Technologies 10342-020) and 
forward primers containing T7 transcription starting site.  
PCR reaction setting: 
Reaction component Volume required 
10x PCR buffer –Mg2++ 5µL 
10mM dNTPs 1µL 
50mM MgCl2 1.5µL 
10mM Forward primer 2.5µL 
10mM Reverse primer 2.5µL 
100ng pGEM template 1µL 
5U/µL Taq polymerase 0.25µL 
H2O 36.75µL 
  
Taq Polymerase T7 template PCR program setting: 
Step Temperature Time/Cycles 
Initiation 94°C 3min/1 
Denaturation 94°C 30sec/35 
Annealing 55°C 30sec/35 
Extension 72°C 30sec/35 
Final extension 72°C 10min/1 
 
2.10.2   In vitro transcription of unlabelled probes using T7 polymerase. 
Approximately 1µg of template was added to the in vitro transcription 
reaction mix containing T7 polymerase (Lucigen, NxGen T7, 30223-1). The 
mix contained 1-2µL of T7 polymerase (50u/µL), 2.5µL of 10x transcription 
buffer (Lucigen, NxGen, 30223-1), 1.25µL of 10mM rNTPs (Roche, 
11969064001), and, if used for 5’ γ-ATP labelling, 7µL of Guanosine, 0.5µL 
RNAse out (Life Technologies, 10777-019) and water up to a total volume 
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25µL. Each reaction was incubated for 1.5h at 37°C. Following the 
incubation step, the reaction was stopped by the addition of 25µL of 2x 
UED (7.5M Urea, 10mM Tris pH8.0, xylene cyanol, bromophenol) and 
boiled at 94°C for 2.5min. Subsequently, the reaction was cooled on ice for 
2min and resolved using PAGE-Urea gel electrophoresis. For pri-miRNA 
and pre-miRNA templates, 6% and 10% gels were used, respectively. RNA 
bands were visualised by staining with RNA stain solution (0.005% “stain-
all” SERVA, 5% formamide, 25% isopropanol, 15µM TrisHCl pH 8.0). The 
bands were excised and eluted from the gel. Subsequently, RNA was 
precipitated and re-suspended in water.  
2.10.3   In vitro transcription of internal labelled probes using T7 
polymerase. 
Approximately 1µg of template was added to the in vitro transcription mix 
containing T7 polymerase (Lucigen, NxGen T7, 30223-1). The mix 
contained 1-2µL of T7 polymerase (50u/µL), 2.5µL of 10x transcription 
buffer (Lucigen, NxGen, 30223-1), 1.25µL of 10mM rCGA nucleotides 
(Roche, 11969064001), 1.25µL of 1mM rUTP, 0.5µL RNAse out (Life 
Technologies, 10777-019), 1µL of stock 32P-αUTP and water up to total 
volume 25µL. The reaction was incubated for 1.5h at 37°C. Following the 
incubation step, the reaction was stopped by the addition of 25µL of 2x 
UED and boiled at 94°C for 2.5min. Subsequently, the reaction was cooled 
on ice for 2min and resolved using PAGE-Urea gel electrophoresis. For 
pri-miRNA and pre-miRNA templates, 6% and 10% gels were used, 
respectively. RNA bands were visualised by exposure to radiography film 
for a brief moment. The bands were excised and eluted from the gel. 
Subsequently, RNA was precipitated and re-suspended in water. 
2.10.4   5’ labelling of in vitro transcribed probes. 
Unlabelled, in vitro-synthesised probe was 5’ labelled with 32P-γATP using 
T4 polynucleotide kinase (PNK) (NEB, M0201S) in PNK reaction mix. The 
solution consisted of 10µL unlabelled template, 1.5µL of 10x T4 PNK 
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buffer (NEB, M0201S), 1µL T4 PNK (10u/µL), and 2µL of stock 32P-γATP. 
The reaction was performed at 37°C for 10 min. Subsequently, 15µL of 2x 
UED was added to quench the reaction. The solution was heated up to 
94°C for 2min and placed on ice for an additional 2min. For pri-miRNA 
and pre-miRNA templates, 6% and 10% gels were used, respectively. RNA 
bands were visualised by exposure to radiography film for a brief 
moment. The bands were excised and eluted from the gel. Subsequently, 
RNA was precipitated and re-suspended in water. 
2.10.5   RNA probe gel extraction and precipitation 
Following visualisation the band of corresponding precursor probe was 
cut out of the gel and incubated with 300µL of elution buffer (0.3M NaAc 
pH5.2, 0.5M EDTA, 0.1%SDS) overnight at RT. Subsequently, the RNA 
was precipitated by the addition of 900µL of 100% ethanol and left on dry 
ice for approximately 30min or placed at -20°C overnight. Samples were 
centrifuged at top speed for 15min at 4°C and washed with 1mL of 70% 
ethanol. RNA probe was re-suspended with 10-15µL of MilliQ-water. 
2.11  In vitro processing and uridylation assays of precursors 
miRNAs 
Probes consisting of the pri-miRNA or pre-miRNA were incubated for 
30min at 30°C with total protein extracts derived from P19 cells at a 
specific developmental stage or condition. Following the incubation, 
proteinase-K mix (2µL SDS-20%, 2µL proteinase-K, 66µL MilliQ-water) 
was added to the reaction and incubated for 10min at 37°C. Subsequently, 
RNA was extracted with 100µL of phenol-chloroform solution and 
precipitated with solution-P (10µL 3M NaAc pH5, 1µL carrier-tRNA, 
300µL 100% ethanol, approximately 90µL of the aqueous phase from the 
phenol-chloroform extraction). Solution-P was placed on dry ice for 
30min. After precipitation, the RNA was centrifuged at 12000 x g for 
15min at 4°C and subsequently washed with 1mL of 70% ethanol. The 
RNA was re-suspended in 20µL of sample buffer. The samples were 
resolved on a 10% PAGE-Urea gel and visualised by radiography. 
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2.12  EMSA analysis of RNA binding 
Pre-miR-9 and pre-let-7a probes were in vitro-transcribed and internally 
labelled with 32P-αUTP as described before. Then, 1µL of probe (100k 
cpm/µL) was mixed with 100 and 200 ng/µL of recombinant proteins in 
the reaction buffer, which consisted of 1µL of solA (32mM MgCl2, 5µM 
ATP, 0.4M CIP), 5µL of RoederD (100mM KCl, 20%(v/v) glycerol, 0.2mM 
EDTA, 100mM Tris pH=8.0, 0.5mM DTT, 0.2mM PMSF), 0.5µL RNAse-out 
(LifeTechnologies) and water to a final volume of 10µL. Reactions were 
performed on ice for 30 min. Following the incubation 10µL of 2x native 
loading buffer was added (0.02% Xylene Cyanol, 0.02% Bromophenol 
Blue). Then, 20µL of samples were loaded on 6% non-denaturing poly-
acrylamide gel. To prevent excessive heating, the gel was resolved in 0.5x 
TBE at 8W with 5min pre-run at 3W. Following the electrophoresis, the gel 
was dried and exposed to a phosphoimager cassette overnight.  
2.13  RNA-protein binding analysis with structural probing 
Pre-miR-9 and pre-let-7a substrates were synthesised by T7 in vitro 
transcription and 5’ labelled with T4 PNK, as described elsewhere in this 
chapter.  
Formamide ladder was generated by incubating 2µL of substrate (100k 
cpm/µL) with 9µL of F buffer (0.5mM MgCl2 in 99.5% Formamide 
(Molekula Deutshland Limited) at 100°C for 10min. The reaction was 
stopped by adding 9µL of 2xUED and placed on ice. 
T1 ladder was generated by incubating 2µL of substrate (100k cpm/µL) 
with 2µL of T1 2x buffer (20mM Sodium Citrate, 7M Urea), which had to 
be prepared shortly before. Then, 1µL of T1 (1u/µL) was added and 
incubated at 55°C for 15min. The reaction was stopped by adding 15µL of 
2xUED and placed on ice. 
Probes for cleaving substrate RNA were prepared from stock solutions in 
three trial concentrations as follows: 
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•   Pb(II) – 0.2, 0.3, and 0.4mM prepared in water from 20mM Pb(II) 
stock water solution. 
•   T1 – 0.5u/µL, 0.25u/µL, and 0.125u/µL prepared in water from 
T1 stock solution 1000u/µL. 
•   V1 – 0.00075u/µL, 0.000375u/µL, and 0.00019u/µL prepared in 
water from V1 stock solution 0.1u/µL. 
Subsequently, the best cleavage conditions were selected per probe. 
Reactions were run in the presence and absence of the recombinant Lin28a 
protein. For the cleavage optimisation, 200ng/µL of protein was used. In 
the final experiments with fixed probe concentrations, Lin28a was used at 
a gradient of 50, 100 and 200ng/µL. 
Each reaction was prepared as follows: 1µL of substrate (100k cpm/µL) 
was added to 7µL of 1x Structure Buffer (12mM Tris-HCl pH=7.5, 48mM 
NaCl, 1.2mM MgCl2). Samples were incubated at 90°C for 1min and left at 
RT for 5min. Then, 2µL of probes was aliquoted into 8µL of substrate 
solution and incubated at RT or 37°C for 10min. Reactions were stopped 
by adding 10µL of 2xUED and placed on ice. 
Samples were resolved on an ultra-thin large polyacrylamide gel that was 
pre-heated before. Then, 2-5µL of samples were loaded per well. 
2.14  Immunofluorescence analysis of samples 
2.14.1   Cell culture staining 
Here, 24h prior to cell staining, coverslips were coated with poly D-Lysine 
(PDL) by adding 2mL of 10µg/mL solution per well and incubated for 
20min at RT. Coverslips were washed with 1x PBS and cells were plated 
on top of them according to standard tissue culture conditions. 
On the day of staining, culture medium was disposed and 1mL per well of 
4% formaldehyde was added. Cells were incubated in this solution for 
10min at RT. Then, 2mL of 1x PBS was added to dilute 4% formaldehyde 
and fixing solution was aspirated. Cells were washed 3 times for 5min 
each with 1x PBS.  
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Cells were permeabilised by adding 1mL of 0.2% Triton-X per well and 
incubating at RT for 10min. Subsequently, wells were washed three times 
5min each with 1x PBS.  
Following washing, cells were blocked with goat serum at RT for 15min 
by adding 1 drop on parafilm and placing a coverslip inverted on top of it. 
Subsequently 25µL of primary antibody diluted accordingly (Appendix A) 
was placed on parafilm. Coverslip was placed inverted on top at RT for 
1h. 
Following the primary antibody, the secondary fluorescent labelled 
antibody was incubated in the similar manner. Coverslips at that point 
were protected from light by foil. Between blocking, primary and 
secondary steps, cells were washed three times for 5min each. Finally, cells 
were counterstained with 20µL of Hoechst (1/2000 in water) at RT for 
5min and washed once with 1x PBS for 5min. Excess liquid was evacuated 
gently and 15µL of mounting media was placed on the slide; the coverslip 
was inverted on top of it with the specimen facing toward the slide. 
Samples were left to dry in the dark for 1h and analysed by fluorescent 
microscope (Zeiss Axio Imager). If required, samples were stored in the 
dark at -20°C.  
2.15  Protein purification 
Full-length Lin28a coding sequence was cloned into modified pGEX-6p3 
vector where linker containing TEV-cleavage site between GST-tag and 
ORF was deleted. This approach allowed for the effective expression of 
soluble N-terminally tagged Lin28a. This protein interacts very strongly 
with RNA present in bacterial cells. GST-tag stabilised Lin28a, allowing 
for efficient purification in an RNA-free manner using PEI-precipitation 
technique. 
2.15.1   Protein expression in bacterial cell system 
pGEX-6p3-Lin28a constructs were transformed into chemically competent 
E. coli BL21 X-gold strain. Briefly, around 100ng of the plasmid was 
incubated with 50µl of bacteria for 30 minutes on ice. In the subsequent 
step, bacterial cells were exposed to heat shock by incubating at 42°C for 
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45 sec followed by 2 minutes on ice. Then, 450µl of SOC media was added 
to the bacteria and cells were incubated for 1h at 37°C. After the 
incubation period, cells were plated on agar plates with kanamycin 
resistance. 
The following day, a single bacterial colony was inoculated in 5mL LB 
with kanamycin. Liquid cultures were incubated overnight at 37°C. In the 
next step, liquid cultures were scale up by inoculating 2L of LB medium 
with kanamycin at 37°C until OD ~0.6 were reached. At that point, liquid 
cultures were placed at 4°C for 20 min to equilibrate growth rate. In the 
final step of expression, large-scale cultures were induced with 1mM IPTG 
and incubated overnight at 16°C. 
2.15.2   Bacterial cell lysis and lysate preparation 
Large-scale bacterial cultures were centrifuged at 5000 x g for 15 min at 
4°C. Pellets were weight and re-suspended 5ml/g of pellet in lysis buffer 
(50mM Tris pH=7.5, 2M NaCl, 0.5% polyethyleneimine (PEI), 2mM DTT, 
10% sucrose) supplemented with pepstatin, leupeptin and AEBSF protease 
inhibitors. Cells were incubated on ice for 20min and sonicated at full 
power with 8-10 pulses with 2-minute gapes between the pulses. 
Cells were spun down 15000g for ~45min at 4°C. Supernatant was 
collected and diluted 4x slowly using dilution buffer (50mM Tris pH=7.5, 
No salt, 0.5%PEI, 2mM DTT, 10%sucrose). Dilution buffer was added in 
steps by adding 5ml at a time. After white precipitate appeared, cells were 
centrifuged at 15000 x g for 50min at 4°C and supernatant was collected. 
Subsequently, ammonium sulphate was added to 60% saturation and 
lysate was spun down 15000 x g for 50min at 4°C. Supernatant was 
discarded and the pellet was resuspended in 5mL of buffer A (50mM Tris 
pH=7.5, 150mM NaCl, 2mM DTT, 10%sucrose). Resuspended fractions 
were pulled and analysed for UV absorbance below 0.7. 
2.15.3   Liquid chromatography approach to purify expressed protein 
A combination of GST-trap affinity column and size exclusion 
chromatography was used to purify expressed protein. Columns were 
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installed and equilibrated on AKTÅ FPLC instruments. Briefly, 5mL HP 
GST-trap column (GE Healthcare) was equilibrated with 5CV water, 2CV 
buffer B (50mM Tris pH=8.5, 150mM NaCl, 2mM DTT, 25mM 
Glutathione, 10% sucrose) and 5CV of buffer A. Samples were run at a 
1mL/min flow rate at 4°C. After the sample load was complete, the 
column was washed with 10CV of buffer A and the bound protein was 
eluted with 10CV of buffer B. During the whole process, fractions of 1mL 
were collected and analysed on SDS-PAGE for protein composition.  
Lin28a containing fractions were pooled and buffer exchanged to buffer 
GF (10mM Tris pH=7.5, 500mM NaCl, 2mM DTT, 5% sucrose) using 
Sephadex G-25 HiPrep 26/10 Desalting column. Samples were 
concentrated up to a final volume of 500µL using 10 kDa MWKO Pierce 
Protein concentrators. Concentrated samples were loaded on S75 16/60 
gel filtration column (GE Healthcare). The size exclusion step was run at a 
flow rate of 0.5 mL/min and fractions of 1mL were collected. Fractions 
containing Lin28a were pooled and buffer exchanged to storage buffer 
(10mM Tris pH=7.5, 150mM NaCl, 2mM DTT, 5%sucrose). Then, 20µL 
aliquots were flash-frozen in liquid nitrogen and stored at -80°C. 
2.16  Next generation sequencing analysis of global small 
RNA fraction 
2.16.1   RNA library preparation 
Total cell RNA was extracted with TRIzol solution and submitted for 
quality control (QC) for SOLEXA sequencing. After a positive QC-result, 
RNA was run on PAGE gel and species below 30nt were extracted and 
ligated to SOLEXA adaptors at 5’ and 3’ ends. Small RNA molecules were 
amplified for 17-cycles using PCR primers against SOLEXA adaptors and 
fragments of around 90bp (small RNA + adaptor) were gel purified and 
used directly for cluster generation and sequencing analysis using the 
Illumina Genome Analyser. The images files generated by the sequencer 
were then processed to produce digital-quality data. Subsequently, raw 
data were processed to generate clean reads by masking adaptor 
sequences and removing contaminant reads (rRNA, tRNA, mRNA).  
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2.16.2   Small RNA sequencing data analysis 
Clean reads were mapped with a zero-match allowance onto a reference 
mouse genome using BGI-designed SOAPaligner software to locate each 
read on the genome sequence (Li et al., 2008). Subsequently, annotation 
was performed against information in miRBase. Next, newly sequenced 
miRNAs were compared to the reference miRNAs from the database to 
identify potential mutations. Remaining reads that were not included in 
any category were classified as potential novel miRNAs and analysed 




2.16.3   Lin28a binding motif mapping and RNA secondary structure 
analysis 
 
The locations of pre- and pri-microRNAs were extracted from miRBase 
v21 [doi: 10.1093/nar/gkt1181]. The genomic DNA of these sequences and 
their flanking region was extracted using Ensembl [doi: 
10.1093/nar/gkt1196] and Biomart [doi: 10.1093/nar/gkv350] on mouse 
assembly GRCm38. A customised perl script was engineered to map the 
location of the Lin28a identified binding motifs. The total number of 
Lin28a binding motifs was displayed in the context of P19 stable cell line 
context.  
 
The RNA mfold algorithm was used to determine a secondary structure of 
the miRNAs. In order to determine the number of base-paired nucleotides, 
an algorithm was developed in python. Briefly, the centre of the terminal 
loop was referenced as position 0 and paired nucleotides were counted 
upstream and downstream of the pre-miRNA sequences.  
 
Detail of the algorithms used to generate plots and map the binding motifs 






3   Post-­‐transcriptional	   regulation	   of	   miRNAs	  
biogenesis	  during	  neuronal	  differentiation	  of	  P19	  
cells	  
3.1   General consideration regarding P19 differentiation 
system 
 
In order to study the biogenesis of neuronal miRNAs, I decided to use P19 
teratocarcionoma cells. They have the potential to differentiate into 
neurons very easily using retinoic acid (RA). Therefore, they make a 
convenient mouse model with which to induce early neuron development. 
The differentiation process was described before and is summarised in 
Figure 3-1 (McBurney, 1993). Briefly it involves plating cells on non-
adhesive plates in presence of RA for four days, which is the stage referred 
to as early neuronal differentiation, followed by withdrawal of RA and re-
plating on adhesive plates for an additional five days when they reach the 
stage which is referred to as late neuronal differentiation. 
 
Figure 3-1 P19 cells – neuronal differentiation model 
Undifferentiated P19 cells were placed in culture on non-adhesive plates in 
media containing 5% serum. To induce differentiation, cells were treated with 
Retinoic Acid (RA) and left to form embryonic bodies. On day 4, embryonic 
bodies were transferred to an adhesive dish and cultured in media with 10% 
serum in absence of retinoic acid until day 9 or day 19 to obtain neurons or glia 
cells respectively.  
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To confirm the successful differentiation, I collected cells at different time 
points of the differentiation and analysed expression markers. I compared 
changes in Lin28a and Lin28b that were shown in the past to be expressed 
in cells in the undifferentiated state (Balzer et al., 2010) (Figure 3-2). To 
determine the generation of early neurons, I analysed the expression of 
Tuj-1 (β-tubulin class III) that is specifically expressed in early neurons 
(Aggarwal et al., 2015). I also verified equal loading when checking the 
expression of α-tubulin, which is a commonly expressed protein in cells 
regardless of their differentiation state. 
With these in mind, I was able to confirm that Lin28a and Lin28b 
expression is gradually decreased during the differentiation of P19 cells. 
Although their expression was still detectable in the early stages of 
neuronal differentiation, it was not detected beyond day 6. On the other 
hand, the expression of neural markers Tuj-1 and GFAP was not detected 
in undifferentiated cells. Tuj-1 protein gradually started to appear at day 2 
of differentiation reaching maximum expression at days 8-10. 
Interestingly, its expression started to decrease beyond that point. 
However GFAP expression was detected only at the very late stages of 
neuronal differentiation. As expected, the expression of α-tubulin 
remained stable across differentiation (Figure 3-2). 
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Figure 3-2 P19 neuronal differentiation markers 
P19 cells at various stages of neuronal differentiation were harvested and 
analysed with western blot for the expression of stage-specific protein markers. 
Starting from day 0 (d0), cells were collected on every other day until day 10 
(d10) and then on day 15 (d15) and day 19 (d19). β-tubulin class III (Tuj1) and 
Glial fibrillary acidic protein (GFAP) antibodies were used to validate neuro- and 
glio-genesis respectively. Lin28a and Lin28b antibodies were used to confirm 





3.2   miRNA levels are dynamically regulated throughout 
neuronal differentiation 
 
3.2.1   Dynamic regulation of miRNA levels during neuronal 
differentiation of P19 cells. 
 
To characterise the dynamics of changes in the miRNA levels during the 
neuronal differentiation, I applied qRT-PCR analysis. I then correlated 
these levels with corresponding levels of their pri-miRNAs. miR-9 and 
miR-124 were analysed from a subset of neuro-enriched miRNA. 
Additionally, let-7 and miR-302a levels were used to determine 
differentiation efficacy, as let-7 is expressed in differentiating cells, 
whereas miR-302a is responsible for maintenance of the undifferentiated 
state. Throughout the genome, pri-miR-9 and pri-miR-124 have each three 
copies of their pri-miRNAs. Therefore, I analysed pri-miR-9-1, pri-miR-9-2, 
pri-miR-9-3 as well as pri-miR-124-1, pri-miR-124-2 and pri-miR-124-3. 
Let-7 and miR-302 are both large families of miRNAs with eleven loci of 
let-7 genes and four isoforms of miR-302. I selected let-7a and miR-302a 
for further analysis. This analysis allowed me to determine whether the 
observed changes in mature miRNA levels could directly account for the 
alterations in their steady-state transcript levels.  
 
For pri-let-7a, I observed a very modest ~2-fold increase in the primary 
levels at early stages of neuronal differentiation that slightly increased to 
~5-fold at the late stages. Pri-miR-302a displayed less defined pri-miRNA 
expression pattern with its levels being at the early differentiation stages 
downregulated ~2-fold. However, in later stages of differentiation, its pri-
miRNA levels oscillate around those observed at the starting point of the 
differentiation (Figure 3-3).  
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Figure 3-3 P19 differentiation time points - pri-miRNAs levels 
qRT-PCR analysis of pri-miR-let-7a and pri-miR-302a levels during neuronal 
differentiation of P19 cells. Expression of pri-miR-302a and pri-let-7a were 
normalised using Cyclophilin A (CypA) expression. Levels were analysed on 
every second day starting from day 0 (d0) until day 10 (d10) and then on day 15 
(d15) and day 19 (d19). 
 
In the case of the pri-miR-124 family, only pri-miR-124-2 displayed a 40-
fold increase in transcription at the early stages of neuronal differentiation 
and its expression also remained at a similar level during later stages of 
P19 differentiation (Figure 3-4).  However, the expression level of pri-miR-
124-1, which remained silenced during early stages reported an abrupt 
~100-fold increase, exceeding the expression of pri-miR-124-2. Contrary to 
pri-miR-124-1 and pri-miR-124-2, the last member of the family, pri-miR-
124-3, did not display any major increase in levels during the neuronal 
differentiation of P19 cells. Similarly to pri-miR-124, the pri-miR-9 family 
transcription level is also relatively low during the early stages of 
neuronal differentiation when compared to the late stages. In particular, 
on day 4 I detected an ~520-fold increase in pri-miR-9-2 levels with no 
comparable changes in pri-miR-9-2, or -3. However, on day 8, which 
corresponds to the late stage of P19 differentiation, pri-miR-9-1, -2, -3 
expression levels increased by ~400-, ~1300- and ~260-fold, respectively 
(Figure 3-4).  
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Figure 3-4 P19 differentiation time points - pri-miRNAs levels 
qRT-PCR analysis of expression levels of pri-miR-124 and pri-miR-9 families 
during neuronal differentiation of P19 cells. Expression of pri-miR-124 and pri-
miR-9 were normalised using Cyclophilin A (CypA) expression. Levels were 
analysed on every second day starting from day 0 (d0) until day 10 (d10) and 
then on day 15 (d15) and day 19 (d19). 
 
The analysis of mature miRNAs indicated very dynamic regulation of 
their production. In particular, I observed a gradual increase of let-7 levels, 
which corresponded to the decrease of Lin28a and Lin28b. This change at 
day 8 reached a ~260-fold upregulation. In contrast, levels of mature miR-
302a very rapidly dropped at the early stages of neuronal differentiation 
and by day 2 they were detected below ~20% of their initial expression. 
These patterns of let-7 and miR-302a expression are in agreement with 
those previously observed during cell differentiation (Balzer et al., 2010; 
Lipchina et al., 2011; Parchem et al., 2015; Wang et al., 2014). Also, let-7 
levels correlated with expression pattern of its known regulator – Lin28. 
Additionally to suggesting post-transcriptional mechanisms regulating 
miR-302a and let-7 production, these two observations validate our 
neuronal differentiation system. 
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Following the initial validation of the assay, I decided to determine 
changes to the mature neuro-enriched miR-9 and miR-124. Interestingly, 
throughout the differentiation, mature levels of miR-124 remained 
undetected. However, levels of miR-9 were changed dramatically but did 
not correlate linearly when compared to pri-miR-9 expression pattern. 
Specifically at the early stages of neuronal differentiation, miR-9 levels 
were induced by ~50-60-fold which suggests that only approximately 10% 
of pri-miR-9 expressed at this stage is processed. Importantly, at the late 
stages of neuronal differentiation I observed a 500-550-fold increase in 
miR-9 expression levels, indicating ~40% processing of its primary 
transcript (Figure 3-5). 
 
Data presented here was normalised to miR-16 and CypA levels in the 
case of mature and primary miRNA levels analysis respectively. 
 
Figure 3-5 P19 differentiation time points - miRNA levels 
qRT-PCR analysis of mature miR-302a, let-7a, miR-124 and miR-9 levels 
throughout neuronal differentiation of P19 cells. Expression levels were 
normalised using miR-16 expression. Levels were analysed on every second day 




qRT-PCR is a very good method allowing for the accurate and fast 
quantification of expression changes. However, it relies strongly on the 
specificity of primers and does not allow for the direct measurement of 
this specificity during the quantification process. However, I determined 
the specificity of primers used in qRT-PCR assays after the amplification 
process with analysis of their melting curve (data not shown). I decided to 
confirm my qRT-PCR results in a more direct way. Therefore, I performed 
northern blot analysis with probes specific for mature miR-9, miR-302a 
and let-7. As the probing sequence is also present in their precursor 
miRNAs, this approach should allow the detection of both mature and pri-
miRNA levels. Furthermore, northern blot analysis allows for the absolute 
detection of RNA levels. Therefore, the observed changes did not require 
any normalisation step. 
 
I confirmed with northern blot the abundance of miR-9, miR-302a and let-
7a at differentiation stages characteristic for a given miRNA (Figure 3-6). 
Importantly, for pri-let-7, northern blot did not show any changes of levels 
at three different time-points of differentiation, but clearly indicated a 
strong induction of mature let-7 levels on day 9. Similarly to pri-let-7, pri-
miR-302a levels detected by northern blot were also not changed 
throughout the differentiation. However, probe against mature miR-302a 
showed its strong downregulation following the initiation of 
differentiation. In the case of miR-9, using northern blot showed a gradual 
increase throughout P19 cell differentiation. Unfortunately, the detection 
of pri-miR-9 was not strong enough to state with high confidence its 
increase throughout the differentiation process. Interestingly, I also did 
not observed any changes of mature miR-124 throughout the 
differentiation process (Figure 3-6). 
Equal loading of RNA was ensured comparing levels of U1, S5 and tRNA 
at three different time points of the neuronal differentiation analysed. 
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Figure 3-6 P19 differentiation time point - northern blot analysis 
Northern Blot analysis of let-7a, miR-302a, miR-9, miR-124 and their precursors 
at day 0, day 5, day 9 of neuronal differentiation of P19 cells. Equal loading was 
ensured by staining total RNA with ethidium bromide to visualise U1, 5S and 
tRNA fractions prior to probe hybridisation. 
 
Finally, to reach a complete level of confidence, I measured in an unbiased 
way levels or pri-miR-9 and mature miR-9 as counts detected in RNA-
sequencing and small RNA-sequencing, respectively. This analysis was 
performed for undifferentiated (day 0) and early-differentiated (day 4) 
cells (Error! Reference source not found.). I confirmed previous 
observations and showed that pri-miR-9-2 normalised counts increased 
from undetectable on day 0 to ~400 on day 4. Importantly, this change 
very poorly corresponded to the change of mature miR-9, which 
accumulated very modestly to ~4 normalised reads on day 4. This was in 
contrast to another miRNA, which is strongly induced upon retinoic acid 
treatment – miR-10a. In this case, pri-miR-10a levels increased from 
undetectable on day 0 to ~170 normalised reads on day 4. Unlike miR-9, 
mature levels of miR-10a followed this change and increased from ~4 
normalised counts on day 0 to ~460 normalised counts on day 4.  
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Importantly, the levels of pri-miR-16 and mature miR-16 remained 
relatively stable during the differentiation. This further supported the use 
of miR-16 as a normalisation factor for qRT-PCR. 
 
Figure 3-7 P19 day4 neuronal differentiation - RNA sequencing. 
Small RNA sequencing and regular RNA sequencing were performed on day 0 
(orange bars) and day 4 (red bars) of retinoic acid-induced P19 neuronal 
differentiation. Primary and mature miRNA levels were analysed for miR-9, 







3.2.2   Post-transcriptional regulation of pri-miR-9 and pri-miR-124 
processing 
 
It has been previously reported that let-7 biogenesis is controlled post-
transcriptionally and my current findings corroborate with these 
observations (Chang et al., 2013; Desjardins et al., 2014; Heo et al., 2009; 
Lightfoot et al., 2011; Loughlin et al., 2012; Piskounova et al., 2011; 
Piskounova et al., 2008). Moreover, they also suggest that miR-9 and miR-
302a biogenesis could be regulated post-transcriptionally as their mature 
miRNA levels did not directly follow the pattern of pri-miRNA 
transcription. 
 
To determine whether biogenesis of brain enriched miR-9 and stem cell 
specific miR-302a is post-transcriptionally controlled, I employed an in 
vitro processing assay. Briefly, radiolabelled in vitro transcribed primary 
miRNA probe was incubated with either extracts derived from 
undifferentiated (day 0 – lane 1) or differentiated (day 9 – lane 2) P19 cells 
(Figure 3-8). This approach allowed post-transcriptional and 
transcriptional events to be uncoupled by eliminating the later. Therefore, 
all of the observed changes could be related to the post-transcriptional 
mechanism.  
 
As before, I used the performance of pri-let-7a as a benchmark, as its in 
vitro processing and post-transcriptional mechanisms have been 
previously extensively studied (Chang et al., 2013; Desjardins et al., 2014; 
Faehnle et al., 2014; Hagan et al., 2009; Piskounova et al., 2008). 
Importantly, I was able to recapitulate previous observations, as I did not 
observe efficient processing of pri-let-7a in extracts derived from early 
stages of neuronal differentiation. However, late-differentiation extracts 
provided favourable conditions for the processing of pri-let-7a, likely due 




In the case of pri-miR-302a, I observed the opposite situation as its 
primary miRNA was efficiently processed in undifferentiated extracts 
when compared to the day 9 reaction. 
Interestingly, I observed a processing pattern for pri-miR-9 similar to that 
of pri-let-7a. Specifically, in vitro processing of pri-miR-9 was almost 
undetectable in day 0 extracts and became more efficient on day 9. These 
results suggested that processing of both miR-9 and miR-302a could be 
regulated by the presence of negative or positive factors in 
undifferentiated and differentiated cells, for both miRNAs acting in 
opposing manner.  Moreover, in the case of pri-miR-9 processing in day 0 
P19 extracts, I observed a non-specific product that did not correspond to 
pre-miR-9, as it was not detected in processing reaction in day 9 P19 and 
HeLa cell extracts. This observation could potentially suggest the 
destabilisation of pre-miR-9 in day 0 P19 extracts. Processing of pri-miR-




Figure 3-8 P19 neuronal differentiation in vitro processing - pri-miRNAs 
Extracts from day 0 and day 9 (lanes 1 and 2, respectively) of P19 cell extracts 
were incubated with in vitro-transcribed pri-miR-9-1 to determine levels of post-
transcriptional processing at different stages of neuronal differentiation. Pri-let-
7a-1a, pri-miR-302a and pri-miR-101 were used to validate distinct differentiation 
stages of P19 cell extracts. 
 
To confirm the specificity of the processing reaction and molecular 
weights of the precursor miRNAs, I compared processing of the pri-let-7a 
and pri-miR-9 in HeLa extracts before and after the depletion of Drosha or 
DGCR8. Importantly, in vitro processing in extracts derived from RNAi 
treated Drosha or DGCR8 cells displayed complete inhibition of the 
primary miRNA processing in the absence of the microprocessor 
components (Figure 3-9).  
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Figure 3-9 In-vitro processing in Drosha/DGCR8 null extracts - pri-
miRNAs 
Pri-let-7a and pri-miR-9-1 probes were incubated with HeLa wild type extracts 
(lane 2) and extracts derived from Drosha/DGCR8 siRNA treated cells to 
estimate specificity of the processing products (lanes 3 and 4). 
 
These findings reinforced my previous in vivo observations of the dynamic 
character of miRNA production. Furthermore, they suggest the existence 
of auxiliary factors post-transcriptionally regulating pri-miR-9 and pri-
miR-302a processing. 
3.2.3   Terminal loop of pri-miR-9 and pri-miR-124 is involved in the 
post-transcriptional regulation of their processing 
 
Previous work supported role of pri-let-7a conserved terminal loop (CTL) 
as a platform to mediate post-transcriptional events (Desjardins et al., 
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2014; Lightfoot et al., 2011; Loughlin et al., 2012). Therefore, I decided to 
compare pri-miR-9 and pri-let-7a terminal loops. As the pri-let-7a terminal 
loop manifested strong evolutional conservancy across vertebrates, I 
determined the level of preservation of the pri-miR-9 terminal loop using 
the muscle DNA/RNA alignment algorithm (Edgar, 2004). As shown in 
Figure 3-10, pri-miR-9-TL is well conserved across mammals, which could 
potentially underline its biological importance.  
Moreover, I used the mfold programme to predict secondary structures 
for both pri-miRNAs. Interestingly, both terminal loops vary in size and 
predicted secondary structures. The pri-let-7a terminal loop is larger, with 
33nt, and is formed of two hairpins (Figure 3-11a). In contrast, the pri-
miR-9 loop is much smaller and with only 14nt was predicted to form a 
classic single hairpin (Figure 3-11a). Interestingly, both loops contained 
the “GGAG” motif that was shown to play an important role in binding 
Lin28a ZnFD and the subsequent uridylation and degradation of pre-let-
7a (Mayr and Heinemann, 2013; Nam et al., 2011). What is even more 
striking is that upstream of the “GGAG” motif, both pri-let-7a and pri-
miR-9 terminal loops contain a stretch of sequence rich in “G” and “U” 
nucleotides that was shown to be important for binding Lin28a CSD 
(Mayr et al., 2012; Nam et al., 2011). 
 
Figure 3-10 pre-miR-9 conservation. 
Pre-miR-9 sequences of several species were aligned using multiple alignment 
muscle algorithm. RNAfold was used to predict secondary and free energy 
values (MFE) structure on the calculated consensus sequence. Red box represents 
the region corresponding to the conserved terminal loop. 
hsa –Homo sapiens, mmu – Mus musulus, rno – Rattus norvegicus, ppy – Pongo 
pygmaeus, ptr – Pan troglodytes, bta – Bos Taurus, cfa - Canis familiaris, aca - Anolis 
carolinensis. 
 
In order to determine the functional relevance of miR-9-CTL, I performed 
an in vitro processing assay in the presence of unlabelled pri-miR-9-CTL 
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and pri-miR-124-CTL, which served as competitors for potential 
processing factors. I used unlabelled pri-miR-124-CTL to control for the 
specificity of the competition assay. As expected, pri-miR-9 was not 
efficiently processed in day 0 P19 cell extracts. However, this processing 
was greatly increased upon addition of the unlabelled pri-miR-9-CTL. This 
effect was specific as I did not observe an increase in pri-miR-9 processing 
efficiency upon the addition of pri-miR-124-CTL (Figure 3-11).  
 
Figure 3-11 P19 day 9 - in vitro processing - CTL competition assay 
In vitro processing was performed in presence of the terminal loops that served 
as competing factors. 
Top panel) mfold representation of miR-9-1 and miR-124-CTL used in the assay 
Bottom panel) Processing reaction of pri-miR-9-1 in undifferentiated cells. No 
competing terminal loop added – lane 2. Terminal loop of pri-miR-9-1 and pri-




3.3   Identification of putative factors mediating the post-
transcriptional regulation 
3.3.1   General consideration regarding protein identification strategy 
 
Thus far, all of my findings suggested the presence of protein factors that 
could interact with the terminal loop of pri-miR-9 and inhibit the 
processing of the precursor miRNA or initiate its destabilisation.  
 
I decided to use RNA-pull-down and mass spectrometry to identify these 
proteins. In order to obtain differentiation stage-specific RNA-pull-down, 
I performed stable isotope labelling of amino-acids (SILAC) in cultured 
P19 cells. Heavy [13C]Arg/[13C]Lys or light [12C]Arg/[12Lys] isotopes 
were incorporated in cultured P19 cells and confirmed using mass-
spectrometry for proper peptide weight detection (data not shown). 
Subsequently, P19Light cells were differentiated as described above to 
obtain day 9 extracts, whereas P19Heavy were maintained 
undifferentiated to prepare day 0 extracts. I then mixed day 0 and day 9 
extracts together before performing pull down to minimise an 
experimental error and obtain unbiased information about stage-specific 
protein composition.  
 
As represented in Figure 3-12, precursor RNA molecules coupled to beads 
were used to precipitate protein complexes from extracts derived from 
undifferentiated (day 0) and differentiated (day 9) P19-labelled cells. The 
results for identified proteins were annotated as heavy to light peptide 
ratios. Therefore, protein complexes that were characteristic for 
undifferentiated P19 cells were represented as an increasing ratio above 1. 
Respectively, protein complexes that were characteristic for differentiated 
P19 cells were represented as a decreasing ratio between 0 and 1. 
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Figure 3-12 Schematic representation of SILAC-MS identification 
approach 
In order to determine putative processing factors interacting with pre-miR-9-
CTL. Full-length pre-miR-9 or its CTL were coupled with the beads and 
incubated with differentially labelled extracts derived from undifferentiated and 
differentiated cells. Extracts were mixed and incubated with bead conjugated 
RNA. Following series of stringent washed ribonucleoprotein complexes were 




3.3.2   Protein identified to interact with pre-miR-9 and pre-miR-124 
 
Using SILAC-assisted RNA-pull-down, I managed to identify several 
proteins that interacted with pri-miR-9-CTL in a stage-specific manner. 
Those who interacted, especially on day 0 P19, were RAP1-interacting 
factor homolog (Rif1), Lin28A, and Line1-type transposase domain-
containing protein Sal-like protein 4 (Sall4). On the other hand, RNA-
binding proteins Musashi-1 (Msi1) and Neuro-Oncological Ventral 




Figure 3-13 SILAC-MS analysis - pri-miR-9-1-CTL 
Results of ribonucleoprotein complexes associated with pri-miR-9-1-CTL 
represented as day 0 /day 9 ratio. 
 
To further confirm the interactions, I performed SILAC combined with 
full-length pre-miRNA pull-down and mass spectrometry using extracts 
from undifferentiated P19 cells. I was able to show that pre-let-7a 
interacted with Lin28a as well as Khsrp and hnRNPA1, all of which were 
implicated in the regulation of let-7 biogenesis. For some reason, I did not 
identify CCHC11 (Tut4) in my pull-down, potentially suggesting that 
Lin28a/Tut4 interaction might be transient under these experimental 
conditions. 
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The pre-miR-9 pull-down revealed a number of other specific factors that 
may contribute to the regulation of miR-9 processing. However, when full 
length pre-miRNA and terminal loop pull-downs were compared, only 
Lin28a was found to associate with pre-miR-9-1. Importantly, I could 
show that Lin28a fold-enrichment with these molecules were similar to 
that observed with pre-let-7a (Figure 3-14). 
These data provide strong evidence that Lin28a can be involved in the 
post-transcriptional regulation of miR-9 biogenesis. Therefore, I decided to 
validate this finding and characterise its functional relevance. 
 
 
Figure 3-14 SILAC-MS analysis - pre-miRNA pulldown 
Ribonucleoprotein complexes associated with full length pre-let-7a-1 and pre-
miR-9-1. Results represented as the enrichment of protein factors on RNA 
conjugated beads versus unconjugated beads. Two tables represents two repeats 
of the SILAC MS analysis. 
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3.3.3   Validation of Lin28a interaction with the terminal loop of pri-
miR-9 
 
In order to validate quantitative mass spectrometry findings, I performed 
separate pull-down reactions in day 0 and day 9 extracts (Figure 3-15). 
Subsequently, I resolved associated protein complexes using SDS-PAGE 
electrophoresis and identified proteins using specific antibodies. I was 
able to demonstrate that proteins bind specifically to conjugated RNA 
molecules as no antibody binding was observed in pull-downs performed 
with unconjugated beads. In day 0 extracts, I confirmed that Lin28a 
interacted with pri-miR-9-1-CTL. On the other hand, Msi1 interacted with 
the terminal loop only in day 9 extracts. Importantly, hnRNPA1, an 
abundant RNA-binding protein, was shown to interact with pri-miR-9-1-
CTL in both day 0 and day 9 extracts. These observations strongly support 
SILAC MS findings that Lin28a interacts with pri-miR-9-1-CTL in 
undifferentiated P19 cells. 
 
Figure 3-15 SILAC-MS - validation of assay specificity 
Pull-downs with unconjugated beads and beads conjugated with pri-miR-9-CTL 
were performed on day 0 and day 9 separately to confirm the specificity of the 
assay and validate the MS results. Following the stringent washes, 
ribonucleoprotein complexes were resolved on PAGE and analysed with western 
blot for the expression of day 0 and day 9 specific Lin28a and MSI1, respectively. 
Equal loadings were ensured by incubation with hnRNP A1 that expression is 
constant between day 0 and day 9. 
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3.4   Functional relevance of Lin28a-pre-miR-9 interaction 
The expression of Lin28a is dynamically regulated throughout neuronal 
differentiation. Its expression is elevated during the early stages of 
development and is switched off during differentiation (Vogt et al., 2012). 
The regulation of its levels is essential for the inhibition of let-7 production 
at the early stages of differentiation and development (Balzer et al., 2010). 
In order to determine whether Lin28a is also involved in the biogenesis of 
miR-9, I implemented two strategies. Firstly, I decided to deplete Lin28a in 
P19 cells and subsequently allow their differentiation, with lower than 
normal levels of Lin28a, until day 4. In the second approach, I generated 
P19 stable cell lines that maintain expression of Lin28a throughout the 
neuronal differentiation. 
3.4.1   siRNA mediated knockdown of Lin28a leads to an increase of 
mature miR-9 levels 
In order to knockdown Lin28a levels, I electroporated a pool of siRNAs 
against mouse Lin28a. Subsequently, 48h after electroporation, I induced 
differentiation with retinoic acid; on day 4, following the RA treatment, I 
collected the cells and analysed the material. Western blot analysis of 
Lin28a expression at day 4 of the differentiation demonstrated that the 
protein was depleted efficiently to around 20-30% of mock treatment 
(Figure 3-16). 
 
Figure 3-16 P19 d4RA - Li28a RNAi - western blot 
P19 cells were treated with control and Lin28a siRNAs and differentiated until 
day 4 (lanes 1 and 2 respectively). Western blot shows levels of Lin28a depletion 
in relation to levels of α-tubulin. To estimate the efficiency of the knockdown, 
serial dilutions of mock extracts were analysed along the depleted samples (lanes 
3 to 7).  
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Next, I analysed mature levels for panel of miRNAs at day 4 of P19 cells 
differentiation. The results were normalised to miR-16 levels and 
represented as fold-change in respect of mock RNAi treatment that was 
fixed to 1 (Figure 3-17). As expected, depletion of Lin28a resulted in a ~4-
fold increase of let-7a levels at day 4 of differentiation. The levels of 
miRNAs unrelated to neuronal development, miR-101 and miR-122, 
remained unchanged. Crucially, Lin28a knockdown resulted in a modest 
but statistically significant 1.6-fold increase of miR-9 levels at day 4 of P19 
neuronal differentiation. 
 
This result suggested that miR-9 could indeed undergo Lin28a-mediated 
regulation. The discrepancy between the observed effect of Lin28 
depletion on levels of miR-9 and let-7 could account for the different levels 
of the corresponding pri-miRNAs. As I showed previously expression of 
pri-let-7a is stable throughout the differentiation whereas pri-miR-9 is not 
present in undifferentiated P19 cells and its transcription is switched on 
early during neuronal differentiation (Laneve et al., 2010). This could 
suggest that the higher amounts of pri-let-7a would give rise to more 
mature let-7a in the absence of the inhibitor. 
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Figure 3-17 P19 d4RA - miRNA levels 
Knockdown of Lin28a was followed with qRT-PCR analysis of mature miR-9 and 
let-7a levels at day 4 of analysis. miR-9 and let-7a levels were normalised to miR-
16 and control RNAi-treated samples were fixed as a baseline. miR-101 and miR-
122 were analysed as negative controls. Statistical analysis was performed using 




3.4.2   Constitutive expression of untagged but not GFP-tagged Lin28 is 
associated with downregulation of mature miR-9 levels 
 
As RNAi mediated depletion of Lin28a resulted in modest upregulation of 
miR-9 levels likely due the low levels of pri-miR-9, I decided to check 
whether the maintenance of Lin28a in the later stages of P19 neuronal 
differentiation can complement the results of the RNAi experiment. At 
later differentiation stages, the expression of pri-miR-9 is high which 
should result in the stronger effects of Lin28a on its processing. To address 
this, I used two P19 stable cell lines.  
 
In the first P19 cell line, human Lin28a was C-terminally tagged with GFP 
protein and randomly inserted into the genome. As a control for this line, 
P19 with the random integration of only GFP was used (the cells were 
gifts from Eric Moss). The second cell line was engineered using 
LifeTechnologies FLP-strategy. Briefly, this is a two-step process involving 
FRT recombinase. In the first step, I randomly integrated the FRT-site to 
the genome and confirmed the single integration site in open chromatin 
state using southern blot and lacZ assay (data not shown). In the second 
step, I targeted previously integrated site with a vector containing FRT 
complementary sequence and untagged-human Lin28a in the presence of 
FLP-recombinase. As a control for this a “mother” P19 cell line with 
integrated FRT only was used.  
 
In order to determine whether prolonged expression of Lin28a affects let-
7a and miR-9 levels, stable cell lines constitutively expressing Lin28a or 
Lin28aGFP were subjected to retinoic acid-mediated neuronal 
differentiation. Western blot analysis of both untagged and GFP-tagged 





Figure 3-18 P19 Lin28a stable cell lines - western blots 
Lin28a:untagged and Lin28a:GFP expression is sustained throughout 
differentiation and remains at similar levels at both undifferentiated and 
differentiated cells. Protein samples derived from day 0 (d0) and day 9 (d9) were 
resolved on 4-12% PAGE and analysed with western blot for the expression of 
Lin28a or Lin28aGFP. Endogenous Lin28a was expressed only in d0 protein 
extracts from control protein extracts – P19 FRT and P19 GFP cell extracts. 
Constitutive expression in d0 and d9 of untagged Lin28a was confirmed in P19 
FRT:Lin28a cell extracts. Lin28a:GFP migrated as higher molecular weight band 
in respect to endogenous Lin28a and its constitutive expression was confirmed in 
d0 and d9 cell extracts. To validate equal loading western blot analysis of α-
tubulin was performed. 
 
The stable expression of untagged and GFP-tagged Lin28a resulted in a 
decrease of let-7 levels in the final stages of the neuronal differentiation of 
P19 cells (Figure 3-19). Surprisingly, constitutive expression of untagged 
Lin28a but not Lin28aGFP resulted in a significant reduction of miR-9 
levels in the final stages of P19 cell neuronal differentiation (Figure 3-19). 
Similar results were obtained from two independent Lin28a integrations. 
This is a very important observation for a couple of reasons. Firstly, it 
validates Lin28a as a post-transcriptional regulator of miR-9 biogenesis. 
Secondly, it shows that GFP-tagged Lin28a could be functionally 
compromised. Finally, it provides evidence that the mechanisms of 
Lin28a-mediated inhibition of microRNA biogenesis might be different for 
let-7 and miR-9. 
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Figure 3-19 P19 Lin28a stable cell lines - miRNA levels 
P19 stable cell lines were differentiated and mature miRNA levels of miR-9, let-7a 
and miR-101 were compared in day 0 and day 9 of individual P19 cell lines. 
Results were normalised to miR-16 expression and expression in the P19FRT cell 
line was set as the baseline. Statistical analysis was performed using t-test on 
representative sample size n=3. 
 
In order to eliminate the possibility that observed down-regulation of 
miR-9 in day 9 is an indirect effect of Lin28a affecting the differentiation 
process in general, I used an inducible stable cell line. In this case, a P19 
stable cell line was generated that expresses transactivator and untagged 
Lin28a upon treatment with doxycycline (Dox). Prior to Dox treatment, 
cells were differentiated with retinoic acid until day 9 at which point Dox 
was added to trigger the expression of Lin28a. The expression of Lin28a 
was confirmed with western blot (Figure 3-20a). Importantly, similarly to 
the untagged constitutive P19:Lin28a stable cell line, both let-7 and miR-9 
levels were downregulated upon the induction of Lin28a (Figure 3-20b). 
Moreover, as the differentiation process occurred in this scenario as in the 
wild-type P19 cells, the observed decrease in let-7 and miR-9 levels could 
account for the induced ectopic expression of Lin28a.  
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Figure 3-20 P19 Tet-On Lin28a - mature miRNA levels 
P19 cells were differentiated as normal and Lin28a was induced with 
Doxycycline upon differentiation. 
a)   Western Blot – Comparison of Lin28a levels between day 0 (d0) and day 9 
(d9) in P19FRT control cell line and Lin28a inducible P19 cells. Protein 
samples were resolved on 4-12% PAGE and analysed with western blot 
for the expression of Lin28a. Equal loading was ensured with western blot 
analysis of α-tubulin. 
b)   qRT-PCR – comparison of mature miR-9, let-7a and miR-101 levels in 
undifferentiated and differentiated cells. Results were normalised to miR-
16 expression and expression of the miRNAs in day 9  of Dox(-) cells was 
set as a baseline. Dox(-) - doxycycline untreated; Dox(+) – doxycycline 
treated. Statistical analysis was performed using t-test on representative 
sample size n=3. 
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I also tested for a potential negative feedback loop on transcription by 
characterising the expression of pri-miR-9 and pri-let-7a in constitutive 
and inducible cell lines (Figure 3-21a and Figure 3-21b). Interestingly, the 
levels of pri-miR-9 transcripts were also decreased upon doxycycline 
treatment, suggesting that Lin28a can directly or indirectly influence the 
abundance of primary miR-9. However, pri-let-7a-1 levels were 
upregulated upon doxycycline treatment showing that Lin28a could play 
a dual role in feedback regulatory circuits. Nevertheless, these findings 
together confirm the role of Lin28a in the regulation of miR-9 production 
and also indicate its dual character by affecting both post-transcriptional 




Figure 3-21 P19Lin28a stable lines - pri-miRNA levels 
P19 Lin28a stable cell lines were differentiated and pri-miRNA levels were 
analysed. 
a)   pri-miR-9-1, -2, -3 levels upon differentiation of P19 cells with constitutive 
expression of Lin28a:untagged. Results were normalised to Cyclophilin A 
expression and the pri-miRNAs expression in day 9 P19 FRT control cell 
lines was set as a baseline. 
b)   Pri-miR-9-1, -2, -3 levels prior to the differentiation and induction with 
doxycycline in P19 inducible cell line. Results were normalised to 
Cyclophilin A expression and the pre-miRNAs expression in day 9 of 
Dox(-) P19 cells were set as a baseline.  Dox(-) – doxycycline untreated; 
Dox(+) – doxycycline treated. 





3.4.3   Lin28a stable cell line displayed change in morphology of their 
embryonic bodies 
Providing that the post-transcriptional regulation of miR-9 is important 
for proper neuronal differentiation, I decided to compare morphology of 
embryonic bodies obtained throughout the differentiation process of 
P19:Lin28a and P19:Lin28aGFP stable cell lines and their controls P19:FRT 
and P19:GFP, respectively. I used the size of embryonic bodies (EB) 
represented as an area, which was measured using image J software on a 
population of approximately 100 cells (Figure 3-22). I observed a striking 
difference between the size of embryonic bodies generated in the process 
of P19:Lin28a and P19:Lin28aGFP neuronal differentiation. Lin28aGFP line 
supported the normal formation of embryonic bodies with sizes in the 
range between 104 and 105 default area units, whereas the P19 line with 
constitutive expression of untagged Lin28a was able to generate 
embryonic bodies that were 10-times smaller with sizes in the range 
between 103 and 104. The average size of embryonic bodies in both 
P19:FRT and P19:GFP controls was similar to the size of P19:Lin28GFP 
embryonic bodies.  
These observations prove two potential implications. First and most 
important is the consequence of Lin28a-mediated inhibition of miR-9 
production, which leads to defects in differentiation and the formation of 
smaller embryonic bodies. Secondly, the phenotype associated with the 
constitutive expression of Lin28a and miR-9 on the EB formation is 
independent of let-7. The last observation is supported by the fact that the 
P19:Lin28aGFP stable cell line fails to produce mature let-7 but has no 
effect on mature miR-9 and subsequently on the observed size of the 
embryonic bodies formed (Figure 3-19). 
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Figure 3-22 P19Lin28a stable lines - cell morphology 
P19Lin28a:untagged and P19Lin28a:GFP lines were differentiated until day 4.  
Top panel – Bright field images of representative groups of embryonic bodies 
formed during the differentiation of P19 FRT and P19 GFP control cell lines as 
well as untagged P19:Lin28a and P19:Lin28a:GFP stable cell lines. 
Bottom panel – Area of the embryonic cell bodies was measured using imageJ 
analysis of microscopy pictures. Statistical analysis was performed using Mann-
Whitney score test on a sample size of n=100 embryonic bodies. 
 
3.4.4   GFP–tag does not affect expression levels or sub-cellular 
localisation of Lin28a 
 
There are certain aspects of these two stable cell lines that require 
additional measurements to ensure that observed differences in EB size 
and the regulation of miR-9 levels are not artefacts of the experimental 
setting. First of all, the two stable cells used in the experiments were 
generated using different approaches. Therefore, I tested whether the 
expression of Lin28a and Lin28aGFP was at similar levels. Moreover, the 
GFP moiety has a size that is similar to Lin28a itself; therefore, it could 
affect not only expression of the protein, but also its localisation. First, I 
checked the expression levels of Lin28a and Lin28aGFP on day 9 using 
western blot. I compared their expression levels in three serial dilutions of 
the extracts and confirmed that the expression of untagged Lin28a and 
Lin28aGFP was at a similar level (Figure 3-23). 
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Figure 3-23 P19Lin28a - Western blot - Expression levels comparison 
P19Lin28:untagged and P19Lin28a:GFP cells were differentiated and expression 
levels between Lin28a:untagged and Lin28a:GFP were compared on day 9 (d9) of 
differentiation. Protein samples were resolved on 4-12% PAGE and western blot 
analysis of Lin28a was performed on the group of serial dilutions of protein 
extract - 100µg, 50µg and 25µg. Equal loading within serial dilution groups was 
ensured with the western blot analysis of α-tubulin. 
  
To determine whether the addition of C-terminal GFP affects the sub-
cellular localisation of Lin28a, I performed immunofluorescence labelling 
of Lin28a and visualised the sub-cellular localisation with microscopy 
(Figure 3-24). Nuclei were stained with Hoechst as a reference. I was not 
able to observe differences in the sub-cellular localisation of Lin28a and 
Lin28aGFP in their stable cell lines. Therefore, both findings suggested 
that previous observations could account for the genuine effect of Lin28a 
and differences in the mechanisms post-transcriptionally regulating miR-9 
and let-7 levels. 
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Figure 3-24 P19Lin28a - immunofluorescence 
P19Lin28a:untagged and P19Lin28a:GFP cells were fixed on day 0 of 
differentiation and Lin28a subcellular localisation was visualised with a Lin28a-
specific antibody. Nuclei were stained with Hoechst. Images to the left represent 
individual channels for Hoechst and Lin28a, respectively. Right image was 
composed by merging the individual channels. Top panel subcellular localisation 
in P19Lin28:GFP; bottom panel subcellular localisation in P19Lin28a:untagged.  
 
3.4.5   Overexpression of pri-miR-9 and pri-let-7a in P19 day 0 
 
To uncouple the effects of differentiation on miR-9 levels, I performed pri-
miRNA transgene overexpression in undifferentiated P19 cells. 
Overexpression of pri-miR-9 and pri-let-7a driven by a cytomegalovirus 
(CMV) promoter resulted in the very low induction of mature miRNAs 
(Figure 3-25). Importantly, overexpression of pri-let-7a-1/miR-16 TL 
mutant, which escapes Lin28a-mediated regulation, produced more than 
~20-fold mature let-7a. This suggests that the accumulation of miR-9 and 
let-7a levels in undifferentiated cells is post-transcriptionally suppressed. 
Interestingly, overexpression of cognate pri-miR-9-1/miR-16 TL mutant 
did not result in de-repression of miR-9 accumulation (Figure 3-25). This 
implies the existence of additional layers of post-transcriptional miR-9 
regulation, most probably preventing an accumulation of mature miRNA 
in undifferentiated P19 cells. 
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Figure 3-25 P19 - pri-miRNAs over expression 
Mutants of pri-miR-9-1 and pri-let-7a conserved terminal loops were transfected 
into undifferentiated day 0 P19 cells. Subsequently levels of mature miR-9 and 
let-7a were analysed with qRT-PCR. Results were normalised to miR-16 
expression levels and the miRNAs expression in day 0 cells transfected with 
wild-type pri-miRNAs were set as a baseline. Statistical analysis was performed 
using t-test on sample size n=3. 
 
To test whether the observed blockage of miR-9 production by pri-miR-9-
1/miR-16 TL mutant is characteristic for undifferentiated P19 cells, I 
performed co-transfection of wild-type pri-miR-9-1-TL or pri-miR-9-
1/miR-16 TL and pri-miR-9-1/miR-30-TL mutants along with Lin28a 
expression vector in HeLa cells. Subsequently, I analysed mature levels of 
miR-9 and let-7a with qRT-PCR. Results were normalised to miR-16 levels 
and represented as fold-change in respect to the transfection of precursor 
miRNA only. According to mfold structural folding predictions, these 
mutants provide different sequence and structural characteristic of the 
pre-miR-9 terminal loop (Figure 3-26). As a benchmark, I also engineered 
similar mutations in pri-let-7a terminal loops.  
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Figure 3-26 mfold prediction of pre-miRNAs mutants secondary 
structures 
Top panel: graphical representation of pre-miR-9 secondary fold and its terminal 
loop mutants 
Bottom panel: graphical representation of pre-let-7a secondary fold and its 
terminal loop mutants. 




I observed that co-expression of Lin28a with wild-type pri-let-7a and pri-
miR-9-1 resulted in strong inhibition of their mature miRNA levels, as 
shown in Figure 3-27a and Figure 3-27b. Importantly, mutants with miR-
16-TL were able to generate more mature miR-9 and let-7a suggesting a 
decrease in Lin28a-associated post-transcriptional blockage. Interestingly, 
the terminal loop of miR-30 is bigger and contain sequence motifs that 
could be recognised by Lin28a and indeed pri-miR-9-1/miR-30-TL and 
pri-let-7a/miR-30-TL generated less mature miRNAs when compared to 
their miR-16-TL counterparts. These findings further strengthen the 
possibility that P19 undifferentiated cells could have additional layers of 
mature miR-9 regulation. However, most importantly, they demonstrated 
in a cellular context that Lin28a post-transcriptionally regulates miR-9 
biogenesis in the differentiation-independent manner. 
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Figure 3-27 HeLa - pri-miRNA-TL mutants overexpression 
a)   pri-let-7a and its terminal loop mutant pri-let-7a/miR-16-TL and pri-let-
7a/miR-30-TL were transfected together with Lin28a. Mature let-7a levels 
were detected with qRT-PCR.  
b)   pri-lmiR-9-1 and its terminal loop mutant pri-miR-9-1/miR-16-TL and 
pri-miR-9-1/miR-30-TL were transfected together with Lin28a. Mature 
miR-9 levels were detected with qRT-PCR. 
Results were normalised to miR-16 expression levels and expression of the 
miR-9 and let-7a in HeLa cells not transfected with Lin28a were set as a 







4   Mechanism	   of	   Lin28a-­‐driven	   post-­‐transcriptional	  
regulation	  of	  miR-­‐9	  levels	  
In the previous chapter, I showed that Lin28a interacts with pri-miR-9 and 
is involved in the regulation of miR-9, acting mainly at the post-
transcriptional and transcriptional levels. Moreover, in vivo data suggest 
that Lin28a could inhibit miR-9 through a different mechanism because 
untagged Lin28a inhibited miR-9 and let-7 processing, whereas only let-7 
was affected by expression of the Lin28aGFP fusion protein. Other groups 
have shown that Lin28a is also involved in post-transcriptional regulation 
of the let-7 family at the cytoplasmic step of pre-miRNA processing 
(Chang et al., 2013; Hagan et al., 2009; Heo et al., 2008; Nam et al., 2011). 
Therefore, I decided to understand in detail the mechanism of Lin28a post-
transcriptional regulation of miR-9 production, focusing on its 
involvement in the metabolism of pre-miR-9. 
4.1   Pre-miR-9 is destabilised in the early stages of neuronal 
differentiation. 
 
To determine whether pre-miR-9 is regulated in a manner different from 
pre-let-7, I performed in vitro processing assays in P19 cell extracts from 
subsequent stages of neuronal differentiation (Figure 4-1). Incubation of 
pre-let-7a showed a slower migrating band, corresponding to the 
uridylated form of pre-let-7a, at day 0 of differentiation. The intensity of 
this band was reduced in reactions with extracts isolated from subsequent 
stages of neuronal differentiation. Importantly, quantification of bands 
corresponding to pre-let-7a at different stages of the differentiation 
enabled the verification that pre-let-7a is also moderately stabilised 
throughout P19 differentiation. In contrast, pre-miR-9 did not express 
signs of uridylation but was significantly destabilised in extracts from day 
0 P19 cells, which was evident from the faster migrating degradation 
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products. Crucially, incubation of pre-miR-9 with extracts derived from 
day 4, 6, and 9 resulted in its gradual stabilisation – 2-, 4-, and 5-fold, 
respectively. Pre-miR-101 probes were more stable throughout the 
differentiation. 
 
Figure 4-1 P19 neuronal differentiation - in vitro processing 
Top panel - Radiolabelled pre-miRNAs probes were incubated with P19 cell 
extracts from progressive stages of neuronal differentiation – day 0 (d0), day 4 
(d4), day 6 (d6), day 9 (d9). Bottom panel – quantification of the processing 
reactions. Results were normalised to processing of the control reaction (lane 1). 
Statistical analysis was performed using t-test on samples size of n=3. 
 
miR-9 could be potentially produced in three different places in the 
genome. Although pri-miR-9-1, pri-miR-9-2 and pri-miR-9-3 are highly 
conserved, I decided to determine stability of their pre-miRNA probes at 
early stages of neuronal differentiation, especially as the terminal loop of 
pre-miR-9-2 bears single nucleotide mutation within “GGAG” motif, 
which is a well characterised Lin28a ZnFD binding site.  
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However, despite this small difference, both pre-miR-9-2 and pre-miR-9-3 
were processed similarly to pri-miR-9-1 in extracts derived from day 0 and 
day 9. This suggested that all three isoforms of pre-miR-9 are destabilised 
in the early stages of P19 neuronal differentiation (Figure 4-2). 
 
Figure 4-2 In-vitro processing of pri-miR-9-2, -3 in P19 day 0 and day 9 
cells 
Radiolabelled pre-miR-9-2 and -3 were incubated in P19 extracts derived from 
undifferentiated day 0 (d0) and differentiated day 9 (d9) cells. 
 
To date, several RNA enzyme have been identified to degrade RNA using 
different mechanisms involving 5’- or 3’-end driven degradation, like Xrn1 
or Dis3l2, respectively (Chang et al., 2013; Chatterjee et al., 2011; Chatterjee 
and Grosshans, 2009). To establish a pre-miR-9 degradation pattern, I 
incubated 5′-end-labelled miRNA precursors in day 0 extracts. Pre-miR-9-
1 is more destabilised than pre-let-7a and pre-miR-101, showing signs of 
3′–5′ and 5′–3′ degradation (Figure 4-3a-c). These results validate our in 
vivo data and point to different mechanisms by which pre-miR-9 and pre-
let-7a are post-transcriptionally regulated during neuronal differentiation. 
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Figure 4-3 P19 d0 - in vitro processing - 5'end labelling 
a)   5’end labelled pre-miR-9-1 and pre-let-7a were incubated in time-
dependent manner with P19 d0 extracts. Reactions were performed in cell 
extracts derived from mock and Lin28a siRNA treated cells.  
b)   Quantification of the pre-miRNAs processing (5’ end labelled). Results 
were normalized to the processing of the control. Statistical analysis was 
performed using t-test on sample size n=3. 
 
 
4.2   Character of Lin28a association with pre-miR-9 
4.2.1   Lin28a interacts specifically with pre-miR-9 
Lin28a has been previously shown to interact with a large variety of RNA 
targets (Cho et al., 2012; Wilbert et al., 2012). Therefore, it was particularly 
important to establish information about the specificity of its interaction. 
Previously, I showed that Lin28a interacted in stage specific manner and 
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did not interact with the matrix beads itself. However, to verify RNA 
target binding specificity, I used a panel of pre-miRNAs and performed 
pull-down in day 0 extracts (Figure 4-4). Pre-miR-9-1, pre-let-7a and pre-
miR-101 displayed efficient Lin28a binding. Interestingly, I showed with 
in vitro processing that pre-miR-101 is relatively stable in extracts derived 
from various stages of P19 neuronal differentiation, which could suggest 
that the binding of Lin28a does not pre-empt all of the requirements 
necessary for its function. Most importantly, this experiment revealed that 
Lin28a did not bind to pre-miR-16, proving that sequence-specific features 
determined its association with pre-miR-9 and pre-let-7a. On the other 
hand, ATP-dependent RNA helicase A (DHX9) dsRNA, which binds in a 





Figure 4-4 P19 day 0 - pre-miRNA pulldown 
Panel of pre-miRNAs were conjugated to the beads and incubated with P19 day 0 
(d0) extracts. Precipitated ribonucleoprotein complexes were resolved on 4-12% 
PAGE and results were analysed with western blot against Lin28a and non-
specific RNA-binding helicase DHX9. 
 
To further strengthen evidence for a specific interaction, I used a pre-miR-
9/miR-16-TL mutant. Importantly, in the case of pull-down using pre-
miR-9/miR-16-TL mutant, Lin28a failed to associate the RNA. This 
subsequently proved that sequence-specific features within pre-miR-9-
CTL are required for the interaction with Lin28a (Figure 4-5). 
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Figure 4-5 P19 day 0 - pre-miR-9-1/miR-16-CTL pulldown 
Pre-miR-9-1/miR-16-CTL was conjugated to the beads and incubated with P19 
day 0 extracts. Precipitated ribonucleoprotein complexes were resolved on 4-12% 
PAGE and results were analysed with western blot against Lin28a and DHX9. 
 
4.2.2   Lin28a interacts directly with pre-miR-9 
Many RNA-binding proteins associated with their targets and form 
multimeric complexes; therefore, Lin28a might either directly recognise 
and bind to the terminal loop of pre-miR-9, or this interaction might be 
mediated via other auxiliary factors. To establish whether Lin28a/pre-
miR-9 interaction is direct, I deployed electromobility shift assay (EMSA) 
and used radiolabelled precursor miRNA molecules for visualisation 
purposes. In the results, any protein/RNA complexes were represented on 
the polyacrylamide gel as a band shift from the original position of the 
radiolabelled pre-miRNA alone. I performed the experiment using pre-let-
7a as a positive control and pre-miR-16 as a negative control.  
 
In the first assay, I incubated pre-miRNA probes with P19 day 0 cell 
extracts and competed for Lin28a binding with an antibody against Lin28a 
(Lin28a-ab). As a control for the specificity of competition assays, I used 
non-specific HRP-anti-mouse antibody (HRP-ab) (Figure 4-6). Incubation 
of pre-miR-16 with the extracts did not result in the formation of any RNP 
complexes, validating the specificity and stringency of the reaction. 
However, upon incubation of the pre-let-7a probe, I observed the 
formation of several RNP complexes represented as discrete bands above 
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the probe with one band of very high intensity. Importantly, the addition 
of Lin28a-ab but not HRP-ab resulted in the disappearance of this high 
intensity band, whereas other bands remained unchanged. This 
observation suggested that Lin28a directly interacts with pre-let-7a and 
the addition of Lin28a-ab interferes with the formation of the complex or 
binds to the pre-let-7a/Lin28a complex preventing it from entering the 
gel.  
 
Similarly, in the case of pre-miR-9, I observed the formation of several 
complexes with two bands of strong intensity. However, the addition of 
Lin28a-ab but not HRP-ab resulted in the disappearance of one of the high 
intensity bands. Therefore, this finding suggested that Lin28a similarly to 
pre-let-7a associates directly with pre-miR-9 and that addition of the 
antibody interfered with the complex formation. Interestingly, a second 
high intensity band representing the complex of higher molecular weight 
did not disappear upon addition of the antibody. This could potentially 
suggest that pre-miR-9 is capable of forming multi-protein complexes or 
that an epitope for Lin28ab is buried inside the complex.  
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Figure 4-6 P19 day 0 - EMSA analysis 
Radiolabelled pre-miR-9-1, pre-let-7a and pre-miR-16 were incubated under 
native conditions with P19 day 0 (d0) extracts (lane 2). Lin28a or mouse non-
specific antibodies were added as competing factors (lane 3 and 4). 
 
To further strengthen the evidence that Lin28a interacts directly with pre-
miR-9, I performed EMSA analysis using recombinant Lin28a. In this 
scenario, any band shift observed corresponded to Lin28a/pre-miR-9 
complex, as no other proteins were added to the assay. Similarly to 
previous experiments, binding to pre-miR-16 and pre-let-7a served as 
negative and positive control, respectively. I performed the experiment 
with a gradient of Lin28a concentrations. As expected, recombinant Lin28a 
did not form any complex with pre-miR-16. However, using both pre-
miR-9 and pre-let-7a probes, I demonstrated that Lin28a binds directly to 




Figure 4-7 EMSA analysis of recombinant Lin28a binding to pre-
miRNAs 
Pre-let-7a, pre-miR-9 and pre-miR-16 were incubated with a gradient of 
recombinant Lin28a. Both pre-miR-9 and pre-let-7a efficiently formed protein 
complexes. Pre-miR-16 did not bind Lin28a. Series of standard dilutions of 
recombinant Lin28a in the range from 6–200 ng were used. 
 
 
4.3   Involvement of Lin28a in the early stages destabilisation 
of pre-miR-9 
 
In-vitro processing with extracts derived from different stages of neuronal 
differentiation clearly showed that pre-miR-9 is affected in a different way 
to pre-let-7a. My previous in vivo data suggested that Lin28a regulates 
miR-9 biogenesis. Therefore, it is essential to determine that the effects 
caused by Lin28a knockdown were related to the observed destabilisation 
of pre-miR-9 during the early stages of neuronal differentiation. 
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4.3.1   In vitro processing indicates that depletion of Lin28a leads to the 
stabilisation of pre-miR-9 
In order to determine whether Lin28a interaction with pre-miR-9 is related 
to its destabilisation, I performed an in vitro processing assay using 
internally labelled pre-miR-9. Similarly to the previous experimental 
setting, I used pre-let-7a and pre-miR-101 as positive and negative 
controls, respectively (Figure 4-8).  
Pre-miR-101 was previously shown to bind Lin28a, but in contrast to pre-
let-7a and pre-miR-9, remained relatively stable throughout 
differentiation. Indeed, pre-miR-101 remained also stable during in vitro 
processing assays with P19 day 0 mock and RNAi-depleted Lin28a 
extracts. However, in vitro processing reactions in Lin28a RNAi-depleted 
extracts resulted in the decreased uridylation of pre-let-7a, which 
corroborates with a known molecular mechanism of Lin28a action on the 
let-7 family. Importantly, RNAi depletion of Lin28a leads to the 
stabilisation of pre-miR-9 in P19 day 0 extracts when compared to the 
processing in non-depleted extracts. Assays were performed in three 
independent reactions and the effects of Li28a RNAi depletion were also 
quantified to demonstrate the significance of the observation. 
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Figure 4-8 P19 day 0 Lin28a RNAi in vitro processing 
Top panel - Radiolabelled pre-miR-9-1 was incubated in extracts derived from 
mock and Lin28a siRNA-treated P19 cells (lane 2 and 3 respectively). Pre-let-7a-1 
and pre-miR-101 were used as positive and negative controls, respectively.  
Bottom panel – quantification of the processing reactions. Results were 
normalised to the processing of the control reactions (lane 1). Statistical analysis 
was performed using t-test on sample size of n=3. 
 
RNAi treatment of cells could potentially result in the silencing of 
additional off-targets parallel to Lin28a knockdown. To determine if the 
observed stabilisation is a direct effect of Lin28a depletion, I performed in 
vitro processing reaction in Lin28a-depleted cell extracts reconstituted 
with recombinant Lin28a (Figure 4-9). I clearly observed that the initial 
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stabilisation of pre-miR-9 in Lin28a-depleted extracts was terminated 
upon the addition of recombinant Lin28a to the reaction, which restored 
degradation of pre-miR-9. 
 
Figure 4-9 P19 day 0 Lin28a RNAi - reconstituted rec Lin28a 
Radiolabelled pre-miR-9 was incubated in extracts derived from P19 day 0 mock 
and Lin28a siRNA treated cells (lane 2 and 3, respectively). Recombinant Lin28a 
was subsequently added to the Lin28a-depleted extracts at concentrations of 100 
and 200 ng (lane 4 and 5, respectively). 
 
Using a 5’-labelled probe, I demonstrated that pre-let-7a is stabilised in 
Lin28a RNAi-depleted extracts, as demonstrated by the in vitro processing 
reaction (Figure 4-10a-c). Moreover, I observed a sustained strong signal of 
radiolabelled pre-let-7a, which would suggest that the main mechanism of 
pre-let-7a degradation is via the 3’-end of the precursor. Interestingly, in 
the case of pre-miR-9, I observed strong destabilisation of both ends, 
which corresponded to previous analysis across differentiation stages. 
Moreover, processing using Lin28a RNAi-treated extracts clearly showed 
the stabilisation of pre-miR-9. However, it also might suggest that Lin28a 
could involve mechanisms mediating degradation via 3’- and 5’-ends, 
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especially as 5’ destabilisation was still present in Lin28a-depleted 
extracts. In order to validate destabilisation of the both ends of pre-miR-9 
more detailed analysis should be performed to eliminate possibility of 
different turnover rates of pre-miR-9 and pre-let-7a. 
 
 
Figure 4-10 P19 day 0 Lin28a RNAi - in vitro processing 5'end labelled 
a)   In vitro processing reactions of pre-miR-9-1 and pre-let-7a (5’end labelled) 
incubated with extracts derived from control and Lin28a siRNA treated 
P19 day 0 (d0) cells. Reactions were performed with increased duration of 
time in range from 1’ to 15’ (lanes 2-5 and 6-9) 
b-c) Quantification of pre-miR-9-1 and pre-let-7a-1 processing in extracts 
derived from mock and Lin28a siRNA treated samples. Results were 






4.3.2   Constitutive expression of Lin28a supports destabilisation in late 
stages of neuronal differentiation 
 
Previously, I demonstrated that constitutive or induced expression of 
Lin28a leads to the downregulation of miR-9 levels in vivo. I also showed 
that reconstitution of depleted Lin28a with the recombinant protein 
reinstated the destabilisation of pre-miR-9 in vitro. Therefore, it would be 
beneficial to demonstrate that extracts derived from day 9 P19 cell lines 
with the stable expression of Lin28a also support the degradation of pre-
miR-9. I decided to perform these experiments using day 9 extracts from 
both untagged Lin28a and Lin28aGFP stable cell lines. Moreover, I used 
internal-labelled pre-miR-9 and pre-let-7a as the analysis of their mature 
miRNA levels revealed significant differences in the activity of these two 
stable cell lines (Figure 4-11). In the case of pre-let-7a, I observed that 
initial uridylation of pre-let-7a in undifferentiated cells is abolished in day 
9 extracts. As a result, the pre-let-7a molecule is stabilised, as 
demonstrated by the quantification of three independent experimental 
replicas. Importantly, day 9 extracts derived from both Lin28aGFP and 
untagged Lin28a P19 cells supported the uridylation and destabilisation of 
pre-let-7a (Figure 4-11). 
In vitro processing of pre-miR-9 supported previous findings that on day 0 
the precursor RNA is destabilised and becomes stabilised in the day 9 
extract. Crucially, I observed a similar result in Lin28GFP day 9 extracts 
which supports previous in vivo findings that GFP-tagged protein does not 
influence miR-9 levels. Importantly, I demonstrated that day 9 extracts 
derived from the untagged Lin28a P19 line were supporting 




Figure 4-11 P19Lin28a stable cell lines - pre-miRNA in vitro processing 
Top panel – in vitro processing of pre-miR-9-1 and pre-let-7a in day 0 and day 9 
extracts of P19Lin28a stable cell lines: lane 2-3 – P19 FRT, lane 4-5 – 
P19:Lin28a:GFP, lane 6-7 and 8-9 P19:Lin28a clone 3 and 4, respectively. 
Bottom panel – quantification of the processing reactions. Reactions were 
normalised to the processing of the controls – lane 1. 
 
4.3.3   Effect of pre-miR-9 terminal loop mutagenesis on Lin28a 
mediated destabilisation of the pre-miRNA 
 
My EMSA analysis of pre-miR-16 binding and pull-down with pre-miR-
9/miR-16-TL suggested that Lin28a could not interact with the terminal 
loop of pre-miR-16. Therefore, I decided to test whether mutagenesis of 
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pre-miR-9-TL is sufficient to abolish destabilisation mediated by Lin28a. I 
performed the in vitro processing reaction in degradation permissive 
conditions of day 0 P19 cells (Figure 4-12).  As expected, the pre-miR-9/16-
TL mutant remained stable upon incubation with the extracts, further 
supporting the role of the terminal loop in Lin28a-mediated degradation 
of pre-miR-9. 
 
Figure 4-12 P19 day 0 - pre-miR-9-1/miR-16-CTL in vitro processing 
Radiolabelled pre-miR-9-1/miR-16-CTL mutants were incubated in extracts 




4.4   Characterisation of motifs responsible for the interaction 
between Lin28a and pre-miR-9 
4.4.1   Use of enzymatic cleavage assay and footprinting to characterise 
pre-miRNA secondary structure and Lin28a binding sites 
RNA secondary structure analysis in the presence of proteins 
(footprinting) is a useful tool to obtain more information about the 
molecular mode of interaction between RNA and proteins. I showed that 
both pre-miR-9 and pre-let-7a interact with Lin28a, but the mechanisms of 
Lin28a action seem to be different. I decided to perform a footprinting 
analysis of 5’-labelled pre-miR-9 and pre-let-7a with RNAse V1, RNAse T 
and Pb++ and recombinant Lin28a. The properties of these cleavage 
enzymes would provide a wealth of information about the secondary pre-
miRNAs structures. RNAse V1 is known to cleave double-stranded 
regions only, whereas RNA T1 specifically cuts single-stranded regions at 
G nucleotides. Pb++ ion is less specific but displays a preference for the 
open conformation for RNA. I used water as a mock treatment. To 
determine Lin28a binding sites, I performed cleavage reactions in the 
presence of a Lin28a gradient to visualise nucleotides that are associated 
and subsequently protected from cleavage.  
 
In the case of pre-let-7, I determined that Lin28 interacts with AGGG and 
the well-known GGAG motif (Figure 4-13a). These regions have been 
previously shown by co-crystal and NMR structural studies to interact 
respectively with the cold-shock and zinc-finger domains of Lin28 
(Loughlin et al., 2012). Interestingly, binding of Lin28 resulted in increased 
cleavage by V1 ribonuclease with the decreased activity of Pb(II) cleavage 
in the region within the terminal loop, which might suggest structural 
rearrangements of pre-let-7 resulting in higher stability of the terminal 
loop (Figure 4-13a,c).  
 
Importantly, I identified the GU-rich region of pre-miR-9 terminal loop as 
an interaction site with Lin28 (Figure 4-13b). Due to the very short nature 
of pre-miR-9-CTL. this might suggest that Lin28 interacts with pre-miR-9 
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via only one of its possible RNA-binding domains. Similarly to pre-let-7a, 
association with Lin28 resulted in the increased activity of V1 
ribonuclease, which might suggest some tertiary-related structural 




Figure 4-13 Structural probing and footprinting analysis of recLin28a 
interaction with pre-let-7a and pre-miR-9 
a)   Pre-let-7a and pre-miR-9 cleavage pattern on 8% PAGE. Reactions were 
processed in groups: ctr – no enzyme added, T1 – RNA T1, Pb – cleavage 
by lead ions, V1 – RNAse V1. Within each of the groups, increased 
concentrations of the recombinant Lin28a were used (50ng, 100ng, 200ng). 
FL and T1L are formamide and RNA T1 ladders, respectively. 
b)   Graphical representation of pre-let-7a and pre-miR-9 secondary structures 
generated with mfold with annotated cleavage sites and Lin28a binding 
site. 
  
Interestingly, the pre-miR-9 terminal loop contains “GGAG” – a motif 
characterised to specifically associate with the zinc-finger domain of 
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Lin28a. However, my structural probing analysis suggested that Lin28a 
binds upstream of this motif. Therefore, I decided to test whether the 
“GGAG” motif within pre-miR-9 is functionally important. For that 
reason, I generated several mutants of pre-miR-9 TL with single and 
multiple nucleotide changes surrounding the motif. I transfected HeLa 
cells with these mutants along with Lin28a and compared their potential 
to generate mature miR-9. To my surprise, I observed no changes in the 
expression levels of miR-9 from pre-miR-9 containing either wild type or 
the mutant terminal loops.  
 
 
Figure 4-14 qRT-PCR - pre-miR-9 mutagenesis of the GGAG motif 
Plasmids expressing pri-miR-9-1 containing wild type ZnF-binding motif 
(GGAG) and its various mutations were co-transfected into HeLa cells with 
Lin28a-expressing vectors. Results were analysed with qRT-PCR and mature 
miR-9 expression levels were normalised to miR-16 expression levels. Analysis 
was represented in pairs for each of the GGAG mutants and Lin28a 
untransfected cells were used as a baseline for each of the pairs.  
 
4.4.2   Immunoprecipitation of Lin28a truncated mutants emphasise the 
role of Lin28a CSD in association with pre-miR-9 
 
My data suggested that the association of Lin28a with pre-miR-9 occurred 
upstream of the “GGAG” motif, mutations of which did not cause any 
relevant effect in the expression of mature miR-9. 
Therefore, I decided to compare the binding efficiency of CSD and ZnFD 
domains to pre-miR-9 and pre-let-7. To test this, I engineered a panel of 
T7-tagged Lin28a truncations and tested their binding abilities by 
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performing RNA pull-downs. As each truncation could affect the stability 
of the protein or its expression, I optimised transfection conditions to 
equilibrate protein levels between truncated mutants (Figure 4-15). This 
step should decrease the bias of RNA/protein interactions that depend on 
differences in protein levels. 
 
 
Figure 4-15 Optimisation of Lin28a truncations expression 
Vectors expressing various Lin28a truncations were transfected to HeLa cells. 
Protein extracts were resolved on 12% PAGE and western blot analysis against 
Lin28a were used to confirm similar expression levels for each of the truncations. 
 
Importantly I found that pre-miR-9 and pre-let-7a displayed strong 
differences in binding properties toward cold-shock and zinc-finger 
domains of Lin28a (Figure 4-16a,b). In particular, quantification of pull-
down efficiency represented as a percentage of input binding revealed 
that pre-miR-9 interacted more strongly than pre-let-7a with mutants 
containing CSD only. Interestingly, I also observed that trimming of 
unstructured N- and C-terminal regions increased efficiency of pre-let-7a 
and pre-miR-9 binding. Also, to my surprise, pre-let-7a exhibits a strong 
binding increase to Lin28a mutants with removed CSD. Previous studies 
placed CSD binding to pre-let-7a prior to ZnFD association, which 
hypothetically should help to expose the “GGAG” motif. These factors 
suggest structural differences between terminal loops of let-7 families. 
However, Lin28a mutant 1-74 could potentially result in incorrectly folded 
CSD domain, therefore in the future it would be interesting to engineer 
more precise point-mutants of CSD to verify its involvement in binding to 
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pre-let-7a and pre-miR-9. Also analysis of Lin28a truncation mutants 
binding to the matrix itself should be performed to exclude possibility of 
non-specific interaction as an outcome of the misfolded mutants. 
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Figure 4-16 Lin28a truncations pull downs 
a)   Pre-let-7 (top) or Pre-miR-9 (bottom) were conjugated to the agarose 
beads and incubated with extracts derived from HeLa cells transfected 
with vector expression full length Lin28a (1->209) and various truncations 
of Lin28a. The first control contained beads without conjugated pre-
miRNAs and were used in the pull-downs with extracts containing full 
length Lin28a (lane 1 and 2). The second control contained agarose beads 
with conjugated pre-miRNAs and was incubated with HeLa cells not-
transfected with Lin28a (lane 3 and 4).  Lanes 5 -18 represent pull-downs 
of pre-let-7a and pre-miR-9 with various mutants of Lin28a. Odd lanes 
visualise input of the reaction (I) and even numbers represent pull-down 
(P). 
b)   Analysis of mapping interactions between Lin28a and pre-miR-9. 
Left side - map of the full length Lin28a and truncations used in the 
pulldown reactions.  
Right side – quantification of the Lin28a mutant pull-downs normalised 
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to the amount of the input in each reaction. 
 
4.5   Identification of the enzyme leading to the degradation 
of pre-miR-9 at early stages of neuronal differentiation 
 
4.5.1   Depletion of several RNA nucleases indicates role of Dis3l2 in 
destabilisation of pre-miR-9 
 
To find a factor that leads to the destabilisation of pre-miR-9 during 
neuronal differentiation, I performed knockdown of selected RNA 
nucleases using pool SMART Target-ON™ siRNAs. Here, 48h after siRNA 
transfection, neuronal differentiation of P19 cells was induced with 
retinoic acid and miRNAs levels were analysed after four days of 
differentiation and compared to reciprocal levels of miRNAs in mock 
siRNA-treated samples. I determined the depletion efficiency performing 
a western blot analysis of protein expression in mock and siRNA-treated 
cells (Figure 4-17b).  
Interestingly, upon knockdown of Dis3l2 I observed an increase in miR-9 
levels similar to that observed in Lin28 depletion (Figure 4-17a). However, 
the levels of let-7 remained unchanged (Figure 4-17a). This observation 
was in line with previously reported effect of Dis3l2 depletion on let-7 
(Chang et al., 2013). I also determined that knockdown of EXOSC3, a 
structural component of an exosome, had no effect on levels of either miR-
9 or let-7 Figure 4-17a.  
 
It has been previously reported that Lin28 attracts Dis3l2 following poly-
uridylation of pre-let-7 and subsequently leads to degradation of pre-let-7 
(Chang et al., 2013). My results also suggest that Lin28 together with 
Dis3l2 play an important role in the downregulation of miR-9 levels 
during neuronal differentiation. However, I showed that the mechanism 
of pre-mir-9 destabilisation is uridylation-independent. Therefore, it might 
suggest that Lin28 directly interacted with Dis3l2, which subsequently 
resulted in pre-miR-9 destabilisation. 
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Figure 4-17 qRT-PCR analysis of microRNA upon depletion of effector 
candidates 
a)   P19 cells were treated with siRNA against Dis3l2 and Exosc3 and 
differentiated. Following four days of differentiation qRT-PCR analysis 
was performed to analyse mir-9 and let-7. Random siRNA with no 
predicted targets were used as a negative control Statistical analysis was 
performed with t-test on sample size n=3. 
b)   Protein samples derived from P19 day 4 cells treated with siRNA against 
Dis3l2 and Exosc3 were analysed with western blot to confirm then 
depletion of Dis3l2 and Exosc3. To estimate efficiency of the depletions, 
serial dilutions of mock siRNA-treated extracts were analysed in the 
range from 100% to 0% in two-fold reduction steps. Alpha-tubulin served 
as loading control.  
 
4.5.2   Lin28a directly interacts with Dis3l2 
To determine whether pre-miR-9 interacts with Dis3l2, I performed a pull-
down assay with pre-miR-9 incubated with extracts derived from P19 day 
0 and day 9 extracts (Fig.3A and Sup.Fig.1). As a control, I used pre-let-7a, 
which was conjugated via the 3’ end to beads. Coupling the pre-let-7a 
with beads via the 3’ end protects it from uridylation. In fact, I showed 
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that pre-let-7a was able to interact with Lin28 but not with Dis3l2, which 
requires pre-let-7a to be poly-uridylated at its 3’ end (Figure 4-18a). 
However, despite the lack of uridylation, pre-miR-9 at day 0 interacted 
with both Lin28 and Dis3l2. Interestingly when we compared pull-down 
performed at day 0 and day 9 we observed much stronger binding of 
Dis3l2 to pre-miR-9 in differentiated cells than in undifferentiated cells 
Figure 4-18b.  
 
Figure 4-18 pre-miRNA Dis3l2 pulldowns in P19 cells 
Pre-miRNAs were conjugated to the beads and incubated with P19 day 0 (d0) 
and day 9 (d9) cell extracts. Following the stringent washes, precipitated 
ribonucleoproteins were run on 4-12% PAGE and analysed with western blot 
against Dis3l2 and Lin28a. 
a)   Pre-let-7a and pre-miR-9 pulldown in P19 day 0 cells 
b)   Pre-let-7a and pre-miR-9 pulldown in P19 day 0 and day 9 cells 
 
To establish whether Lin28 directly binds to Dis3l2, I performed Co-IP 
experiments using recombinant Dis3l2 and Lin28 (Figure 4-19). I showed 
that the addition of recombinant Lin28 and immunoprecipitation with 
anti-Lin28 antibody was able to pull-down slightly higher amounts of 
Dis3l2 when compared to pull-down without recombinant Lin28. These 
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results show that despite a lack of poly-uridylation in P19 cells, pre-miR-9 
in contrast to pre-let-7a is interacting with Lin28a and Dis3l2.  
 
 
Figure 4-19 Recombinant Lin28a and Dis3l2 Co-IP 
Recombinant Lin28a and Dis3l2 were mixed together and subsequently 
incubated with the beads conjugated with antibodies against Lin28a (left panel) 
or Dis3l2 (right panel).  Following stringent washing, immunoprecipitated 
complexes were run on 4-12% PAGE and analysed with western blot against 
Lin28a or Dis3l2. 
 
4.5.3   Formation of tertiary complex between Lin28a-Dis3l2-pre-miR-9 
molecules 
To establish whether the direct interaction between Lin28a and Dis3l2 is a 
result of tertiary complex formation upon binding to pre-miR-9, I 
performed EMSA analysis (Figure 4-20). As a reference, I used pre-let-7a, 
which is known not to interact with Dis3l2 when it is not poly-uridylated. 
I observed that recombinant Lin28a and Dis3l2 bind to pre-miR-9 
independently, however when incubated together they form a tertiary 
complex on pre-miR-9. Moreover, in this, only residual amounts of 
monomeric complex remained present. However, for pre-let-7a, even 
though both recombinant Lin28a and Dis3l2 bound independently to the 
precursor RNA, the incubation of both proteins together showed that pre-
let-7a dominantly associated as monomeric complexes, which is in 




Figure 4-20 EMSA with recLin28a and recDis3l2 
Radiolabelled pre-miR-9 and pre-let-7a were incubated with recombinant Lin28a 
and Dis3l2 (Lin28a and Dis3l2 individually – lanes 2 to 5, Lin28a and Dis3l2 
together – lanes 6 and 7). Following the incubation, protein ribonucleoprotein 
complexes were resolved on 10% PAGE and visualised with phosphoimager. 
 
To prove that this tertiary complex is achieved via direct interaction of 
Dis3l2 with Lin28a and not by two independent binding sites of proteins 
to the RNA, I performed competition-binding assay where Lin28a specific 
antibody (Lin28a ab) was added to the reaction setting (Figure 4-21). The 
addition of Lin28 ab resulted in a supershift or the disruption of an 
interaction between Lin28a as well as Dis3l2 and pre-miR-9. This 
unspecific effect on Dis3l2 antibody most likely accounts for its polyclonal 
nature. Lin28 ab was generated against His-tagged Lin28a and 
unfortunately the same tag was used to purify recombinant Dis3l2. 
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However, the addition of Lin28 ab in combination with recombinant 
Lin28a and Dis3l2 resulted in a supershift of monomeric complexes, but 
did not affect formation of tertiary complex Dis3l2/Lin28/pre-miR-9. This 
suggested that in the case of tertiary complex epitope for the antibody, the 
interaction is buried inside the assembly. To demonstrate that the 
observed result is specific to Lin28 ab, I used non-specific anti-IgG 
antibody (IgG ab) that did not result in the shift or disruption of complex 
formation when used with recombinant proteins in combination or 
individually (Figure 4-21).  
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Figure 4-21 EMSA - recombinant proteins and antibody competitors 
Radiolabelled pre-miRNA were incubated with recombinant Lin28a and Dis3l2 
(lanes 2, 5 and 8). Lin28a (lanes 3, 6 and 9) and non-specific mouse IgG (lanes 4, 7 
and 10) antibodies were added to compete for protein binding. 
 
To further strengthen the specificity of Lin28 ab action, I showed that the 
addition of an antibody against another RNA-binding protein, Msi-2, 
similarly to IgG ab did not result in the supershift or complex disruption 
(Figure 4-22). These results prove that Dis3l2 via direct interaction with 
Lin28a bound to pre-miR-9 and this interaction is essential for the 





Figure 4-22 EMSA - recLin28a and recDis3l2 - Lin28a and Msi2 ab 
competition 
Radiolabelled pre-miR-9 was incubated with recombinant Lin28a and Dis3l2 
(lane 2). Lin28a and Msi2 antibodies were added to compete for protein binding 
(lanes 3 and 4, respectively). 
 
 
4.5.4   Depletion of Dis3l2 leads to stabilisation of pre-miR-9  
 
I showed that Lin28a and Dis3l2 form a tertiary complex with pre-miR-9. 
Previously, I also showed that pre-miR-9 is destabilised during the early 
stages of P19 neuronal differentiation (Nowak et al., 2014). To determine 
whether the formation of the Lin28-Dis3l2 complex would result in the 
degradation of pre-miR-9, I performed in vitro processing assays using P19 
day 0 extracts with RNAi depleted Dis3l2. To strengthen the evidence that 
the observed effect is directly associated with the absence of the knocked-
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down protein, I rescued RNAi condition by adding either active Dis3l2 or 
enzymatically inactive Dis3l2 mutant with the mutation in the RNB 
domain, in which a conserved aspartic acid residue predicted to 
coordinate a divalent cation was replaced by asparagine (D391N). 
Importantly, the depletion of Dis3l2 resulted in stabilisation of pre-let-7a 
uridylated form – the observation that remained in agreement with 
previous findings (Figure 4-23a,c) (Chang et al., 2013). This effect was 
rescued by the addition of recombinant Dis3l2. Reinstating with 
enzymatically active Dis3l2 resulted in complete degradation of the 
uridylated form of pre-let-7a. On the other hand, functionally inactive 
recombinant Dis3l2 was not able to restore the degradation of uridylated 
precursor.  
 
Interestingly, the depletion of Dis3l2 also resulted in a stabilisation of pre-
miR-9 despite its non-uridylated form (Figure 4-23b,c). The degradation of 
the pre-miR-9 precursor observed during the early stages was again 
detected when functionally active recombinant Dis32 was added. 
Functionally inactive Dis3l2 had a moderate effect on destabilisation of the 
precursor.  
 
These and my previous results suggested that Dis3l2 is directly involved 
in uridylation-independent degradation of pre-miR-9. This direct 
mechanism of degradation mediated by Dis3l2 is achieved by its 




Figure 4-23 P19 day 0 Dis3l2 RNAi in vitro processing 
Radiolabelled pre-miR-9 and pre-let-7a probes were incubated with P19 day 0 
extracts treated with mock or Dis3l2 siRNA (lanes 2 and 3). Recombinant active 
Dis3l2 or its inactive mutant was added to reconstitute wild type conditions 
(lanes 4 and 5 respectively). 
a)   Processing results for pre-miR-9 
b)   Processing results for pre-let-7a 
c)   For pre-miR-9 processing in individual conditions (lanes 2-5) were 
quantified and normalised against processing of the control (lane 1). For 
pre-let-7a uridylated form was quantified in individual conditions (lane 
2-5) and normalised against uridylation efficiency of mock siRNA-treated 






5   Genome-­‐wide	  analysis	  of	  Lin28a	  effects	  on	  miRNA	  
biogenesis	  during	  neuronal	  differentiation	  
5.1   Analysis of miRNA changes during neuronal 
differentiation 
 
My results so far have indicated that pre-let-7a and pre-miR-9 are 
regulated via two distinct mechanisms involving Lin28a and Dis3l2. 
Therefore, it would be interesting to see how these two mechanisms affect 
biogenesis of other miRNAs in genome-wide context. To test this, I 
decided to employ a small-RNA sequencing technique on samples derived 
from day 0 and day 9 of P19:Lin28a as well as P19:Lin28aGFP stable cell 
lines. As a reference for P19:Lin28a and P19:Lin28aGFP, I also sequenced 
small RNAs derived from P19:FRT and P19:GFP stable cell lines, 
respectively. 
 
Following RNA-sequencing, normalised reads were subsequently mapped 
to known miRNA according to miRBase using SOAPaligner. 
Subsequently, differential expression profiles of miRNAs between day 9 
and day 0 of above stable cell lines were generated. I used scatterplots to 
visualise day 9/day 0 fold change between P19:Lin28a: and P19:FRT 
(group 1) or P19:Lin28aGFP and P19:GFP (group 2) (Figure 5-1). 
Interestingly, analysis of overall miRNA change between differentiated 
and undifferentiated stable cell lines revealed that constitutive expression 
of untagged Lin28a regulated a larger number of miRNAs when 
compared to its Lin28aGFP counterpart.  
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Figure 5-1 Comparison of miRNA levels in P19 stable cell lines - small 
RNA-seq. 
miRNAs ratio day 9/day 0 ratio of expression levels were compared between 
P19:GFP and P19:Lin28aGFP (top panel) as well as P19:FRT and P19:Lin28a 
(bottom panel). Subsequently, Lin28a:GFP/P19:GFP and P19:Lin28a/P19:FRT 
ratios for related miRNAs were calculated and miRNAs with less than 2-fold 
change in P19:Lin28aGFP/P19:GFP group were marked with red circles for both 
of the groups. 
 
I performed validation of small RNA-sequencing data using qRT-PCR and 
analysing changes of mature miRNA in day 0 and day 9 of the stable cell 
lines (Figure 5-2). Based on the analysis of several miRNAs I was able to 
show a similar dynamic pattern of miRNA levels using qRT-PCR analysis 
and a small RNA-sequencing technique, which validates the results 




Figure 5-2 validation of small RNA-sequencing 
Selected mature miRNA were analysed with qRT-PCR on day 0 and day 9 of the 
differentiation of P19 cells. Results were represented as ratio day 9/day 0 for 
each of the stable cell lines. As a reference, similar calculations were performed 
for the related miRNAs changes that were obtained from small RNA sequencing. 




5.2   Dual role of Lin28a during P19 neuronal differentiation  
 
To further characterise genome-wide miRNA changes caused by 
constitutive expression of untagged Lin28a, I used day 9/day 0 fold-
changes to generate comparative ratios of changes between groups 1 and 
2. Subsequently, I selected those miRNAs that were relatively unchanged 
between P19:Lin28aGFP and P19:GFP (Figure 5-1 – red circles) and 
visualised their fold-change between P19:Lin28a and P19:FRT using 
heatmap (Figure 5-3). 
 
I was able to verify miR-9-3p and miR-9-5p levels to be strongly 
downregulated during neuronal differentiation of P19:Lin28a stable cell 
line. Moreover I observed downregulation of miR-124-5p, miR-124-3p and 
miR-134; miRNAs that were previously described to play a role in 
neuronal development. Interestingly, large groups of miRNAs were 
shown to be upregulated upon neuronal differentiation of the Lin28a 





Figure 5-3 small RNA-sequencing - heatmap expression analysis 
miRNAs with stable day 9/day 0 ratio in P19:Lin28a:GFP and P19:GFP (less than 
2-fold change) were selected and their change between P19:Lin28a and P19:FRT 
were calculated, represented as a ratio and visualised with the heatmap. MiRNAs 
with positive P19:Lin28a/P19:FRT ratio are represented by a green colour 
whereas miRNAs with negative P19:Lin28a/P19:FRT ratio are represented by a 
red colour. 
 
5.3   Sequence analysis of pri-miRNA proximal genomic 
regions 
 
My genome-wide data suggest that Lin28a could potentially stabilise a 
range of precursor miRNAs. Therefore, it was interesting to determine 
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whether they have the potential to associate with Lin28a via previously 
characterised binding sites (Cho et al., 2012; Wilbert et al., 2012). To test 
that, I decided to map identified Lin28a binding motifs to regions flanking 
each direction 500bp of pre-miRNA genomic coordinates of previously 
selected miRNAs. This approach should allow me to include potential 
regulatory site within pre-miRNAs and their immediate vicinity as well. I 
was able to show that the motifs “CCGGCC”, “GAGCAC”, “GAGGGC”, 
“AAGAAA”, “CAGAGG”, “GAGGAG” are overrepresented in genomic 
regions proximal to selected miRNAs as related to overall miRNA 
population (excluding selected miRNAs) (Figure 5-4).  
Moreover, the majority of these motifs reside outside the mapped pre-
miRNA sequence within pri-miRNA or its genomic proximity, as shown 
for group of representative miRNAs (Figure 5-4). 
These could potentially suggest the direct involvement of Lin28a in the 
stabilisation of their precursor RNA molecules. 
 
Figure 5-4 Characterisation of Lin28a binding motifs based on CLIP-
data. 
Hexamers identified previously with CLIP sequencing (left panel) were mapped 
within the genomic proximity (500bp upstream and downstream) of the selected 
group of pri-miRNAs and their overall enrichment within pri-miRNAs loci was 
represented between selected miRNAs group and all remaining known miRNAs 
(right panel). 
 




In order to determine whether Lin28a is involved in the stabilisation of 
precursor miRNA at early stages of neuronal differentiation I decided to 
perform in vitro processing reaction. I used P19 day 0 extracts with RNAi-
depleted Lin28a and compared the in vitro processing to mock P19 day 0 
reactions. The assays were performed with representative group of 
internally radiolabelled in vitro-transcribed pri-miRNAs and pre-miRNAs 
(Figure 5-5). Unfortunately, I was not able to find a strong candidate that 
would confirm that the depletion of Li28a would lead to its 
destabilisation. 
 
Figure 5-5 P19 day0 - in vitro processing of pri-miRNAs and pre-
miRNAs 
Radiolabelled pri- and pre-miRNA probes were synthesised for miR-29a and 
miR-155 and subsequently incubated with P19 day 0 extracts from cells treated 
with mock or Lin28a siRNA. 
a)   In-vitro processing results of pri-miR-29a and pri-miR-155  
b)   In-vitro processing results of pre-miR-29a and pre-miR-155 
 
 145 
This observation could mean that the stabilisation is due to another post-
transcriptional event indirectly regulated by Lin28a. Alternatively, it could 
be an effect of steady-state level control regulated in some way by Lin28a.  
To test whether the steady-state levels of selected miRNA groups is 
affected by the constitutive expression of Lin28a, I performed qRT-PCR 
analysis of their pri-miRNAs on day 0 and day 9. Importantly, I found that 
the steady-state levels of pri-miR-155 was upregulated in the presence of 
Lin28a (Figure 5-6). This potentially suggests that at least in a subset of 
instances, the observed upregulation of mature miRNA could be partially 
accounted for the control of miRNAs steady-state levels. 
 
Figure 5-6 qRT-PCR - pri-miRNAs change during neuronal 
differentiation 
Selected pri-miRNAs levels were analysed on day 0 and day 9 and subsequently 




5.5   Characterisation of pre-miRNA secondary-structure 
arrangements between different functional groups  
 
My current findings suggest that Lin28a regulates pre-let-7a and pre-miR-
9 post-transcriptionally via distinct but to some extent similar 
mechanisms. Interestingly, genome-wide analysis showed a large group of 
miRNAs affected with the constitutive expression of untagged Lin28a. I 
decided to determine whether certain secondary arrangements, like an 
abundance of double-stranded regions, are overrepresented in this group. 
To test that, I obtained information in “miRBase”, which is a miRNA 
database about paired-bases with pre-miRNAs regions. Subsequently, I 
developed python script to count the number of paired-bases across a 
selected pre-miRNA group. Analysis was performed counting positions 
up and down the centre of individual pre-miRNA – representing the 
terminal. As a benchmark, I used analysis of randomly selected pre-
miRNA sequences from “miRBase” that were primed in ten independent 
drawing rounds (Figure 5-7). 
Interestingly, using this approach I was able to demonstrate that groups 
affected by untagged Lin28a have fewer base-paired nucleotides within 




Figure 5-7 Analysis of secondary structures features of selected pre-
miRNAs. 
Centre of the terminal loop was marked as position 0 and subsequently the 
number of paired nucleotides along the pre-miRNA sequence (upstream and 
downstream from position 0) was summed up and represented as a frequency 
per total pre-miRNA size. Calculations were performed on the selected group of 
the pre-miRNAs as well as on pre-miRNAs obtained from ten independent and 
random drawing rounds. Additionally, average free energy and base pair 





6   Discussion	  
In recent years, miRNAs have drawn a great amount of interest across 
various life science disciplines, supporting their extensive role in all 
aspects of cell biology in higher eukaryotes. For instance, the genome-
wide approach has shown that miR-221 induces sprouting in zebrafish 
endothelial cells (Nicoli et al., 2012). Moreover, zebrafish knockdown of 
miR-221 inhibits the proliferation and migration of tip cells, whereas the 
overexpression of miR-221 in endothelial cells promotes vessel sprouting.  
Another example involves the role of miRNAs in the regulation of β-cell 
activity and subsequent management of glucose metabolism (Walker, 
2008). Overexpression of miR-375 suppresses glucose-induced insulin 
secretion, whereas its inhibition enhances insulin production. Moreover El 
Quaamari and colleagues showed that in rat, miR-375 levels are regulated 
by glucose. In liver hepatocytes, the cell cycle is affected by miR-21, which 
was shown to control levels of several cell cycle regulators (Song et al., 
2010). As mentioned in the Introduction, there are many more examples of 
miRNAs playing essential roles in the development and maintenance of 
the nervous system (Meza-Sosa et al., 2012). Therefore, miRNAs appear to 
be very important mediators of various diseases and targets for 
developing novel therapeutics (Broderick and Zamore, 2011). Not 
surprisingly, the multi-step miRNA maturation pathway has also been 





6.1   Dis3l2 degrades pre-let-7a in a uridylation-dependent 
fashion 
 
A large amount of attention has been dedicated in recent years to Lin28 
regulation of the let-7 family, partially because it was one of the first 
identified miRNAs (Bracht et al., 2004). Moreover, it has been shown that 
let-7 and Lin28 are very important for embryonic development (Moss and 
Tang, 2003; Van Wynsberghe et al., 2011). In general, during development, 
let-7 levels are controlled by post-transcriptional regulatory mechanisms. 
Several studies have proposed that in a canonical way, Lin28 associates 
with pre-let-7 and serves as a platform for the Zcchc family, also known as 
TuTase – an enzyme catalysing the addition of uracil to the 3’-end (Hagan 
et al., 2009; Heo et al., 2008). Subsequently pre-let-7a-p(U) acts as a 
substrate for Dis3l2, an RNA 3’-5’-exonuclease (Chang et al., 2013; 
Ustianenko et al., 2013).  Non-canonical mechanisms post-transcriptionally 
regulating let-7 levels were also described. Lightfoot and colleagues first 
proposed an alternative pathway; they showed that Lin28a association 
with the pre-let-7a terminal loop also interferes with Dicer processing by 
melting a stem of the terminal. Another mechanism is based on the fact 
that the Lin28 family includes two paralogues - Lin28a and Lin28b. The 
latter protein contains nuclear localisation signal (NLS) and nucleolar 
localisation signal (NLoS), which is important for its nucleoli localisation 
(Piskounova et al., 2011). Piskounova and colleagues suggested that 
Lin28b sequesters its target from the microprocessor by transferring them 
to nucleoli, which impede their processing inside the nucleus.  
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Figure 6-1 Model of Lin28a mechanism regulating pre-let-7a post-
transcriptional degradation. 
Lin28a associates with pre-let-7a terminal loop and engages Tut4 to generate 3’-
poly(U) tail. Subsequently the pre-let-7a uridylation leads to degradation driven 
by 3’-5’ exonuclease Dis3l2. 
 
Results of my PhD work support the finding that pre-let-7a is uridylated 
and subsequently degraded by a 3’-5’ exonuclease Dis3l2. P19 in vivo data 
reinforced the hypothesis that Lin28a and Lin28b levels are high in 
undifferentiated cells and as the cell progress through differentiation, their 
levels gradually decrease with no detectable expression beyond day 6. As 
expected, this change of Lin28a expression coincides with an increase in 
mature let-7 levels.  
 
I also confirmed previous findings regarding the molecular mechanism of 
Lin28a action. My in vitro processing indicated that pre-let-7a is highly 
uridylated in undifferentiated cells and this uridylation gradually 
decreased as cells were progressing through differentiation. This gradual 
decrease in uridylation overlaps with a decrease in Lin28 levels. 
Interestingly, loss of uridylation very modestly affected the stability of 
pre-let-7a during neuronal differentiation. This could be caused by the 
presence of Lin28b, which might affect the stability of pre-let-7a or 
alternatively might be a result of destabilisation via various RNA 
nucleases during the in vitro reaction itself. In vivo, pre-let-7a might be 
shielded from the non-specific degradation. Alternatively, cells express a 
large amount of RNA molecules that could compete for interaction with 
the RNA nucleases that could favour them based on affinity. Poor 
agreement between loss of uridylation and stabilisation of the pre-let-7a 
form was particularly visible upon depletion of Lin28a. Knockdown of 
Lin28a resulted in a clear decrease in the pre-let-7a-p(U) form and did not 
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increase the stability of pre-let-7a. Having said that, the maintained 
expression of Lin28a in differentiated P19 cells not only led to the 
formation of poly-uridylated pre-let-7a but also strongly supported its 
destabilisation. These opposing states clearly indicate that uridylation of 
pre-let-7a is sufficient to trigger its destabilisation and that pre-let-7a could 
also be degraded non-specifically in vitro with other RNA nucleases. 
Analysis of mature let-7a levels in Lin28a’s loss-of-function and gain-of-
function in P19 cells supported the possibility of pre-let-7a non-specific 
degradation in vitro. The knockdown of Lin28a ultimately resulted in 
increased let-7a levels. On the other hand, constitutive expression of 
Lin28a or induction followed differentiation greatly supress the expression 
of mature let-7a. These findings recapitulated previous observations 
regarding the effect of Lin28a on mature let-7. At least two groups 
previously reported that Lin28a knock down ultimately leads to increase 
let-7 levels (Heo et al., 2008; Piskounova et al., 2011). Moreover, Balzer and 
colleagues also showed that constitutive expression of Lin28a:GFP fusion 
protein in P19 cells resulted in strong inhibition of let-7 production during 
neuronal differentiation in vitro (Balzer et al., 2010).  
 
Lin28a belongs to small set of proteins that when combined efficiently can 
promote pluripotency (Yu et al., 2007). Interestingly, it is the only protein 
which is not a transcription factor from the group of pluripotency factors. 
However, because Lin28 is expressed in broad range of tissues, it could 
potentially play a role beyond pluripotency maintenance (Yang and Moss, 
2003; Yokoyama et al., 2008). Balzer and colleagues suggested that Lin28 
could act as a fate-promoting factor (Balzer et al., 2010). They showed that 
prolonged expression of Lin28a during neurogliogenesis primed cells to 
favour earlier occurring neurogenesis over late occurring gliogenesis. 
They suggested that Lin28 arbitrated the switch between neuro-glia fates 
could account for the two independent modes of Lin28 action that depend 
on the activity of CSD and ZnFD (RNA binding domains). (Balzer et al., 
2010). Furthermore, they showed that the repression of let-7 correlated 
with the inhibition of gliogenesis. However, its low mature levels did not 
inhibit neurogenesis, as observed during the differentiation of the 
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Lin28a:GFP and Lin28b:GFP stable cell lines (Balzer et al., 2010). My 
results with P19 stable cell lines further supported Balzer and colleagues 
findings. I observed the occurrence of neurogenesis despite constitutive 
expression of Lin28a:GFP fusion protein. The cells differentiated normally 
presenting embryonic bodies of a size similar to P19:GFP embryonic 
bodies. Importantly, Lin28a:GFP stable cells favoured neuronal 
differentiation events but did not allow for the accumulation of high let-7a 
levels. This is a striking finding, as during development, low let-7 levels 
are generally associated with less efficient differentiation and large 
quantities of let-7 were shown to promote differentiation (Roush and 
Slack, 2008). What is more, several groups reported a link between high 
let-7 levels and neuronal differentiation (Rybak et al., 2008; Wulczyn et al., 
2007). These dissonant findings might suggest that low let-7 levels permit 
neuronal differentiation in certain cellular systems. One potential 
explanation is the lack of lineage specificity observed during the global 
differentiation of P19 cells. The nervous system of higher vertebrates is 
extremely complex and contains various groups of neurons that can be 
differentially grouped based on their anatomical characteristics or 
functional output (Peters, 1984; Ramón y Cajal, 1995). Therefore, it would 
be interesting to test the role of Lin28 and let-7 in the differentiation of 
specific neuronal lineages. Fast development of stem cell research 
nowadays allows for their very specific differentiation. There have been 
methods describing the differentiation of induced pluripotent stem cells 
into dopaminergic neurons, ventral motoneurons, retinal neurons, etc. 
(Schwartz et al., 2008). Alternatively, the development of an animal model 
with knock-in expression of Lin28a in the brain would allow these 
lineages to be tracked within their native environment and the role of let-7 
in their development to be assessed. 
The major finding of my thesis is that unlike constitutive expression of 
Lin28a:GFP, constitutive expression of untagged Lin28a blocked neuronal 
differential progression. This finding further supported the hypothesis 
suggested by Balzer and colleagues that two distinctive pathways control 
gliogenesis and neurogenesis. Not surprisingly, untagged protein also 
supported the repression of let-7 observed in the Lin28a:GFP cell line. This 
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strongly suggests the existence of additional factors affected by untagged 
Lin28a that regulate neuronal differentiation. Moreover, phenotypic 
differences between Lin28a:GFP and  untagged Lin28a observed during 
differentiation of P19 stable cells also suggest that neurogliogenesis is 
controlled by two genetically distinctive pathways and that Lin28a 




6.2   miR-9 levels are regulated both transcriptionally and 
post-transcriptionally 
 
miR-9 is a very ancient miRNA that dates back to the transition toward 
triploblast with functions and set of targets that encountered substantial 
changes during the evolution of bilatera (Wheeler et al., 2009). Throughout 
the evolution of various species, miR-9 proved to be involved in processes 
related to neuronal development by employing mechanisms based on 
opposing strategies. For instance, in Drosophila, miR-9 sensory precursors 
(SOP) are specified in two-step process (Skeath and Carroll, 1994). In the 
first step, groups of cells acquire pre-neuronal competence. In the second 
step, one of these cells become SOP as a consequence of lateral inhibition 
mediated by non-SOP neighbours. Interestingly, miR-9 plays an indirect 
role in specifying SOP cell by being restricted to non-SOP and arbitrating 
lateral inhibition processes (Li et al., 2006). However, in higher vertebrates 
miR-9 has been directly linked with neuronal development. At first, the 
genome-wide profiling of miRNA classifies miR-9 as a brain-enriched 
miRNA (Krichevsky et al., 2003; Lagos-Quintana et al., 2002). 
Furthermore, its expression profiling suggests that miR-9 is dynamically 
regulated throughout neuronal differentiation (Miska et al., 2004; Sempere 
et al., 2004). It has been shown that the expression of miR-9 is switched on 
during mid-embryogenesis after the development of the neuronal scaffold 
and is associated with active neurogenic areas (Coolen et al., 2012; Darnell 
et al., 2006; Walker and Harland, 2008). MiR-9 is generally excluded from 
brain regions containing undifferentiated neuronal progenitors or from 
areas with late differentiation onset, midbrain-hindbrain region or retina, 
respectively (La Torre et al., 2013; Leucht et al., 2008).  
For these reasons, miR-9 is a perfect candidate to play an essential role in 
the neuronal differentiation of P19 cells. My experiments showed that the 
expression of both primary and mature miR-9 does not occur in 
undifferentiated P19 cells, but only in differentiating neurones. This 
observation of the delayed expression of miR-9 is consistent with the 
differentiation of hESC and rat neuronal progenitors (Delaloy et al., 2010). 
Transcription of the miR-9 precursor has been previously studied in 
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human neuroblastoma derived SK-N-BE cell line (Laneve et al., 2010). 
Laneve and colleagues showed that pri-miR-9-2 transcription does not 
depend on its host gene and is linked to the regulatory elements REST and 
CREB. REST, as a chromatin remodelling factor, regulates several 
neuronal genes, whereas CREB was shown to be involved in several 
neuronal functions, including neuronal proliferation and differentiation 
and synaptic plasticity (Impey et al., 1996). In undifferentiated cells, the 
association of unphosphorylated CREB and REST directly blocks 
transcription of miR-9 primary transcripts. During the differentiation, 
REST expression levels drop and CREB undergoes phosphorylation, 
which causes its activation, subsequently leading to the removal of pri-
miR-9 transcription blockage (Laneve et al., 2010). It would be interesting 
to determine whether the REST/CREB mechanism operates in the same 
manner in P19 cells as in the SK-N-BE model. It could be performed using 
ChIP and luciferase reporter assays.  
 
Importantly, I found a substantial delay between the expression of mature 
miR-9 and pri-miR-9 during the differentiation of P19 cells. In particular, I 
observed that early after the start of differentiation, only 10% of pri-miR-9 
was processed into mature miRNA. This observation indicated additional 
layers of post-transcriptional control of miR-9 production. In fact, I was 
able to uncouple transcriptional and post-transcriptional events with in 
vitro processing assays, which showed that pri-miR-9 is more efficiently 
processed in differentiated than in undifferentiated cells. Moreover, I 
showed that this post-transcriptional regulation is linked to the terminal 
loop of pri-miR-9. Indeed, terminal loops have been shown in the past to 
play an important role in the processing of at least pri-let-7, pri-miR-7 or 
pri-miR-18a. It has been discovered that terminal loops are platforms for 
binding auxiliary factors such as Lin28a/KSRP, HuR/Msi2 or hnRNPA1 
(Michlewski and Caceres, 2010; Michlewski et al., 2008; Piskounova et al., 
2008). Following these examples, I used RNA pull-down assays coupled 
with quantitative mass spectrometry to identify factors that had the 
potential to specifically interact with pre-miR-9 CTL (Conserved Terminal 
Loop) in undifferentiated cells. Surprisingly, one of the most potent 
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protein interactors turned out to be Lin28a. Using the same strategy, I 
identified Lin28a to interact with pre-let-7a, but I could not validate its 
interaction with TuT4 protein (Piskounova et al., 2011). Potentially, this 
was an effect of its transient interaction with pre-let-7 and therefore 
further optimisation of capture conditions could help to eliminate this 
issue.   
 
To date, several studies have used UV crosslinking and 
immunoprecipitation coupled with high-throughput sequencing (CLIP-
seq) to identify targets for Lin28a binding (Cho et al., 2012; Wilbert et al., 
2012). However, these studies focused on undifferentiated embryonic stem 
cells and somatic cells, which could possibly result in an incomplete 
identification of Lin28a targets. Especially when these targets display a 
spatio-temporal expression pattern depending on the cell type or 
developmental timing. In my studies, using retinoic acid-induced P19 
cells, I managed to capture physiologically relevant roles of Lin28a in the 
context of neuronal differentiation. I validated high-throughput pull-
down and mass spectrometry findings and proved that pri-miR-9-CTL 
interacts specifically with Lin28a in undifferentiated cells. I also proved 
that Lin28a has a role in restricting miR-9 production to the later stages of 
neuronal differentiation. In the past, it has been shown that the depletion 
of Lin28a de-repressed let-7 levels in embryonic stem cells (Viswanathan 
et al., 2008). I applied a similar strategy and succeeded in showing that the 
knockdown of Lin28a resulted in increased miR-9 levels in differentiating 
P19 cells. However, an increase in miR-9 was approximately less than 3-
fold when compared to let-7. This could be explained by the difference in 
the levels of primary transcripts between the two miRNAs. As mentioned 
above, pri-miR-9, in contrast to pri-let-7a, is not transcribed due to 
REST/CREB blockage in undifferentiated cells (Laneve et al., 2010). 
Therefore, this delay in pri-miR-9 production when compared with pri-let-
7 could have directly translated to the differences in de-repression of miR-
9 and let-7. It would be interesting to test whether this discrepancy could 
be erased by providing equal levels of primary transcripts of let-7 and 
miR-9. One way of achieving that could involve providing higher levels of 
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pri-miR-9 in undifferentiated P19 to match levels of pri-let-7 by transient 
transfection or the generation of stable cell lines expressing pri-miR-9 
independently from REST/CREB repressors.  
 
In addition, the poor match between let-7 and miR-9 induction could be a 
result of the presence of Lin28b. It is possible that their precursors respond 
differentially to Lin28a and Lin28b. Therefore, the depletion of Lin28a is 
sufficient to increase of let-7 levels but is not sufficient to provide enough 
background for miR-9 induction. In the future, it would be interesting to 
compare the increase in miR-9 levels upon double Lin28a and Lin28b 
knockdown.  
 
The most interesting result of my thesis came from the analysis of Lin28a 
gain-of-function experiments. As described above, let-7 levels were 
repressed in differentiated cells carrying constitutively expressed 
Lin28a:GFP or untagged Lin28a. However mature miR-9 levels were only 
down-regulated in P19 lines expressing untagged Lin28a and were not 
affected by the constant expression of Lin28a:GFP fusion protein.  This is 
of particular interest as the repression of let-7 was not sufficient for the 
inhibition of neurogenesis. Moreover, I observed that down-regulation of 
mature miR-9 level by constitutive expression of Lin28 was associated 
with a morphological phenotype. Developing embryonic bodies presented 
significantly smaller size than their counterparts obtained from control 
P19 cell lines as well as the Lin28a:GFP cell line. This finding is in 
agreement with a previous study of Delaloy and colleagues. They found 
that direct blocking of miR-9 activity using locked-nucleic acid strategy 
resulted in the formation of much smaller neurospheres upon 
differentiation of human embryonic stem cells and rat primary cortical 
progenitors (Delaloy et al., 2010). Furthermore, they suggested that miR-9 
is important at early stages of neurosphere formation for the maintenance 
of a pool of neuronal progenitor cells by limiting their migration and 
promoting proliferation. This action of miR-9 was linked to stathmin – its 
molecular target, which was shown to affect these cellular processes 
(Delaloy et al., 2010). That said, the exact role of miR-9 in the early stages 
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of neuronal differentiation is still not fully understood, especially as a 
reduction in the differentiation rate and an increase in proliferation have 
been observed upon miR-9 loss-of-function studies in embryonic neuronal 
progenitors or adult neural stem cells (Bonev et al., 2011; Coolen et al., 
2012; Shibata et al., 2011).  
 
These discrepancies could suggest that the execution of miR-9 functions 
depends on the developmental stage of cells, and that this could be 
accounted for miR-9 distinctive spatio-temporal regulation of its mRNA 
targets. Therefore, stage-specific analysis of miR-9 targets would help to 
build a more accurate model of miR-9 function during neuronal 
differentiation. Equally important to miR-9 loss-of-function study is 
analysis of the mature miR-9 overexpression phenotype. It was shown that 
miR-9 gain-of-function leads to reduced proliferation in zebrafish embryo 
or mouse embryonic cortex and promotes differentiation of neuronal 
progenitors (Leucht et al., 2008; Zhao et al., 2009). In the future, it would 
be interesting to determine whether an increase in mature miR-9 levels in 
P19 cells would result in an increase in their differentiation upon retinoic 
acid priming. This could be determined by delivering miR-9-5p/-3p 
duplexes into differentiating P19 cells or expressing a pri-miR-9 mutant 
with the ability to escape transcriptional and post-transcriptional 
regulatory mechanisms.  
 
My results demonstrated that the terminal loop of pri-miR-9 is an 
important element for association with factors involved in post-
transcriptional regulation of its biogenesis. Therefore, I attempted to test 
this role of the terminal loop by overexpressing pri-miR-9 and pri-let-7a 
mutants that could be transcribed independently of the differentiation 
state and escape post-transcriptional blockage. Overexpression of pri-let-
7a/miR-16-CTL mutant in undifferentiated P19 cells resulted in strong de-
repression of let-7a levels. Unfortunately levels of mature miR-9 did not 
change upon transfection with the pri-miR-9/miR-16-CTL mutant 
suggesting additional layers of miR-9 regulation, possibly affecting the 
stability of mature miR-9. Potential regulation via the stability of miR-9 
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will not be a great surprise as several examples describing the molecular 
mechanisms affecting the stability of mature miRNAs have been reported. 
For example, in C. elegans 5’-3’ exonucleases XRN1 and XRN2 were shown 
to degrade a variety of miRNAs (Chatterjee et al., 2011; Chatterjee and 
Grosshans, 2009). In mammals, an unknown exonuclease is involved in 
the degradation of miR-183, miR-96, miR-192, miR-204 and miR-211 (Krol 
et al., 2010a). Degradation of mature miRNA was also reported in 
pathological conditions. In melanomas, interferon-inducible 3’-5’ 
exonuclease PNPase-old-35 (PNPT1) is involved in the degradation of 
miR-221, miR-222 and miR-106 (Das et al., 2010). 
 
I further proved that this potentially additional mechanism was specific to 
P19 undifferentiated cells, as overexpression of similar mutants in HeLa 
cells resulted in de-repression of the processing of both pre-let-7a/miR-16 
and pre-miR-9/miR16 terminal loop mutants. HeLa cells are not primed to 
undergo neuronal differentiation and do not express endogenous Lin28a. 
Thus, the above observation is important for two reasons. First, it shows 
that additional mechanisms controlling levels of miR-9 are operating in 
P19 undifferentiated cells. Second, it also indicates that Lin28a-mediated 
post-transcriptional mechanism controlling miR-9 production is 
independent from a differentiation state of the cell. However, it would be 
interesting in the future to establish P19 stable cell line expressing pri-
miR-9/miR-16-CTL mutant and determine whether this additional 
putative post-transcriptional blockage is associated with certain stages of 





6.3   Lin28a regulates pre-miR-9 stability in a uridylation-
independent manner 
 
The current understanding of transcription events occurring in humans 
and yeast suggest that their entire genome operates as a huge RNA factory 
(Amaral et al., 2008). Therefore, proper surveillance machinery allows for 
the rapid and precise selection of functional RNA molecules (Houseley 
and Tollervey, 2009). These processes are especially prevalent and 
important for the biology of non-coding RNA. For example, transcribed 
miRNA precursor has to undergo two steps of maturation before stable 
mature miRNA is generated. Within the time of maturation, both pri-
miRNA and pre-miRNA could be rapidly degraded as a result of 
mechanisms that monitor subcellular miRNA levels. In fact one of the 
oldest and most well-studied human miRNAs, let-7, employs this 
surveillance machinery to control its levels in cells (Viswanathan et al., 
2008). 
 
In my PhD work, I suggested that the production of miR-9 relies on post-
transcriptional control of pre-miR-9 stability. Using the P19 differentiation 
model, I showed that pre-miR-9 is highly unstable in cell extracts derived 
from undifferentiated cells and gradually becomes stabilised during the 
time course of neuronal the differentiation. Interestingly, I observed that 
this effect is independent of uridylation as no higher molecular weight 
intermediate was detected. This finding is particularly interesting in light 
of the recent work by Lim and colleagues. Using a genome-wide 
approach, they were able to show that mammalian mRNA molecules are 
consistently oligo-uridylated and that this process promotes their decay 
(Lim et al., 2014). This was also observed for pre-let-7, which in embryonic 
stem cells is uridylated by the Lin28/TuT4-mediated mechanism, 
followed by Dis3l2-mediated degradation (Heo et al., 2008; Heo et al., 
2009; Piskounova et al., 2011). However, Suzuki and colleagues observed 
that in cells with low Lin28a/b levels. pre-let-7 is still degraded in spite of 
the lack of uridylation. They demonstrated that the mammalian immune 
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regulator MCPIP1 ribonuclease also known as Zc3h12a mediates 
uridylation-independent degradation of pre-let-7 (Suzuki et al., 2015). 
These observations were particularly relevant to my findings. I also 
showed that Lin28a mediates the uridylation-independent degradation of 
pre-miR-9. I reported that the knockdown of Lin28a abolished the 
destabilisation of pre-miR-9 in extracts derived from undifferentiated cells. 
Furthermore, reconstitution with recombinant Lin28a is sufficient for 
restoring the degradation process. Interestingly, Lin28a:GFP fusion 
protein was not able to destabilise pre-miR-9 in differentiated cells, 
whereas untagged Lin28a was sufficient to induce the destabilisation of 
pre-miR-9, similar to that which was observed in the early stages of 
differentiation. This finding was in contrast to the in vitro processing of 
pre-let-7a, which was strongly destabilised by both Lin28a:GFP and 
untagged Lin28a. The difference observed between the in vitro processing 
of pre-miR-9 and pre-let-7a is important as its provides more support for 
previously suggested hypothesis regarding the different molecular 
mechanisms affecting neurogenesis and gliogenesis observed during 
differentiation of the P19 stable lines. These findings implied that the 
positioning of GFP at C-terminal of Lin28a interfered with its activity on 
pre-miR-9 destabilisation. Interestingly, recombinant, N-terminally tagged 
GST-Lin28a was able to destabilise pre-miR-9 after reconstitution in 
Lin28a-depleted extracts. Even though GST and GFP are different 
biological molecules, they both share a similar size. Therefore, distinct 
positioning of tags, C-terminal and N-terminal for GFP and GST 
respectively, would suggest that the mechanism of action could depend 
on Lin28a activity at its C-terminus.     
                                          
Lin28a was shown previously using genome-wide techniques to interact 
with a large number of RNAs, including mRNA and ncRNA (Cho et al., 
2012; Wilbert et al., 2012). Importantly, Lin28a, as opposed to DHX9, a 
non-specific RNA-binding protein, did not bind to pre-miR-16. 
Furthermore, interaction between Lin28a and pre-miR-9 was abolished 
after its conserved terminal loop was changed to the terminal loop of pre-
miR-16. Significantly, the pre-miR-9/miR-16-TL mutant was not 
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destabilised by Lin28a in undifferentiated cells. These results prove that 
Lin28 interacted in a specific manner with pre-miR-9-CTL.  
RNA molecules are known to form large multimeric complexes with 
various proteins, for instance Drosha/DGCR8 or RISC complexes. 
Therefore, it was important to establish whether the interaction between 
Lin28a and pre-miR-9 is direct. Using whole cell extract and recombinant 
protein, I showed that Lin28a was able to shift pre-miR-9, which 
demonstrated its capacity to directly interact with pre-miR-9. 
Interestingly, I observed that two prominent protein complexes are 
formed with pre-miR-9 as opposed to one discrete complex with pre-let-
7a. Interestingly, previous structural studies of pre-let-7a and Lin28a 
suggested that Lin28a interacts with two or even possibly three distinct 
sequence motifs within the terminal loop of pre-let-7 (Desjardins et al., 
2014; Loughlin et al., 2012; Nam et al., 2011). Moreover, recent findings 
suggested also that Lin28a likely undergoes stepwise assembly on pre-let-
7-CTL, as 1:1, 1:2 and 1:3 complexes were observed (Desjardins et al., 
2014). Furthermore, the association of one or more Lin28a molecules could 
modulate its activity. Desjardins and colleagues demonstrated that a 1:1 
complex of pre-let-7g/Lin28a is sufficient for maximum dicer inhibition, 
whereas for pre-let-7a, maximum inhibition was observed in the case of a 
1:3 complex (Desjardins et al., 2014). Surprisingly, in my EMSA assay with 
recombinant Lin28a:GST, I did not observe the efficient assembly of 
multimeric Lin28a molecules on pre-let-7a terminal loop. This was 
potentially a consequence of either protein concentration below saturation 
levels suggested in Desjardins and colleagues’ work or the presence of 
GST at the N-terminus of Lin28a, which could interfere with step-wise 
assembly.  
Therefore, these findings could mean that pre-miR-9 can also associate 
with more than a single molecule of Lin28a. However, I showed that in the 
case of two complexes formed upon pre-miR-9 incubation with whole cell 
extracts, only the one with the lower molecular weight was displaced with 
Lin28a-specific antibody. This observation is important for two reasons. 
Firstly, the complete disappearance of a lower MW band reinforced the 
fact that Lin28a directly interacted with pre-miR-9. A potential 
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explanation for the observed phenomena could be that the antibody 
sequestered Lin28a and buried the pre-miR-9 interaction site, which 
subsequently prevented the formation of the pre-miR-9/Lin28a complex. 
Nevertheless, if pre-miR-9/Lin28a interaction is mediated by an 
additional protein, then the displacement of Lin28a would result in a 
moderate shift of one of the observed discrete bands rather than its 
complete disappearance. The second important reason is that the higher 
MW band was not displaced in the presence of the Lin28a-specific 
antibody. The model of step-wise assembly of Lin28a suggested by 
Desjardins and colleagues indicates that each molecule of Lin28a interacts 
with pre-let-7 independently (Desjardins et al., 2014). For that reason, 
every additional molecule of Lin28a present on pre-miR-9 should be 
displaced by Lin28a antibody in similar manner. Therefore, the observed 
higher MW should be counted as the assembly of pre-miR-9 in some other 
tertiary complex that potentially contain Lin28a together with other 
proteins.  
 
My findings also suggest that Lin28a associates with pre-miR-9 engaging 
only one of its two RBDs. I showed computationally that pre-miR-9 folds 
into the hairpin structure containing a much smaller terminal loop in 
comparison to its counterpart on pre-let-7a, which is capable of interacting 
with both of Lin28a domains at the same time (Loughlin et al., 2012; Nam 
et al., 2011). Two motifs within pre-miR-9-CTL that could potentially bind 
Lin28a are in close proximity to each other. Such presentation of the motifs 
would require the RBDs in close proximity if Lin28a:pre-miR-9 interaction 
was mediated by both of the domains at the same time. This type of 
arrangement would very likely force great tension inside the Lin28a 
backbone which is why it is unlikely that pre-miR-9-CTL interacts with 
both RBDs at any given moment. In fact, using footprinting cleavage assay 
I showed that Lin28a associates pre-let-7a with both characterised 
previously motifs within its terminal loop (Desjardins et al., 2014; 
Loughlin et al., 2012; Nam et al., 2011). However, footprinting with Lin28a 
and pre-miR-9 showed that protected nucleotides were located upstream 
from its consensus “GGAG” motif. Moreover, I showed that “GGAG” 
 164 
mutants of pre-miR-9-CTL escaped Lin28a-mediated regulation 
suggesting that this region of the loop is functionally redundant regarding 
the interaction with Lin28a. I also showed using Lin28a truncations that 
both domains were capable of interacting with their characterised motifs 
within the loops of pre-miR-9 and pre-let-7a. However, I observed 
substantial differences between their binding efficiency when presented 
independently from each other. Lin28a-ZNF(123-209) mutants interacted 
substantially stronger with pre-let-7a than with pre-miR-9 when 
compared to full length Lin28a interaction with the corresponding pre-
miRNAs. The observed increase in binding efficiency in the case of pre-let-
7a could potentially be explained by the step-wise assembly model 
(Desjardins et al., 2014). It is quite possible that the ZNF domain when 
presented independently could assemble the multimeric pre-let-7a/Lin28a 
complex more efficiently than in context together with CSD. However, 
more detailed biophysical characterisation of Lin28a-ZNF(123-209) in 
complex with pre-let-7a should follow to allow the more accurate 
interpretation of this finding. Interestingly, both zinc-knuckles are 
required for efficient binding to both pre-let-7a and pre-miR-9-1. Lin28a-
ZNF(156-209) mutant failed to bind pre-let-7a and associated very weakly 
with pre-miR-9. It is likely that zinc-fingers within Lin28a are presented in 
a structural context that allows the efficient interaction with specific 
sequence motifs. Disruption of this structural arrangement likely results in 
a loss of activity of the ZNF domain of Lin28a. In fact, there are few 
examples of domains where individual elements have to be presented in 
certain structural arrangements to retain functional activity. One of these 
examples is the arrangement of WD40 domains. In the normal situation, 
they are presented in proteins as a run of 7-8 repeats that form well 
defined β-propellers. The removal of individual WD40 domains breaks the 
arrangement and results in a loss of functional activity of WD40 domains 
(Smith et al., 1999). 
 
Nevertheless, the most striking observation was in the case of Lin28a-
CSD(1-74) and Lin28a-CSD(1-123) mutants. I showed that both mutants 
had very low binding efficiency with pre-let-7a. However, their binding 
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efficiency to pre-miR-9 was 2-3-fold higher than to pre-let-7a. These 
observations suggest that in the case of pre-miR-9, a cold shock domain 
might be sufficient to mediate the formation of a pre-miR-9/Lin28a 
complex. Importantly, this possibility remains in agreement with 
footprinting and mutational analysis. Both showed that ZNF domain 
consensus motif, “GGAG”, is not relevant in the case of pre-miR-9 for 
Lin28a function and binding. Together, these findings allow speculation 
that the ZNF domain remains unoccupied following binding to the pre-
miR-9 terminal loop and could be important for interactions with putative 
downstream effectors that lead to destabilisation of pre-miR-9 observed in 
undifferentiated P19 cell extracts. 
 
To date, many different pathways for RNA degradation have been 
proposed (Houseley and Tollervey, 2009). RNA nucleases are especially 
relevant for the biology of miRNAs as they control various stages of their 
biogenesis (Ha and Kim, 2014). In particular, certain pre-miRNAs could be 
degraded by MCPIP1 and IRE1α endonucleases, whereas mature miRNAs 
stability is controlled by the activity of XRN1 and XRN2 exonucleases 
(Chatterjee et al., 2011; Ramachandran and Chen, 2008; Suzuki et al., 2011; 
Upton et al., 2012). I showed that pre-miR-9 is actively destabilised in 
undifferentiated P19 cells in the process dependent on Lin28a association 
with its conserved terminal loop (Nowak et al., 2014). Importantly, Lin28a 
can only play a role of an adaptor protein as it lacks nuclease activity. 
Following RNAi experiments with selected RNA nucleases, I found that 
Dis3l2 knockdown resulted in a modest but significant 1.5-fold increase in 
miR-9 levels. This increase resembled the change of miR-9 levels observed 
upon knockdown of Lin28a. Modest change observed in Dis3l2 and Lin28a 
knockdowns can be explained with low pri-miR-9 levels during early 
stages of neuronal differentiation.  
 
The involvement of Dis3l2 in the degradation of pre-miR-9 is particularly 
interesting because I showed that its destabilisation is independent from 
uridylation, whereas the uridylation process was shown previously to be a 
prerequisite for Dis3l2 activity in context of pre-let-7 degradation (Chang 
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et al., 2013; Ustianenko et al., 2013). However, in spite of the lack of 
uridylation, I showed that Dis3l2 associates with pre-miR-9 in 
undifferentiated cells but was not able interact with non-uridylated pre-
let-7a. Moreover, I showed that this interaction is most likely mediated by 
the direct interaction of Lin28a and Dis3l2 but this remains to be further 
validated in detail. By co-immunoprecipitating recombinant Lin28a and 
Dis3l2, I showed that these proteins interact but the confidence level 
remained low in this experiment due to potential inference from a similar 
tag presented on both proteins. However, using EMSA, I showed that both 
recombinant Lin28a and Dis3l2 formed a tertiary complex with pre-miR-9. 
Furthermore, this complex was not displaced using a Lin28a-specific 
antibody, which corroborated EMSA assays performed with pre-miR-9 
and total cell extract derived from undifferentiated P19 cells. 
 
Furthermore, I showed in vitro that pre-miR-9 was stabilised upon RNAi-
mediated depletion of Dis3l2 and its degradation was restored in a 
uridylation-independent manner with the addition of enzymatically active 
recombinant Dis3l2. Interestingly, the addition of enzymatically inactive 
Dis3l2 also resulted in low-level pre-miR-9 degradation. This was in 
contrast to pre-let-7a, where the depletion of Dis3l2 resulted in 
stabilisation of the uridylated form and only the addition of enzymatically 
active recombinant Dis3l2 affected its stability. These experiments were 
performed in total cell extracts with the depletion of only endogenous 
Dis3l2. 
Therefore, this discrepancy in functionality of enzymatically inactive 
Dis3l2 between pre-miR-9 and pre-let-7a could potentially be accounted 
for the increased activity of some other unknown nuclease. Furthermore, 
using 5’-end labelling in vitro processing, I showed that 5’-end of pre-miR-
9 is unstable compared to pre-let-7a. Therefore, formation of the tertiary 
complex could cause structural rearrangements of pre-miR-9 that would 
potentially favour its 5’-3’ degradation by other exonucleases. However, 




6.4   Lin28a regulates a wide range of miRNAs during 
neuronal differentiation 
 
At least three independent studies have shown a broad scope of Lin28a 
targets genome-wide (Cho et al., 2012; Hafner et al., 2013; Wilbert et al., 
2012). Interestingly, in the majority of cases, Lin28a was shown to interact 
with mRNA, whereas snoRNA and miRNA were in the minority of the 
targets (Hafner et al., 2013). However, these studies concentrated either on 
undifferentiated embryonic stem cells or differentiated well-established 
cell models like HEK293 (Cho et al., 2012; Wilbert et al., 2012). None of the 
studies so far have attempted to capture the dynamic role of Lin28a 
throughout the differentiation in genome-wide context.  
 
Encouraged by the fact that large group of miRNAs display neurospecific 
or neuroenriched expression pattern, I performed small RNA sequencing 
analysis of RNA samples derived from P19 cells with constitutive 
expression of untagged Lin28a and Lin28a:GFP fusion protein at two 
stages of the differentiation. This strategy allowed capturing the dynamic 
role of Lin28a and Lin28a:GFP on global miRNA production. Interestingly, 
I observed that the constitutive expression of Lin28a:GFP – a uridylation 
permissive mutant, affected only a small group of miRNAs, including 
some of let-7 members. However, the constitutive expression of untagged 
Lin28a resulted in extensive changes in the miRNA profile across two 
stages of differentiation. Importantly, the levels of corresponding proteins 
were similar. I observed that levels of the large group of miRNAs that 
were predominantly unchanged by the expression of Lin28a:GFP were 
upregulated in the presence of untagged Lin28a during differentiation. 
Furthermore, I used published information about motifs that were 
previously identified in a genome-wide context to interact with Lin28a 
(Wilbert et al., 2012). Mapping these motifs to the genomic proximity of 
pre-miRNAs of the selected group of miRNAs displayed their large 
potential to interact with Lin28a. In the majority of cases, these motifs 
occupied regions were outside pre-miRNA, presumably within pri-
miRNA sequence.  
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There are examples of RNA proteins that regulate their target mRNA by 
binding sequences upstream or downstream of the transcription unit. For 
example, Roquin is known to regulate the deadenylation of mRNAs by 
interacting with constitutive decay-elements with stem-loop motifs 
usually located outside core coding sequence of the targeted mRNAs 
(Schuetz et al., 2014). Thus, it seems feasible for Lin28a to utilise motifs 
that were mapped in the proximity of pre-miRNAs sequence to stabilise 
the precursor molecule. Unfortunately, I was not able to demonstrate the 
direct involvement of Lin28a in the stabilisation of a selected group of pre-
miRNAs that were upregulated in the Lin28a-differentiated state. This 
potentially could mean that constitutive expression of Lin28a during 
differentiation indirectly leads to upregulation of these miRNAs, possibly 
by affecting other uncharacterised protein factors. Additionally, Lin28a 
might have an impact on the transcription of pri-miRNAs. In fact, I 
showed that pri-miR-155 was upregulated upon differentiation of 
P19:Lin28a line when compared to control cell lines. 
  
Alternatively, the negative results, observed in vitro, might be a result of 
Lin28b activity in the extracts. Lin28b is thought to localise inside the 
nucleolus of cells. Therefore, it is potentially sequestered from these pri-
miRNAs, where levels were upregulated and play a marginal role in their 
regulation. However, in extracts, Lin28b is no longer stored in the 
nucleolus and due to its sequence similarity to Lin28a, might play a 
redundant role in the regulation of pri- or pre-miRNA stability. Therefore, 
in the future it will be beneficial to perform similar analysis in context of 
Lin28a/b double knockdown. In fact, it has been shown in the case of pri-
miR-155 that the endonuclease MCPIP1 interacts and cleaves the terminal 
loop of the precursor miRNA (Suzuki et al., 2011). Therefore, binding of 
Lin28a or Lin28b to the pri-miR-155 terminal loop could have an opposing 
effect on the regulation of RNA destabilisation. 
 
I also performed analysis of double-stranded regions in subset of miRNAs 
precursors, levels of which were upregulated by the constitutive 
expression of Lin28a during the neuronal differentiation. Interestingly, I 
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found that their pre-miRNAs contained fewer paired nucleotides across 
the stem when compared to the global population of pre-miRNAs. This 
observation could pave the way to understand in detail the events leading 
to destabilisation of pre-miR-9 executed by Lin28a/Dis3l2. It has been 
shown that the Dis3l2 RNA entry point forms a wide funnel, allowing the 
entrance of structured RNAs (Chang et al., 2013). In the case of pre-let-7, 
the poly(U) tail was indicated to play important role in the initiation of 
pre-let-7 degradation. However, it is possible that unstructured, single 
stranded RNA might have more space inside the wide funnel and could 
potentially reach the active site of Dis3l2 utilising non-specific interactions 
and hydrolysis events, shown previously to be crucial for later stages of 
pre-let-7 degradation (Chang et al., 2013).  
 
Lin28a association with the terminal loop of pre-let-7g leads to the 
subsequent dissociation of the double-stranded region in the proximity of 
its binding (Lightfoot et al., 2011). Using computational modelling and 
structure probing, I revealed that pre-miR-9 is less structured. Therefore, 
the association of Lin28a might lead to the dissociation of not only a small 
double-stranded region around its binding site, but could be propagated 
across the entire pre-miRNA hairpin, leading to relaxed RNA 
conformation. Association of Dis3l2 could further propagate this effect 
and subsequently this unstructured pre-miR-9 could be in the final step 
targeted for uridylation-independent degradation. Further structural and 
biophysical characterisation of the pre-miR-9/Lin28a/Dis3l2 complex 
should allow to its molecular mode of action to be unravelled. 
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6.5   Biological implications of Lin28a regulation of miR-9 
production 
6.5.1   Role in neuronal development 
 
Highly evolutionarily conserved miR-9 was shown to be involved in 
various biological processes associated with the central nervous system 
(CNS). For example, it was shown to control microglia inflammatory 
response in CNS by down-regulating monocyte chemotactic protein- 
induced protein 1 (MCPIP1), a crucial component of an activation 
pathway (Yao et al., 2014). Simultaneously, miR-9 is known to play an 
important role in shaping the development of the nervous system. It was 
previously shown to control cellular pathways defining sensory organs in 
Drosophila (Li et al., 2006) or structuring the midbrain-hindbrain barrier 
in zebrafish (Leucht et al., 2008). The role of miR-9 in mammals was 
directly linked to the regulation of progenitor fate. In particular, its 
expression was shown to be associated with active neurogenic areas and 
excluded from regions destined to contain undifferentiated progenitors for 
an extensive amount of time, like the midbrain-hindbrain boundary or 
ciliary marginal zone (Coolen et al., 2012; Kapsimali et al., 2007; Leucht et 
al., 2008). Also, gain-of-function studies showed that the expression of 
miR-9 and miR-124 led to reprogramming of adult fibroblasts into neurons 
(Yoo et al., 2011). Interestingly, miR-9 downregulation increased the 
proliferation of progenitor cells, but only temporarily as the cell 
differentiation was reversed after a certain amount of cell cycles (Coolen et 
al., 2012; Shibata et al., 2011). Altogether, these observations suggest that 
miR-9 is not a master regulator of differentiation fate, but acts as switch 
promoter favouring the transition of progenitors from a proliferative to 
neurogenic mode. Therefore, all major findings of my thesis corroborate 
with previously suggested functions of miR-9. During neuronal 
differentiation, miR-9 levels are controlled by a two-step mechanism. In 
the first step, chromatin co-repressor factors alter the epigenetic landscape 
of the genome, promoting the expression of many neurogenic genes. 
These events include REST/CREB orchestrated regulation of pri-miR-9 
transcription (Laneve et al., 2010). In the second step, Lin28a acts as a 
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surveillance mechanism, allowing the production of miR-9 only at the 
eligible developmental timing, ensuring proper progression of the 
neuronal differentiation steps.  
 
6.5.2   Role of Lin28a and miR-9 in neuropathies 
 
Evolution placed miR-9 in the central point of the switch controlling the 
proliferation and differentiation modes of progenitor cells. This is not 
surprising as its role is associated with development of brain cancers, 
including meduloblastomas (MB), the most frequent paediatric brain 
cancers originating from cerebellar progenitors, and glioblastomas (GB), 
the most common and aggressive form of adult brain cancer. In MB, levels 
of miR-9 were shown to be reduced compared to the surrounding 
samples. Furthermore, in cell lines originating from MB, the down-
regulation of miR-9 resulted in an increased proliferation rate of the cells 
(Ferretti et al., 2009). In contrast, in samples extracted from GB, elevated 
levels of miR-9 were observed (Schraivogel et al., 2011). Interestingly, a 
reduction of miR-9 in primary cell cultures derived from GB resulted in 
the inhibition of their self-renewal potential (Schraivogel et al., 2011). 
Abnormal miR-9 levels were also found in neurodegenerative disorders. 
In particular, its levels were down-regulated in the brain of Alzheimer 
patients and up-regulated in the cortex of patients with Parkinson disease 
(Cogswell et al., 2008; Hebert et al., 2008; Kim et al., 2007). In addition, 
miR-9 was also associated with the progression of amyotrophic lateral 
sclerosis (ALS), a disorder of the motor neurons. In particular, miR-9 
levels were down-regulated in a mouse model of motoneuron disorder 
and ectopic expression of miR-9 can reduce levels of neurofilament heavy 
subunit, a major cause of neurodegenerative symptoms (Haramati et al., 
2010).  
 
For these reasons, understanding the molecular mechanism regulating 
production of miR-9 is very important and can lead towards designing 
novel therapeutic strategies. For instance, in the case of ALS and MB, it 
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would be interesting to determine using mouse models whether Lin28a 
activation is accompanied by miR-9 down-regulation. If so, delivering pre-
miR-9/miR-16-TL mutants could result in increased levels of mature miR-
9 and subsequently ameliorate disease symptoms. On the other hand, the 
information obtained from molecular analysis of Lin28a and pre-miR-9-
CTL could help to design a CRISPR-based tethering assay to bring Dis3l2 
to pre-miR-9 and subsequently prime it for degradation. This tethering 
approach could be used to reduce the growth of GB and the addition of an 





6.6   Closing remarks  
  
In my PhD project, I determined that the biogenesis of brain-specific miR-
9 is controlled both transcriptionally and post-transcriptionally. I showed 
that its post-transcriptional regulation is based on a mechanism that relies 
on pre-miR-9 destabilisation in the early stages of neuronal differentiation. 
Furthermore, I showed that Lin28a protein associates with the terminal 
loop of pre-miR-9 and in uridylation-independent mode leads to the 
association of Dis3l2, which targets pre-miR-9 for degradation (Figure 6-2). 
Importantly, I showed that lower miR-9 but not let-7 levels are associated 
with abnormal neuronal differentiation. Furthermore, using a genome-
wide approach, I demonstrated that Lin28a dynamically regulates 
numerous miRNA during neuronal differentiation. Interestingly, mature 
levels of a subset of regulated miRNAs are upregulated during 
differentiation in the presence of Lin28a.  
 
Figure 6-2 Model of Lin28a mechanism destabilising pre-miR-9 in early 
stages of neuronal differentiation 
Lin28a associates with the pre-miR-9 terminal loop and in the uridylation-
independent mode leads to association of 3’-5’ Dis3l2 exonuclease that 
subsequently mediates pre-miR-9 degradation. 
 
Several questions remain unanswered and require detailed analysis to 
obtain better picture of Lin28a function in the regulation of miR-9 and 
other miRNAs. Firstly, co-crystal or NMR structural analysis should be 
performed to determine in detail the molecular architecture that supports 
the formation of a Lin28a/Dis3l2 tertiary complex and the degradation of 
pre-miR-9. Furthermore, precise analysis upon clear Lin28a/b knockdown 
or knockout should be performed to determine whether the role of Lin28 
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Appendix	  A	  –	  List	  of	  primers	  and	  antibodies	  
Taq polymerase T7 template primers 
Pre-miR-9-Fw TAATACGACTCACTATAGGTCTTTGGTTATCTAGCTGTA 
Pre-miR-9-Rv ACTTTCGGTTATCTAGCTTTA 











Mature let-7a F_qRT TGACAGCACGTAAATATTGGCG 
Mature miR-21 F_qRT TAGCTTATCAGACTGATGTTGA 
Mature miR-124 F_qRT TAAGGCACGCGGTGAATGCC 
Mature miR-9 F_qRT TCTTTGGTTATCTAGCTGTATGA 
Mature miR-302a F_qRT TAAGTGCTTCCATGTTTTGGTGA 
Mature miR-101 TACAGTACTGTGATAACTGAA 
Pri-let-7a Fw CAGGAAATGAAACCACAGCA 
Pri-let-7a Rv CCTCCTCGGTAATCCTGGTT 
Pri-miR-16 Fw TGGGGTTCGATCTTAACAGG 
Pri-miR-16 Rv TGTCACGATGGTAGGCAAAA 
Pri-miR-124 Fw TCCTCCTCCTAGTCCCCTTC 
Pri-miR-124 Rv CTGCAGCTCCAGACAATGAA 
Pri-miR-9 Fw TTCGGTCTCTGTCGTGTCTG 
Pri-miR-9 Rv AAGGGACACGAGTGGAGTTG 
Pri-miR-302a Fw TTCTGGAGGAGAACACGAATC 
Pri-miR-302a Rv TGAGGAGAAAGAAAACAAAATGG 
Pri-miR-101 Fw  CTTCCTGCCCTGAGTTTCGT 
Pri-miR-101 Rv CACAGCTGCCTGAGAGTCAA 
Pri-miR-9-1 Fw GGAGCCTTTCCACTAGCA 
Pri-miR-9-1 Rv AGGTCGGAATCTAGGCTGAAACCAAGC 
Pri-miR-9-2 Fw AGCTTGCTGCACCTTAGTCT 
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Pri-miR-9-2 Rv TGTGTGCGGCTAGAACATCC 
Pri-miR-9-3 Fw CCATTGTAAGGCTGGGTGGT 
Pri-miR-9-3 Rv CTCCTCTCGCAGGCTAATCG 
Pri-miR-124-1 Fw GGAAACGAAAGGATGCGGGA 
Pri-miR-124-1 Rv GGGAACGCGATGAGCTAAGG 
Pri-miR-124-2 Fv TGGGTTTTAGGTGCGCTGTA 
Pri-miR-124-2 Rv ACTCCCACCTCAGCTTTCCT 
Pri-miR-124-3 Fw CTCTGCACCCGTCAGAAGAC 
Pri-miR-124-3 Rv CAACTCCGAGGAGCCAGTTT 





Terminal loop sequences – RNA chromatography 
miR-9_TL UAUGAGUGGUGUGGAGUCUUCAU 
miR-124_TL CCUUGAUUUAAAUGUCCAUACAA 
Lin28a truncations primers 
hLin28a_1_XbaI_Fw TTTCTAGAATGGGCTCCGTGTCCAACCAGCGTTT
G 
 hLin28a_190_BamHI_Rv TTGGATCCTCAGTAGGTTGGCTTTCCCTGTGCACTAGGG 












Antibody Supplier Dilution 
Anti-Rabbit IgG HRP linked  Cell Signalling Technology 1:1000 
Lin28 (A177)  Cell Signalling Technology 1:1000 
Lin28a(Ab46020)  Abcam 1:2000 
Msi1 (N3C3)  GeneTex 1:1000 
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hnRNP A1 (D21H11)  Cell Signalling Technology 1:1000 
Exosc3 Abcam 1:2000 
GFAP Sigma Aldrich 1:500 
β-tubulin III (Tuj1) GeneTex 1:50000 
α-tubulin Sigma Aldrich 1:50000 
Dis3l2 Custom Made 1:1000 
 
